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Abstract
Peptide-based Molecular Motor Design
Lara Siobha´n Rebecca Small
This thesis concerns the use of dimeric coiled-coil peptides as components for synthetic
protein motors. Studies of the hub structures of two motor designs are described.
Firstly, I discuss experiments on the interactions between peptides designed for use in
the Tumbleweed hub [1], a three-legged motor design containing three dimeric coiled-
coil domains. Biophysical characterisation is carried out, including experiments to test
the specificity of the interactions, which enable the peptides to be successful potential
components for a stable hub structure.
Secondly, I discuss the design of another motor hub, with two coiled-coil domains, using
similar peptides to those used in the Tumbleweed system. The requirements for this design
to produce a progressive motor are discussed. The design requires one peptide spanning
the length of the motor hub, which has residues involved in both coiled-coil domains. These
two coiled coil-contributing regions are linked by a central span of residues. Inducing a
conformational change in this central region, in order to change the dimensions of the
hub, is investigated, with the introduction of an azobenzene moiety in its cis and trans
isomeric forms, using MD simulations. The ability of various residues to affect the range
of conformational states this central region occupies is also investigated. Experimental
studies of one of the possible systems are outlined and analysed.
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Chapter 1
Introduction
This thesis discusses research into the use of designed coiled-coil peptides as motor compo-
nents. The introductory chapter, therefore, initially covers natural motors, the inspiration
for such work, their hierarchy of structure and function, and their features that are desir-
able to reproduce through synthetic biology; synthetic machines that have been produced
thus far, from a range of materials, are then covered lightly, before focus is brought to the
previous work on the Tumbleweed, the continuation of which is a major component of this
work.
1.1 Synthetic Biology
Synthetic biology can both confirm our ideas about how natural systems function, and
allow us to use nature’s construction rules to make new systems with designed attributes
[2]. Work in the area is greatly varied, from the synthesis of novel amino acids [3], through
track-walking DNA molecules [4; 5; 6; 7; 8; 9; 10; 11; 12; 13], to the synthesis of a genome
which is replicated when put into a cell [14]. A summary of the pathways taken by research
into synthetic biology is shown in Figure 1.1. For constructions from simple units, there is
the use of naturally occurring small molecules (natural amino acids, DNA bases), or the
synthesis of designed molecules, such as peptide nucleic acids (PNAs) and β-amino acids, to
build designed higher-order structures. Other work starts with the use of larger structures
found in nature, but moving them to new environments. An example of this is Path 5 of
Figure 1.1, the path taken by the Venter Institute [15], where researchers transplanted the
whole genome of one bacterium into another (they have since transplanted a full synthetic
genome into bacteria cells [14], published after Figure 1.1). Our work follows Path 8, using
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designed peptides for synthetic biology.
Figure 1.1: The various directions of synthetic biology. The bottom left of the diagram
shows the natural units used by nature to construct systems, while the top right shows
completely synthetic systems. The hub of the Tumbleweed synthetic motor [1] follows
Path 8. Copyright notice in Appendix A [2].
1.2 Natural Motors
Molecular motors are prevalent in mammalian cells. Three ‘families’ of motors, kinesins,
myosins and dyneins, use binding and hydrolysis of ATP to move, transporting cargo
around the busy cellular environment along actin filaments and microtubules [16]. They
are natural converters of chemical energy into mechanical work. The roles they play are
extensive and diverse. For example, myosins are responsible for generating muscle contrac-
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tion, kinesins are involved in mitosis (cell division), moving vesicles and mitochondria, and
dyneins move cilia and flagella. There are differences between the families, but particularly
when comparing myosin and kinesin with dynein. Myosins travel along actin filaments,
while kinesins and dyneins both travel along microtubules (kinesins travel toward the ‘plus’
polar ends, to the cell edges, and dyneins travel inwards where microtubules converge at
a central point), but kinesins and myosins are much more structurally alike than dyneins.
1.2.1 Myosins & Kinesins
Myosins and kinesins are both dimers, held together through coiled coil formation (a
property used in the Tumbleweed and Bar motor designs), with ‘heads’ which bind to
their respective tracks, upon nucleotide binding (myosin V and kinesin-1 have one binding
site in each of their two heads), and ‘tails’ bound to cargo (Figure 1.2). Both of these
motor proteins travel hand-over-hand (so the heads alternate between being the leading
and trailing head) [17; 18; 19] (Figure 1.3), using one ATP molecule for each step, and
have good levels of processivity - they can take multiple steps before detaching from their
track. Kinesin-1 has a fixed step size of ∼16 nm (equating to a centre of mass change
of ∼8.3 nm) per ATP hydrolysis [18; 20], and is only slowed by loads over 3pN. It does
not tend to take backsteps [16]. It travels along just one protofilament of a microtubule
and can take around 100 consecutive steps in vitro [16]. Myosin V, by contrast, shows
significant backstepping for loads over 1pN, and also can take ‘halfsteps’ [16]. Myosin V’s
steps are ∼36 nm, with a resultant centre of mass change of ∼18 nm [21].
The stepping process of myosin V is shown in Figure 1.3. Myosin V is active when cargo
is present; it is otherwise inactive (Figure 1.2), with the motor and cargo-binding domains
interacting with each other in a more compact structure than the active one. In order
for myosin to progress along actin filaments, ATP is needed. The ATP binds to a head
domain, and in both the ATP-bound, and subsequent ADP-Pi-bound, states, it has a low
affinity for actin. Once Pi is released, and only ADP is still bound, the head’s affinity for
actin is high, as is the nucleotide-free state after ADP is released. As shown in Figure
1.3a, with both feet bound to ADP, they are also bound to the actin filament. Once a
foot releases ADP (1.3b; it is thought that strain exerted between the two heads on each
other is how the trailing foot loses ADP first [21]), ATP can bind and cause the foot to
lift (1.3c). Hydrolysis of ATP to ADP and Pi provides a power stroke and the foot moves
forwards (1.3d). Actin binding, followed by the release of Pi, then allows the foot to more
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strongly bind actin, 36 nm ahead of its previous site, and the cycle repeats (1.3a). The
phosphate release (shown in Figure 1.3) and ATP hydrolysis (>250s−1) are both rapid
steps, while ADP release from the actin-myosin is slower (12-16s−1 [22]), limiting the rate
of the process [22; 21]. It is thought that when both heads are bound with ADP and
actin, it is the strain exerted on the two heads which causes the trailing one to release
its ADP whilst preventing release from the leading head [23; 24; 25; 26], giving the motor
directionality.
Head
domain
Coiled-c
oil doma
in
(cargo-binding 
region absent)
Head
domain
Figure 1.2: Structure of myosin V in the inactive state. Shown (in the centre) is the coiled
coil which drives the protein’s dimer formation, surrounded by the chains’ neck and head
domains. The neck domains each bind six calmodulin molecules, while the head domains
bind ATP/ADP. At the other end of the coiled-coil domain, a cargo-binding domain is
present in the full motor protein (not shown in this structure). Figure made in PyMol [27]
from PDB file 2DFS [28].
1.2.2 Dyneins
In comparison, only a few of the dyneins found are processive, and hence of interest in
terms of the properties we are trying to replicate with our synthetic system. Cytoplasmic
dynein-1 has two heads of far greater complexity than those of the other families, the
motor itself being around 10 times the size of kinesin-1 [16]. Its heads have more than one
binding site and dynein also makes use of other proteins (accessory proteins), which appear
to be important for it to function. Its step size varies more than for the other motors,
depending on the load attached, and this increased complexity may make dynein more
open to controlled variability in motion. Its motion is highly variable, with both stochastic
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ADP
ATP
Pi
Figure 1.3: Stepping mechanism of myosin V along an actin filament. Figure adapted
from [21]. While both heads are ADP-bound, they have a high affinity for actin (a). It is
when ADP is released (b), and ATP is able to bind, that a lower actin affinity causes the
head to release (c). ATP hydrolysis provides the power stroke, and the now ADP-plus-
phosphate-containing head moves ahead of the other to its new position (d), binds, and
then releases the phosphate group (e). This returns it to the high actin affinity state of
ADP (a) [21].
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and coordinated stepping, seemingly dependent on the separation of its motor domains
[20]; when both feet are close to each other, steps seem mostly stochastic, by either foot,
but as separation increases, stepping is increasingly by the back foot. Qiu et al. found
that 74% of steps were temporally alternating between feet, but in 83% of the steps, the
stepping foot was not spatially overtaking the other foot [20]. Cytoplasmic dynein’s step
size seems to be around 14 - 16 nm in 2D, while its tail (a measure similar to centre of
mass change given for other motors) moves around 10 nm, and 8 nm in the direction of
motion along a microtubule [20]. Unlike kinesin, it uses multiple protofilaments, and, due
to their sharing a common track, it has been suggested that dynein may move to other
protofilments if a kinesin is travelling along the same path. It is thought that dynein
motors may work in teams to transport larger cargo [16].
1.2.3 Desirable Properties
The different motor proteins offer different models for motor design - it may be simpler to
create a motor that moves like kinesin or myosin, but it could also be of interest to have
the range of potential variability which dynein offers.
Some of the desirable properties of biological motors, advantageous to be reproducible in
synthetic motors, are as follows:
1. Autonomous Motion: the ability of motors to move independently, without external
control, taking multiple steps without an external influence added/changed per step.
2. Directional motion: the ability of motors to walk in a particular direction, either
due to the track or the motor itself.
3. Processive motion: a successful motor must take multiple steps without dissociating
and falling off the track.
4. Efficiency: obviously efficiency is desirable, with minimal missteps and stalling.
5. Structural stability: for the motor molecule itself, being stable enough that its parts
do not spontaneously dissociate is a necessity.
6. Cargo binding ability: controllably binding/unbinding a cargo (and transporting it)
would be an advantage, and a likely means of giving a motor a clear function.
7. Environmental sensitivity: an efficient motor will only carry out its task when
needed, informed by interaction (signal/response) with its surroundings. The ability
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to provide a fuel which produces a power stroke would be a very desirable property
in a synthetic motor.
1.3 Synthetic Machines
Complementing, and inspired by, the research and growing knowledge of natural motor
function and structure, is the work using this knowledge, and testing our understanding,
through the construction of designed objects, either made from biological molecules, or
trying to emulate natural machine functions.
‘Current technologies are focused on miniaturization of functional systems with molecular
machines as one of the ultimate goals’
Ariga, Mori & Hill (2012) [29]
The field of nanoscale machines is diverse. There are small ‘machines’, such as rotors,
switches and now even walkers of some description, made from small molecules, through
to larger constructions made from biological building blocks such as DNA nucleotides and
amino acids. In terms of progress, work involving DNA is more advanced than peptide
work; DNA Watson-Crick base pairing [30] makes it easy to design complementary strands,
and research using DNA for nanostructures has continued to thrive, with increasingly
complex structures being produced. This advantage in terms of ease of design also provides
disadvantages, as the complexity afforded is limited. The possible interactions between
amino acids are far greater and more complex; peptides form a variety of secondary,
and higher order, structures. In the grand scheme of things, peptide work also has the
advantage over DNA that natural biological motors are proteins, and hence advances
made should also increase our understanding of the natural world. There are also natural
machines such as the ribosome which consists of both RNA and proteins [31]. Here are
a few examples of what has been achieved with small molecules and DNA in terms of
molecular structures/machines. A more detailed introduction to peptide structure, and
peptide nanostructures is in the next section.
1.3.1 Mini Machines
Small molecule machines vary greatly, and just a few are discussed here to give an im-
pression of the vast landscape of nanomachines and the desirable properties that can be
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realised. Five examples are shown in Figure 1.4. Some are fairly simple, such as molecular
switches (1.4a) and molecular shuttles (1.4b). Some more complex examples include the
nanocar (1.4c), which tries to replicate motion by emulating macroscopic motion, and the
Leigh group’s walker (1.4d) [32] and peptide synthesiser (1.4e) [33].
The bisthioxanthylidene switch (1.4a) controllably switches conformation, due to thermal,
electrochemical and photochemical changes [34; 35], and these conformations correspond
to red, blue and non-fluorescent states. In the rotaxane shuttle (1.4b), the ring has a
preference for the left benzidine unit on the axle (84% of rings are in the left position in
CD3CN solution at equilibrium), but can be switched to the right-side biphenol group by
electrochemical oxidation/protonation [36]. A rotaxane ring-axle structure also forms the
basis of the synthetic peptide synthesiser (1.4e); the ring travels along an axle, performing
native chemical ligations (NCL) with amino acid phenolate esters placed along it, forming
a peptide chain of defined sequence [33]. In the Leigh walker (1.4d), metal-complex feet
bind to the anchorages, with one (Pt(II)) foot remaining bound at the central anchorage
at all times, and a Pd(II) foot switching between the two other sites, induced by proto-
nation/deprotonation and thermal activation [32]. The nanocar takes a slightly different
design direction, that of miniaturization; it has fullerene wheels that roll like motorcar
tyres, as opposed to slide, to perform translational motion [37]. The version in Figure
1.4c has a chassis sufficiently flexible to overcome one-atom-high gold hurdles [38], but no
means of carrying a cargo. Between these small machines, most of the desirable properties
listed in 1.2.3 have been demonstrated. However, none of these have the full set, and while
this would be an achievement, it would not greatly assist our understanding of biological
motors due to the large differences in composition.
1.3.2 Designer DNA
A step closer to natural motors than small molecules is DNA. DNA design takes advantage
of the strength of interaction between Watson-Crick base pairs (cytosine (C) - guanine (G)
and adenine (A) - thymine (T)) [30]. In nature, the ratios of C:G and A:T are close to 1:1
[39; 40; 41; 42]; other base pairings are less stable, with the alternative hetero pairings less
stable than homo pairs [43]. The structures of these two pyramidine-purine (C-G, T-A)
pairings have comparable sizes, enabling a regular double helix with a constant diameter
to be formed [44; 43]. This almost-exclusive pairing of A with T and C with G means
that creating complementary strands (and making others uncomplementary) is straight-
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(a) Bisthioxanthylidene: thermal, electro-
chemical and photochemical switches in-
duce conformational changes.
  
(b) Molecular shuttle: a rotaxane
shifts position with electrochemical
oxidation/protonation.
  
(c) One of a family of nanovehicles: the
‘nanocar’ can move translationally using
fullerene wheels which roll like car tyres.
(d) Two-footed ‘walker’ on a three anchor-
age track: thermal activation and proto-
nation/deprotonation drive the motion of
one foot between two positions.
(e) Molecular peptide synthesiser: NCL reactions occur at each
step, allowing the rotaxane to progress and build up a peptide
chain.
Figure 1.4: Examples of small molecule-based machines. Copyright notices in Appendix
A [34; 36; 38; 32; 33].
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forward.
DNA structure is driven by finding an energetically favourable state, so designing se-
quences which make the desired structures highly preferable allows DNA to be used as a
nanomaterial. If the formation of a cube is desired, then the formation of a cube should,
by design, maximise the number of base pairs satisfied in the designed sequences. To
cause a change in state, such as a bonding change, the new state has to be more desir-
able, either due to a reduction in the current state’s stability or by opening up a more
desirable state to the system. In many designs, changes in structure are made possible by
including ‘toeholds’ - single stranded stretches of DNA at the end of double strands. If a
toehold-containing strand (the target strand) is bound to a complementary strand by all
bases except for the toehold bases, then a suitable incoming strand can hybridise to the
toehold, and a displacement reaction can take place to replace the first complementary
strand with the new strand. The toehold can either be present in the initial system, and
an incoming strand create more base pairs than the initial arrangement, or be created
by hydrolysis, induced by nicking enzymes, which are only activated by the first comple-
mentary strand binding to the target strand (thus completing a recognition sequence for
the enzyme). In this case, the section cleaved by the hydrolysis is just a few nucleotides,
which can spontaneously dissociate from the double strand [45].
An important development in the field of DNA nanotechnology was that of DNA origami.
In this now famous 2006 paper, Paul Rothemund describes the technique of using one
long DNA strand and many smaller complementary strands (‘staples’) to form a variety of
shapes, and demonstrates several, including a star and smiley face, to show the generality
of the concept. For a given shape, a design is made comprising of rows of helices, and
crosslinks connecting the rows. A single unbroken strand is then drawn through every
helix, crosslinking them in different positions to the first set of crosslinks. The original
crosslink markings are replaced with short DNA strands, which then link two helices via
base pairing; wherever two of these short strands back into each other, they are both
modified so that each links one of its own helices with one of the other staples’ (see Figure
1.5). A computer program is used to find suitable sequences and the shapes formed just
by using an excess of staples with long strands and annealation for under two hours (95◦C
to 20◦C). The paper has been cited over 1000 times [46], the method is now regularly used
for many synthetic nanostructures, including as the foundation for DNA walker tracks
[12; 13], and a 3D analogue of the technique has been successfully implemented [47].
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(a) One long DNA strand (black) forms half of each helix in the shape,
and binding with complementary smaller staple strands (coloured)
guides the formation of a desired shape.
(b) Two of the origami designs. Top left: Folding paths. Bottom
left: Bending of helices, showing where they touch at crossovers and
bend apart away from them. First to last DNA bases indicated by
transition from red through yellow, green and blue to purple. Top
right: 165 nm x 165 nm AFM images. Bottom right: AFM images
with 100 nm scale bars shown.
Figure 1.5: The concept of DNA origami, and AFM images showing proof of concept.
Copyright notice in Appendix A.
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Dynamic Structures
Having controllable functions for these nanostructures is desirable. The Turberfield group
in Oxford has some nice examples of nanostructures with easily visible uses. They devel-
oped a tetrahedron formed from four DNA strands (each forming parts of three tetrahedron
sides) [48], and have since modified this design, to allow a conformational change (using
a ‘fuel’ strand that comes in and opens a hairpin, extending one edge) which is reversible
(using an ‘antifuel’ strand) [49], enclosed molecules within tetrahedra through covalent
attachment prior to tetrahedron formation [50], and non-covalently, through DNA recog-
nition binding post-tetrahedron formation [51]. Molecules have been released from the
tetrahedra by degrading the enclosure [51], and tetrahedra have been delivered to human
embryonic kidney cells cytoplasm, and remained intact for at least two days [52], demon-
strating characteristics that are required in potential drug delivery systems.
DNA has also been used to create several walkers [6; 7; 4; 8; 5; 11; 9; 10; 13]. These walkers
use a couple of common ideas in different ways and combinations. The main methods of
binding between a track and a walker are by the two having complementary strands that
hybridise, or by connecting the two via a third strand, which hybridises with part of a
track anchorage, and part of a motor strand [6; 7]. These are made processive by using
other strands to displace a linking strand [6; 7], such as in the motor shown in Figure 1.6a,
or by destruction of part of the track [4] so as to make movement favoured (an example
of which is shown in Figure 1.6b). Some of these motors require external control, such as
the addition of different DNA strands [6; 7], but autonomous motion, without the neces-
sity of external additions, is desirable. Hydrolysis of DNA [4; 5], ATP hydrolysis [8] and
again, DNA hybridisation [9; 11; 10], as the fuel for motion have been used. The Turber-
field group have extended their single strand autonomous walker work to demonstate the
ability to control the direction of a motor given a choice of paths. They have done this
using blocking strands at junctions, and by controlling the unblocked path through a) the
addition of unblocking strands, and b) the inclusion of a region in the motor strand itself
which catalyses an otherwise hindered block-unblock hybridisation [13].
Some of these walkers are much closer to the natural motors discussed in Section 1.2
than the small machines (Section 1.3.1), and alongside, or combined with, the static DNA
structures, may be suitable for a number of applications. Our aim, however, in addition
to creating structures which can be given applications in the future, is to further our un-
derstanding of the interplay of interactions in natural motors and machines. For this we
13
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(a) Shin & Pierce’s two-strand walker [6] binds each
foot to an anchorage with a different ‘linking’ strand,
and moves the motor along (once both feet are bound
to anchorages) by adding in both a complementary
‘unlinking’ strand, which displaces the bonds between
one linking strand and its motor foot and anchorage,
and a new linking strand that can bind the newly-
released foot to the next free anchorage. The system
tackles the issue of backstepping by having four dif-
ferently sequenced anchorages, instead of two, so that
the new linking strand added in is highly biased to
binding the foot to the forward anchorage (provided
that dimensional constraints are sufficient that the
motor can’t reach back four steps).
(b) Bath, Green & Turberfield’s single-strand DNA
motor and DNA track [4] has anchorages which are
all the same. The track is therefore less complex
than that of Shin & Pierce, but to impart direction-
ality, a restriction enzyme cuts part of the anchorage
when the motor/cargo is bound, destroying the track
and hence preventing backstepping (the free energy
change to do so would be large). The DNA cargo
moves to the next site, where all of the base pairs
can bind again, by reaching over to the next anchor-
age strand where the recently-created unbasepaired
region of the motor strand is also satisfied. All of
the still-bound nucleotides on the first anchorage then
need to dissociate at the same time in order for the
move to take place.
Figure 1.6: Two popular methods of directional DNA walkers.
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need to use the same starting materials, amino acids.
1.4 Peptide-based Nanostructures
1.4.1 Overview
The wider range of amino acid building blocks and their interactions makes peptide struc-
tures more difficult to predict than DNA constructs, but means there are greater possi-
bilities open for de novo design, and there is a growing bank of knowledge on designing
desired peptide structures.
De novo peptide design, like many biophysical fields, has motivations in medical solutions.
Several groups have taken natural peptide sequences, modified them [53], or designed their
own [54; 55; 56; 57; 58; 59; 60; 61] to form hydrogels [62]. Some of these β-structured hy-
drogels have had properties such as antibacterial activity [63], no immune response [53],
and the ability to support cell growth [64]. Fmoc dipeptide-based hydrogels have shown
the pH of gelling and cell support to be amino acid dependent, and that one simple sys-
tem of an Fmoc-dipeptide (diphenylalanine) and tripeptide (arginine-glycine-aspartate)
can bind integrin proteins and support cells which need to adhere to the scaffold to grow
[65]. Several fibrous peptides have also been designed, and form gels and scaffolds with
α-helical [66; 59], coiled-coil [56; 57; 58] and collagen/collagen-like [61; 67; 68; 60] struc-
tures. Peptide amphiphiles, usually with both a polar peptide and a non-polar aliphatic
region [62], have been shown to have some impressive properties, including the ability to
help spinal cord injury recovery in mice [69; 70], and prevent cancer cell growth (by dis-
ruption of a protein-protein interaction) [71]. Antiviral/antibacterial peptide nanotubes
have also been produced [72; 73; 74], while coiled coils/coiled coil-phospholipid composites
have been used to create nanoparticles with antigens attached [75; 76].
As this project principally concerns coiled-coil peptide domains, this section will discuss
the formation of peptides and coiled coils, followed by developments in nanostructures,
with particular focus on those formed from coiled coils.
1.4.2 Amino Acids and Peptides
Formation
Peptides are chains of amino acids, of which there are 20 in the canonical alphabet coded
for directly in DNA [77] (these are listed with their one- and three-letter abbreviations in
15
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Appendix B.2, which will be used throughout this thesis). Eleven of these are synthesised
by the human body, and the other nine have to be ingested (‘essential’ amino acids).
There are many others found naturally, including a few only found in prokaryotes, or
coded for only in the presence of other specific molecules, and many that are the result of
post-translational modifications to canonical amino acids [77]. Outside the natural world,
there are unnatural amino acids, such as those being chemically synthesised, intended to
possess more desirable pharmacological properties than their natural counterparts, such
as a resistance to enzymatic degradation [78]. The peptides in this project only use some
of the standard 20 amino acids.
To form peptides, amino acids undergo condensation reactions to form a covalent bond
between the carbon atom of one amino acid’s carboxyl (-COOH) group and the nitrogen
atom of the next molecule’s amino group (-NH2), as shown in Figure 1.7a. The variation
H2N
OH
O
R
H2N
H
N
O
R
N
H
R
OH
O
O R
(a) The general structure of an amino acid (H2NCHRCOOH) is shown, followed by the structure
of a tripeptide, formed from the reaction between amino acids to form peptide bonds. A water
molecule is released for every additional amino acid bound. The end of the peptide with its
-NH2 group intact is the N-terminus, and the -COOH end is the C-terminus. The R group is
the part of the structure which varies between different amino acids.
N
H
COOH
(b) The only exception to the general structure shown in (a) in the standard 20 amino acid
alphabet is proline, with its ring structure replacing the (usually separate) -NH2 and R groups.
Figure 1.7: Amino Acid Structure and Peptide Formation.
in side chains (represented by the ‘R’ group) gives the amino acids different properties.
The amino acids are often grouped into those which are hydrophobic (F, A, M, I, L, Y, V,
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W) and those which are polar (D, E, H, K, N, Q, R, S, T) [62]. Glycine, proline (Figure
1.7b) and cysteine are less easily grouped. Glycine is the simplest (its R group is just a
hydrogen atom), and only achiral proteinogenic amino acid. Cysteine, due to the sulphur
atom in its side chain, can form disulphide bonds, a property we make use of in this
project. Proline does not have the same general structure as the other 19 (Figure 1.7);
its ring structure gives it reduced conformational flexibility. The presence of an aromatic
moiety in phenylalanine (F), tryptophan (W) and tyrosine (Y) means that they absorb
UV light. There are also negatively (D, E) and positively (R, H, K) charged amino acids,
another property regularly used in coiled-coil design. The sequence of amino acids forming
a peptide is known as the peptide’s primary structure.
Secondary Structure
The varying properties of different amino acids allow different peptide secondary struc-
tures to form. The two most common peptide secondary structures are the α-helix and
the β-sheet [79], and then there are other (less structured) structures such as loops, turns
and random coils.
An α-helix (Figure 1.8, a&b) has 3.6 residues (amino acids) per turn, and is held in
shape by hydrogen bonds between the ith and (i+4)th residues [79]. Helices vary from
four residues to over 40 residues and are most commonly found on the surfaces of pro-
teins. Consequently, α-helix sequences often have hydrophobic residues every three or four
residues, so that one side of the helix is hydrophobic and the other is polar; if on a protein
surface, the helix will have its hydrophobic surface buried inwards and the polar surface
facing outwards towards the solvent.
The amino acids, unsurprisingly, have different helical propensities. Results vary from
study to study, depending on the method and model used, due to the different intertwined
interactions of the system. It is often impossible to completely separate out different ef-
fects, but there are common features of all of the studies. Alanine is consistently found to
have a high helical propensity [80; 81; 82]. The restriction of its conformational space due
to its methyl side chain appears to be the reasoning behind this [80]; glycine, lacking in
such a side chain, is one of the most destabilising amino acids in α-helices, due to its great
conformational flexibility [81; 80]. Proline is consistently, out of the twenty most common
amino acids, least suited to an α-helical environment [82; 81; 80], and results in a kink or
bend in the helix [83].
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The β-sheet (Figure 1.8, c&d) is another common secondary structure. β-strands, gener-
ally between five and ten residues long [79], hydrogen bond to each other to form β-sheets.
These can have mixed, parallel or antiparallel forms, defined as whether all of the N- to C-
termini of the strands run in the same (parallel) or alternating (antiparallel) directions.
Tertiary and Quaternary Structure
From these secondary structures, motifs can be formed - intermediates between the sec-
ondary structures and full blown proteins. They are small collections of secondary struc-
tures joined together in a combination found regularly in proteins [79]. Some examples
(shown in Figure 1.9) are the zinc finger (where, classically, two cysteine and two histidine
residues bind a zinc atom, and the residues between the second cysteine and first histidine
are known as the finger [79]), the helix-turn-helix (found in many DNA binding proteins
such as TrpR [86], PurR [87], CAP [88], cro repressor [89; 90] and λ repressor [91]), colla-
gens (the most common proteins in humans, non-exhaustively, found in the skin, tendons
and bones [92]; three parallel (Gly-X-Y)-repeating chains supercoiled together, where X
and Y are commonly proline and hydroxyproline [79]), and the coiled coil (a motif that can
form by the wrapping together of more than one alpha helix into a more stable structure
[79], discussed in Section 1.4.3 onwards). There may be more than one motif in a peptide
chain, and the way that the whole peptide chain folds up into a more globular form is
its tertiary structure. Many proteins are made up of several chains, and the interaction
between these already folded chains to give the final 3D protein structure is the quaternary
structure.
1.4.3 Coiled Coils
Coiled coils are well suited to the production of small self-assembling units, making them
a good candidate for synthetic design.
Coiled coils have been a known structure since 1953 [97; 98], proposed as a solution when
descriptions of α-keratin as an α-helix led to inaccurate density calculations, and mea-
surements which did not correspond to its diffraction pattern. Crick [97] suggested that if
helices wound together, it would slightly reduce the number of residues per turn, and with
knobs (side chains) into holes (spaces between side chains) packing (Figure 1.12), they
would be able to remain in such a conformation; the resultant density from this structure
was much closer than that of an α-helix to the α-keratin observed density. The energy
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(a) The α-helix is commonly represented as a spi-
ral (as shown here, with the peptide side chains also
shown) to represent the helical backbone.
(b) It is far more difficult to see the α-helical back-
bone in a representation showing both the backbone
and sidechains. The hydrogen bonds stabilising the
structure are also shown here.
(c) The β-strands of a β-sheet are commonly repre-
sented by arrows, pointing from the N- to C-terminus
(side chains also shown here).
(d) The β-sheet is held together by a network of hy-
drogen bonds.
Figure 1.8: Peptide secondary structures. The α-helix and β-sheet are the two most
common secondary structures. Figures made with PyMol [27] using PDB files 1GZX
(residues 118-140) [84] of human haemoglobin, and 1GWE (residues 116-123 and 126-133)
[85], of catalase from Micrococcus lysodeikticus.
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(a) Dimeric coiled coil: peptide corresponding to
the leucine zipper of yeast (Saccharomyces cerevisiae)
transcriptional activator GCN4.
(b) Collagen 3-helix: synthetic model pep-
tide containing region of human type III
collagen.
(c) Zinc finger: synthetic peptide corresponding to
the 31st zinc finger from Xenopus protein Xfin.
(d) λ-cro repressor protein (from bacteriophage λ),
with helix-turn-helix motif (residues 16-35) shown in
red.
Figure 1.9: Common peptide motifs. Figures made with PyMol [27] using PDB files 2ZTA
[93], 1BKV [94], 1ZNF [95] and 6CRO [96], respectively.
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needed for such deformation of the helices was expected to be low and hence plausible.
Peptides that form coiled coils have a characteristic sequence, known as the heptad re-
peat [97; 99], of HPPHPPP, where H represents a hydrophobic residue and P a polar
residue. The residues are conventionally labelled abcdefg (and hence a and d are usually
hydrophobic). The e and g residues are often charged, and can form salt bridges between
the helices. The coiled-coil structure therefore usually has an inner seam of hydropho-
bic residues forming a hydrophobic ‘core’, flanked by e and g salt bridges, with polar
residues on the outer surface. Coiled coils with all of the helices’ N-termini at the same
end are known as parallel; those with some helices running in the opposite direction are
antiparallel [99]. The individual peptides in a coiled coil may or may not be helical in
isolation; some coiled coil-forming peptides are only helical when stabilised by the pres-
ence of an appropriate partner (forming heteromeric coiled coils), or are self-stabilising,
forming homo-oligomeric structures.
Experimental determination of individual structures, searching protein databases for pep-
tides with coiled-coil characteristics, and designs of new peptides based on rules implied
by the above studies have drastically increased the understanding of the sequences leading
to the formation of different coiled-coil oligomers.
The Protein Data Bank (PDB) [100], established in 1971, contains structure files (gen-
erally determined by NMR or X-ray diffraction) for many protein and DNA/RNA-based
molecules, and is freely available, making it a great resource for large scale searches/analyses.
Several algorithmic programs have been developed to extract coiled coils from protein
sequence databases using different search criteria. Some look at the occurrence of cer-
tain residues in particular heptad positions (COILS [101], PAIRCOIL [102], PAIRCOIL2
[103]), some use Hidden Markov Models (MARCOIL [104], CCHMM [105]), and others
use these plus additional data, such as amphiphilicity of sequences (SOSUIcoil [106]), or
searching for (using algorithms such as PSIBLAST [107]), and using, sequences which
are evolutionarily similar (CCHMM-PROF [108], PCOILS [109]), to identify coiled-coil
motifs. There are then programs which try to predict oligomeric state from coiled-coil se-
quences. SCORER (now upgraded to SCORER 2.0 [110]) scores sequences against amino
acid profiles, to differentiate between parallel dimers and trimers, while MultiCoil [111]
and SPIRICOIL [112] relate sequences to known structures in order to predict oligomeric
state (only between parallel dimers and trimers for MultiCoil). SOCKET takes a differ-
ent direction to finding coiled coils - it looks for the characteristic knobs-into-holes (KIH)
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packing in known structures in order to select coiled coils from the PDB [113].
Natural Coiled-coil Structures
Two, three, four and five-helix classical coiled coils have been found naturally [114]. No
natural classical hexamer has been seen, but is feasible due to the existence of a naturally
occurring complex coiled coil which includes a six-helix coiled coil [115], and the synthesis
of a designed hexamer [116]. Complex coiled coils are structures formed by more than
one classical coiled coil (and hence have multiple hydrophobic cores) [114], and though
less common, occur in various forms in the PDB, the most common being two- and three-
dimer constructs. Moutevelis & Woolfson review the coiled coils seen so far in their 2009
paper [114]. Here we concentrate on the most common structures, the dimer, trimer, and
tetramer (Figure 1.10). It is minor differences in sequence that can result in oligomerisation
switches between these three, and these tend to be the structures most commonly used in
de novo design.
Knobs-into-holes Packing
Before discussing the residues which somewhat specify the oligomerisation state of coiled
coils, it is useful to understand the means by which the helices pack together. Knobs-
into-holes (KIH) packing, coined in 1953 by Crick, is characteristic of coiled coils. Leucine
zippers, known as such due to their possessing a leucine repeat every heptad [119], form
coiled-coil structures and are found in several transcription factor proteins. It was the X-
ray structure of the homodimeric GCN4 leucine zipper published in 1991 which confirmed
Crick’s KIH packing (Figure 1.12) for a two stranded parallel coiled coil [93].
As previously mentioned, the a and d residues of each helix form the hydrophobic core.
Coiled-coil helices are all individually right handed, but supercoil around each other left
handedly, reducing the residues per turn (in supercoil space) from the characteristic α-
helical 3.6 to 3.5. The heptad repeat therefore covers two turns (Figure 1.11), so each
‘layer’ of a coiled-coil helix has either an a or d residue close to the inner seam.
It is worth noting at this point that right-handed coiled coils do also exist, but are far less
frequently observed. However, a natural example of a tetrameric right-handed coiled coil
has been found in the tetrabrachion protein of Staphylothermus marinus [120], with an
11-residue repeat, covering 3 turns (3.67 residues/turn), as opposed to the usual 2 turns
for left-handed coiled coils. It has leucine and isoleucine residues at a and h positions. A
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(a) GCN4-p1 dimer (b) GCN4-II trimer (c) GCN4-LI tetramer
Figure 1.10: Dimeric, trimeric and tetrameric classical coiled coils. The dimer shown is the
original GCN4-p1, a leucine zipper from the yeast protein GCN4. It has leucine residues
at d positions, and 4 out of 5 of its a residues are also hydrophobic. Mutants GCN4-II and
GCN4-LI both have isoleucine residues at their 1st-4th d positions, and at their (2nd-5th)
a positions, have isoleucine, and leucine, residues respectively. The mutant GCN4-IL (not
shown, with isoleucine a and leucine d residues), appeared to be dimeric in nature, like
the wild-type peptide [117]. Figure made using PyMol [27] and PDB entries 2ZTA [93],
1GCM [118] and 1GCL [117].
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designed tetramer has also been created [121] using an 11-residue repeat; both of these
structures are less supercoiled than equivalent left-handed coiled coils.
In a typical left-handed parallel dimer, the two helices are rotationally offset 180◦ from
each other, and the a and d residues face inwards towards each other, and in the helical
axis dimension, towards the N-terminus (Figure 1.13) [99]. The g and a residues are
approximately in the same layer as each other, while the e and d residues are in the other.
Dimers can therefore, interact with pairwise-complimentary KIH packing [122]: an a knob
in Helix 1 fits into a hole formed by the d−1, g−1, a and d residue side chains of Helix 2
(where d−1 is the d residue of the previous heptad), but this Helix 1 a knob also forms
one side of a hole for a knob on Helix 2. d knobs fit into holes formed by a, d, e and a+1
residues of the opposite helix.
In higher order coiled-coil oligomers, the interactions cannot be pairwise; there is instead
cyclic complementarity [122]. For a trimer, an a knob from Helix 1 fits into a hole in Helix
2, while an a knob from Helix 2 fits into a hole on Helix 3, and an a knob from Helix 3
fits into a hole in Helix 1. With the same helix labelling, the d knobs act in the opposite
direction: a Helix 1 d knob fits into a Helix 3 hole, a Helix 3 d knob fits into a Helix 2
hole, and a Helix 2 d knob fits into a Helix 1 hole. This opposing directionality applies to
tetramers as well as trimers.
Peripheral KIH packing is seen in tetramers (and somewhat in trimers, for residues with
sufficiently long side chains), where e and g residues can also be knobs which pack into
holes formed in neighbouring helices (formed by c,d and a,b residues respectively). There
are essentially two heptad repeats superimposed on each other, offset by one residue. For
a given helix, the e knobs interact with the same neighbouring helix as a knobs, and g
knobs interact with the same helix as d knobs.
This all means that there are separate a and d layers in parallel coiled coils (Figure
1.12). Dimers and tetramers have alternating layers of parallel and perpendicular packing.
However, it is the a residues which have parallel packing in dimers, and perpendicular
packing in d layers, while tetramers have the inverse. Trimers have acute packing angles
for all, intermediate between parallel and perpendicular packing angles.
Antiparallel oligomers have mixed a and d layers and hence have different KIH packing,
and participating residues.
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Figure 1.11: Coiled coils have seven residues per two turns, and hence the approximate
directions of the a-g sidechains (white circles) can be displayed on a ‘helical wheel’.
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(a) There is parallel packing in
the dimer a layers and tetramer
d layers.
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(b) Parallel trimers have acute
packing, an orientation between
parallel and perpendicular, in
both the a and d layers.
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(c) There is perpendicular pack-
ing for dimer d layers, and
tetramer a layers.
Figure 1.12: The knobs-into-holes packing [97] of parallel coiled coils. The grey circles
are the side chains in the shown layers contributing to a hole, while the black circles are
both knobs, and part of a hole for another knob. Parallel and perpendicular packing is
determined by the approximate angle between a knob’s Cα (white circle)-Cβ(black circle)
vector, and the Cα-Cα vector between the knob’s hole residues in that layer (in the (a)
dimer and (c) tetramer, the vector between the white ‘g’ and the white ‘a’ circles).
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(a) Parallel Coiled Coil (b) Antiparallel Coiled Coil
Figure 1.13: Parallel and antiparallel structures. Arrows indicate the direction from N- to
C-termini. All side chains point towards the N-terminus, and hence the packing is different
between parallel and antiparallel structures. While parallel oligomers have separate a and
d layers (discussed in Figure 1.12), antiparallel oligomers have mixed a and d layers [99].
Dimers, Trimers and Tetramers - Specifying Oligomeric State
In addition to confirming KIH packing, the GCN4 leucine zipper (‘GCN4-p1’), a 45 A˚
long, 30 A˚ wide dimer [93], and subsequent mutations of this 33 amino acid sequence,
revealed several of the now famous ‘rules’ for coiled-coil formation.
A central asparagine residue at an a position helps specify for dimericity
GCN4-p1 has a clear leucine repeat at its d positions (the definition of a leucine zipper),
but not all hydrophobic a residues. Four out of five are hydrophobic (three valine, one
methionine), but the central a position is occupied by a polar asparagine (N) residue. A
hydrogen bond forms between the asparagine residue in each of GCN4-p1’s helices [93].
This occurrence of non-hydrophobic a residues was also found in several other leucine
zippers [123] [119], some having more than one non-hydrophobic a residue. This property
led O’Shea et al. [93] to suggest that they must perform a function; it was proposed
that in causing instability, they allowed specificity to be imposed. A mutant with valine
replacing the asparagine residue supported this; it had a higher melting temperature than
GCN4-p1, indicating higher stability, and did not solely form dimeric species.
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Isoleucine prefers parallel packing
Harbury and coworkers [117] mutated the (2nd-5th) a and (1st-4th) d residues of GCN4-
p1 to valine, isoleucine or leucine (for example, GCN4-IL had isoleucine at a positions and
leucine at d positions). The valine containing mutants (-VI, -VL and -LV), and GCN4-LL
did not form one specific oligomeric structure. Mutant GCN4-IL formed a parallel dimer,
GCN4-II a parallel trimer and GCN4-LI a parallel tetramer. The swapping of leucine and
isoleucine between dimeric GCN4-IL and tetrameric GCN4-LI corresponded to a swap in
the packing of the a and d layers (Figure 1.12); isoleucine prefers parallel packing. This
packing preference was proposed as the reason for GCN4-II’s trimeric structure; as a dimer
or tetramer, half of the a and d isoleucines would have to pack in a perpendicular fashion
- acute packing (a compromise) is more preferable [118].
Designed peptides containing one asparagine per peptide in an otherwise hydrophobic
(leucine) core formed a heterodimeric parallel coiled coil [124], and without the asparagine
a heterotetramer with more than one arrangement resulted [125]. The parallel nature of
the asparagine-containing coiled coils is likely due to an antiparallel orientation forcing
polar asparagine residues to pair with hydrophobic leucine residues [93], which is energet-
ically unfavourable compared to asparagine-asparagine interactions.
Reasons for dimer formation appear to be amino acid specific; it is not an
overall polar group characteristic
Further studies swapping Asn-16 for aminobutyric acid [126] and glutamine [127] resulted
in dimer-trimer mixtures, while lysine and norleucine [127] formed dimers, like asparagine
(it had earlier been found that glutamine was a frequent occupier of a trimer positions,
and lysine of a dimer positions [128]). However, the norleucine side chains buried into the
core while the lysine side chains pointed outwards towards the solvent. A trimeric struc-
ture would allow less solvation of lysine, so it appears that maximising solvation favours
dimerisation in lysine mutants, unlike the apparent hydrogen bonding driver for the wild-
type asparagine coiled coil. The glutamine mutants were again different; in both dimer
and trimer form, the glutamine mutants contained one and two water molecules respec-
tively in their coiled-coil cores, but different interactions occurred in the two oligomers.
The reasoning behind the dimeric preference of certain residues may even vary for a given
residue between different peptide sequences. An intended homodimer, CC-Di, by the
Woolfson group [129], needed its initial ‘a=I,d=L’ sequence to be changed to include a
central a asparagine to form a dimer instead of a trimer (which it initially formed, in
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both crystal and solution forms), but it was not evident that the dimeric favourability of
this Asn-containing peptide was due to hydrogen bonding. It was proposed that perhaps
the burying of the Asn in a dimer was less so than in a trimer, and hence less energet-
ically disfavoured. Their subsequent synthesis [129] of the design inspiration, GCN4-IL,
indicated that it might in fact form both dimers and trimers in solution as opposed to
specified dimericity, not disproved by the inability to solve its crystal structure (both by
the Woolfson group, and its absence in the earlier work). Alongside CC-Di, the Woolfson
group designed CC-Tri and CC-Tet, with sequences identical to CC-Di’s original sequence
(no asparagine), but with II and LI at a and d positions; these formed homotrimers and
homotetramers respectively, as per the Harbury rules [129].
Other Considerations - Salt Bridges and Steric Constraints
In addition to a and d interactions, there are also salt bridges and steric considerations
which contribute to structure determination. Many coiled coils have charged e and g
residues, and their importance appears to be varied.
In O’Shea, Lumb and Kim’s heterodimer design [124], the only difference between the two
peptide sequences is that one has positive e and g residues, and one had negative ones -
the e and g positions were used to specify heteromericity. On the other hand, the designed
Coil-Ser [130], intended to be a parallel homodimer [80], in fact proved to be an antiparallel
trimer. This was the most stable configuration in terms of hydrophobic potential energy,
but had several repulsive interactions between e and g charges [130] designed to encourage
dimer formation (but failing to do so).
e and g salt bridges can occur in all oligomers, and although less common, other salt
bridges can occur. The GCN4-II trimer [118] had more e-g bridges than the -IL dimer
and -LI tetramer, but they were present in all three. Several g-b and c-e bridges were also
seen in the tetramer.
Coil-Ser also demonstrates the effect of steric constraints on configurations. The peptide
has all a and d leucine residues with the exception of one tryptophan (for spectroscopy).
The layers of hydrophobic residues with two tryptophan and one leucine residue were
forced to have one tryptophan facing outwards towards solvent, due to steric constraints
[130]. The antiparallel nature of the trimer avoids a steric clash of having three Trp
residues in a single layer, which would occur in a parallel trimer [130; 99]. Support for the
steric clash discouraging a parallel Coil-Ser is given by the formation of a parallel trimer
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[131] by a Coil-Ser mutant with valine a residues.
1.4.4 Designing Coiled Coils
In order to use coiled coils as (parts of) components for synthetic constructs, the coiled
coils’ self assembly needs to drive the components to combine in an ordered, specific,
reproducible way.
Channon et. al [132] describe the idea of not just designing a single sequence to form a
given structure, but to design what they term ‘tectons’, a set of sequences which form
their own structures and connect together through self assembly to form higher order
structures.
As has been discussed, there are some ‘rules’ for coiled-coil design, but they are more like
guidelines; there are exceptions. Some level of helicity is frequently imparted on peptides
as a result of designing coiled coils, but it is not necessary for the peptides to be helical
in isolation; they may still be highly folded and helical when mixed with an appropriate
partner to form a coiled coil. Choosing residues which allow helicity but don’t necessarily
encourage it nor prevent it may be preferable, as a clear structure change is then visible
upon partner interaction.
The frequently seen ‘a=isoleucine, d=leucine’ [118] with one centrally placed a asparagine
residue is a popular starting point in dimer design, [93; 117; 128], plus complementary e
and g residues to help stabilise the structure. Glutamine, lysine and glutamic acid are
popular e and g choices. Coiled coils rarely contain proline or glycine as they are ‘alpha
helical breakers’ [133].
Most coiled coils in nature are ‘blunt ended’ - the peptide chains interact with each other
fully. However, it is possible for peptides to interact in a staggered manner, so that one
chain interacts with half of two other chains (Figure 1.14). Arranging charged residues
so that the first heptads of one chain are conducive to salt bridge formation with the
end heptads of another chain in a parallel dimer is one way of achieving this [134]. These
‘sticky ended’ peptides [135] are particularly useful when forming extended structures such
as fibres (Section 1.4.1).
Designing Orthogonal Sequences
Bromley et al. [135] describe a means of designing sets of coiled-coil parallel dimers which
are orthogonal, and hence could be used to bring together different components in a
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Figure 1.14: The interactions between two peptides can result in many configurations.
For a dimeric structure there are several possibilities: homomeric or heteromeric species,
staggered (‘sticky’) or unstaggered (‘blunt’) coiled coils (as shown here). Each of these six
configurations shown can be either parallel or antiparallel.
system into a set configuration, reproducibly, over multiple copies. Figure 1.15 describes
their method. The idea is to calculate the interaction energies of all possible sequences
in all configurations (Figure 1.14), and maximise the gap in energy between desirable
structures and all of the alternatives. From the pairs found using the process shown in
Figure 1.15, preference for the final set was given to sequences which also fulfilled the
following criteria:
1. ‘E at g, K at e’ sequences (as seen in bZIP proteins [136; 137])
2. Positive sequences (for solubility, and hence purification)
3. Sequences that when linked to each other are still orthogonal
The b, c and f positions were then filled to include one tyrosine per sequence, and alanine
and glutamine residues, to give sequences of six unique masses [135]. This technique is
used in the design of the Tumbleweed peptides.
1.4.5 Coiled-coil Nanostructures
The Woolfson group used another pair of designed parallel heterodimeric coiled-coil pep-
tides, linked together by (GN)X residues to form a monomer, to demonstrate the use of
steric effects (due to both the linker and helices) to control self assembly of structures
[138]. Fibres formed for an X=1 linker, and square and triangular constructs for X=3
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Sequence space for one heptad
limited by restricting a positions
to N or I, d to L, e and g to
Q, K or E, and not assigning
residues to b, c and f positions.
All combinations of these
heptads used to make
three-heptad sequences
Interactions scored for each
three-heptad sequence with
all others, for all dimer
configurations (Figure 1.14)
Every pair tested against
every other pair for all
dimer configurations
From all of the successful
pairs of pairs, a set of three
dimers where all three possible
two-dimer sets passed the
selection process was chosen
Isoleucine (I) at
a, leucine (L) at
d favours dimer
formation ([117],
[128]), and many
dimers have an
asparagine (N)
at a central a
position ([93],
[123], [124], [125],
[128]). Charged
residues at e and g
positions can form
salt bridges ([133])
Score between
two three-heptad
sequences is sum
of three interacting
heptad pairs
Scores given for
interactions between
heptads one and two
(same or different) for
a1:a2, g1:e2 and g2:e1
1 gabcdef gabcdefgabcdef
2 gabcdef gabcdefgabcdef
A        B        C
Heptads with N at the a
position are disallowed in
the first and third heptads
Sequence pairs for
which the blunt ended
heterodimer is not
the highest scoring
configuration are rejected
Pairs of sequence pairs
for which the two
chosen (in previous step)
heterodimers are not the
highest scoring are rejected
(18 possible sequences)
(9 · 18 · 9 = 1458 sequences)
Figure 1.15: The scheme for designing orthogonal coiled-coil dimer sets, as described by
Bromley et al. (2009).
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and 4 respectively (X=5 formed a dimer-trimer mixture, and X=2, various colloid-like
structures). A monomeric structure of the linked pair was prevented by steric constraints
due to the peptides’ parallel dimer preferentiality, but is likely possible with a sufficient
linker length.
Coiled coil interactions have been used to create several more complex structures, and two
of the most interesting are spherical, but rather different to each other.
The Woolfson group have used coiled-coil interactions alongside disulphide bonding to
produce SAGEs - Self Assembled caGE-like particles (Figure 1.16b) [139]. They use a
designed homotrimer and heterodimer. By disulphide bonding homotrimer monomers to
either of the heterodimer peptides, they form six-peptide structures driven by the trimer
formation, and then, by mixing the two variants of these six-peptide structures, form cages
of sizes around 100 nm, driven by the heterodimer formation. The cages are spherical; it is
thought that with the disulphide bond acting as a hinge (towards one end of the peptides),
repulsion between lysine residues at the other ends of the disulphide bound homotrimer
and heterodimer peptides causes them to form a ‘V’ shape, flexible enough for them to
form a sphere with only hexagonal faces.
The Burkhard group have used a de novo trimer coiled-coil design alongside a modified
coiled-coil domain of COMP (which forms a pentamer) [140] to synthesise a monomer
with both domains, separated by a linker. These monomers can be used to form spheri-
cal objects [75]. They have then decorated these SAPNs (Self Assembled Peptide/protein
Nanoparticles) with epitopes from actin [141], avian influenza [142], malaria (Figure 1.16a)
[143], SARS [144] and HIV-related [145] proteins. The particles are of the order of 20 to
40 nm, depending on their decoration, and some SAPN experiments have induced immune
responses, a good indicator of their potential for future vaccines [143].
1.5 The Tumbleweed Motor
1.5.1 Concept
The Tumbleweed is a synthetic protein motor design [1]. It comprises of a hub which
connects three legs (each with a ‘foot’), and this motor, by rotating diffusively, walks
along a track, with one or two feet bound at any one time. In the present design, the
Tumbleweed comprises of a peptide-based hub (including the legs), with ‘feet’ made from
protein repressors of Escherichia coli, which are DNA-binding, walking along a track made
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(a) The malaria-decorated SAPN of the Burkhard group: a single monomer with
trimer and pentamer-forming domains, and malaria epitope, and a formed nanopar-
ticle. Image taken from [143].
(b) The formation of SAGEs by the Woolfson group. Image taken from [139].
Figure 1.16: Examples of coiled-coil nanostructures. Copyright notices in Appendix A.
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of DNA. In order to control the feet that are bound at any given time/position, the three
feet are different repressors, and each binds to a different DNA sequence when a certain
different ligand is present. The concept is explained further in Figure 1.17. A possible
structure of the Tumbleweed is shown in Figure 1.18d. Directionality will be imparted by
having a directional track (A-B-C-A-B-C), and controlling the feet which are bound and
unbound through external ligand control. At present there is no power stroke, which, in
some natural motors, imparts directionality, only a means of preventing stepping in one
direction and allowing it in the other, through regulating binding. The Tumbleweed can
diffuse in the wrong direction, but because there are three different binding sites on the
track, if the foot behind the one bound sets down, its ligand will be absent and hence
it will not bind to the track (in the absence of non-specific binding, discussed in Section
1.5.3).
This PhD project focuses on the hub construction, but it is important to be clear where
this fits into the Tumbleweed project as a whole; work has been carried out elsewhere on
the DNA track, the repressor feet, and the nanofluidics system, along with simulations
that both assisted in the design and continue to gain further results on the system. That
work is reviewed here in the rest of this chapter.
1.5.2 Timescales
There are many timescales which need to be considered when designing a motor like the
Tumbleweed. At any given time, two ligands will be present in solution. Two given
ligands will be present together for a length of time τligand, after which one of the two will
be replaced by the third ligand of the system. These will then be present in the system
together for another τligand, after which the ligand which has been in the system for 2τligand
is replaced with the ligand which had been absent in the last τligand-long ‘pulse’. There
are therefore three different pulses which occur in sequence, and are then repeated: ligand
A with ligand B, B with C, and C with A, each lasting τligand.
Consider the situation when there are front and back feet bound to the track, and the
third foot is unbound. When the ligands are changed, the back foot (called the back foot
for this whole example), whose ligand is no longer present, needs to detect this, react, and
detach from the DNA track. This depends on the rate at which the ligand and repressor
associate/dissociate (klig-rep), and the rate at which the repressor unbinds the track once
it is no longer bound to a ligand (k-ligoff ). The free foot also then needs to find its binding
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Figure 1.17: The Tumbleweed and its proposed method of motion. The DNA track has
alternating patches to which the three different ligand-bound feet can bind. Changing
the solution (ligands) present will cause the feet to attach and detach in turn. In Part 1,
ligand a has been present for a time, and hence foot A has been able to bind to binding
site (BS) A. Ligand b has been added, and so B can then also bind, to BS B (Part 2).
Ligand a is then removed, and ligand c added. A lifts up (Part 3), and the motor can
diffusively rotate so that C can reach BS C, and bind due to ligand c’s presence (Part
4). This process would continue with the removal of b, addition of a, lifting of B and
binding of A, followed by the removal of c and readdition of b, plus lifting of C, to return
us to the situation in Part 1. Cycle repetition would allow the motor to make multiple
rotations/steps.
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site and bind (which takes, on average, a characteristic diffusion time τdiff), before the
front foot unbinds and lifts. The front foot can unbind due to the next ligand change
(τligand after the previous ligand change) removing its ligand from solution, or because it
naturally dissociates even with its ligand still present (τbound after binding, on average).
If the free foot does not bind before the front foot lifts, the motor will fall off the track, as
no feet will be bound. It is therefore important that the combined processes of the back
and free feet are quicker than both τligand and τbound. The ligands need to be changed
more quickly than the average motor foot naturally dissociates, or there will be periods of
the cycle when the back foot naturally dissociates, but the free foot stays unbound as its
ligand is still not present, leaving just the front foot bound. This would lead to a greater
part of the stepping cycle with only one foot bound, and the shorter the characteristic
binding time τbound, the more likely it is that the single bound foot will dissociate and the
motor will be lost from the track. Therefore, a τbound significantly longer than τligand is
desirable.
These interlinking timescales are more clearly described by an inequality equation:
τbound  τligand > 1
k−ligoff
+ τdiff + τlig−rep (1.1)
where
τbound =
1
k+ligoff
(1.2)
τlig-rep is thought to be on the order of picoseconds for the Tumbleweed repressors [146],
much quicker than the other timescales. τbound is thought to be of the order of 100s
[1; 146], and 1
k-ligoff
at least one hundred times faster (1s) [1; 146], or even 1 ms according to
some experimental data [146]. τligand (discussed in Section 1.5.4) is on the second timescale
[147], and τdiff of the order of 100µs [1; 146; 148].
Non-specific binding is seen in natural motors, and is thought to help motors find their
next binding site, as they clearly do not search all of the possible space. It may therefore
be an advantageous property, but if the non-specific binding is too strong, a foot may not
release when its ligand is removed, a problem for a processive motor design. The strength
of non-specific binding can therefore affect both the rate at which feet detach from DNA,
and find their new binding sites.
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l
d
(a) The 2D Y model.
h
f
(b) The 3D triangular model.
d
(c) 3D coarse-grained model for Langevin sim-
ulations.
(d) A likely structure of the Tumbleweed, from
feet crystal structures and predicted hub struc-
ture.
Figure 1.18: The many faces of the Tumbleweed. The 2D model has one single joint,
while the 3D triangular model has one flexible joint (shown in grey) for each foot [1]. The
3D Langevin model has each foot represented by a sphere of size and drag coefficient to
approximate protein counterparts, and the hub has three legs joined in the centre with
another sphere. The leg lengths (rik) were maintained by harmonic potentials, and the
sphere sizes/excluded volumes by repulsive L-J potentials. It has both a flexible hub joint
and leg-to-foot (ankle) joints.
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1.5.3 Simulations - Non-specific binding, hub flexibility and timescales
Various models of the Tumbleweed concept have been produced to examine the importance
of steric and separation constraints, flexibility of joints, and timescales, both as part of
the initial design stages [1], and ongoing work on the system [146; 148].
The simplest model is the Y motor model (Figure 1.18a) [1]. A 2D simulation was carried
out with an overdamped Langevin equation (also used in simulations in Chapter 4.2,
where it is discussed further), with three spherical ‘feet’ connected by stiff axial spring
potentials at a single joint of variable flexibility representing the motor, and a line of
binding potentials representing the track. Ligands were supplied for τligand-long pulses,
of (a,b), (b,c) and (c,a) ligand pairs successively (and repetitively), and foot binding was
only allowed during the presence of the correct ligand, with immediate unbinding when
the ligand was removed. It was found that, for an inflexible joint (θ = 120◦), leg length
l = d/2sinθ), the joint could make multiple steps. If the leg was made a little shorter, the
motor struggled to bind to two sites at one time and was therefore more likely to detach.
Allowing thermal fluctuations around a 120◦ angle resolved this. As DNA is flexible and
the binding process will induce changes, some flexibility in the motor design might be
needed to tolerate variations in the DNA binding site separations.
A slightly more complex 3D simulation (Figure 1.18b), with a triangular hub, tackled
both flexibility and steric effects. The feet were given a triangular shape, with a screened,
repulsive Lennard-Jones potential (the screening length approximating the true repressor
size), each attached via a rigid joint to hub joints of variable flexibility. To sterically allow
sequential site binding, the length of the hub sides (h) needed to be bigger than those of
the foot sides (f ). Successful stepping was seen for a hub length twice that of the feet
with a τdiff of 150µs.
For more complex simulations, other timescales were introduced. In earlier simulations,
1
k-ligoff
was taken as simultaneous with the ligand change. It needs to be included if one
wants to be realistic and investigate non-specific binding [146; 148].
A study on the effects of timescale relationships and ligand switching efficiency on stepping
using a classical master equation (which describes transitions between states), with input
of results from previous Molecular and Langevin Dynamics models [1], gave the likely
binding state of motors at a given time, from which stepping/lack of stepping could be
inferred [146]. Transitions which gained or lost one foot binding were allowed; a two-
foot-bound motor could not detach, nor a non-bound motor bind multiple feet, in one
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transition. Matrices of rates for ligand binding transitions at a constant DNA binding
configuration and vice versa were built to describe motor state changes. τdiff and τligand
values of 200 µs and 1s were used, respectively, along with a τbound value of 100 s and
1
k-ligoff
of 1 ms. For a fixed τligand and varying τbound (0.1-100 s) and τdiff (2, 20, 200, and 2000 µs),
it was found that, as one might expect, motors were more likely to detach from the track
(within the first 30 steps) as τbound decreased (as it was increasingly likely for a foot to
detach undesirably), and as τdiff got longer (due to increased binding site searching time,
with only one foot bound). For microsecond τdiff timescales, the motors were still quite
successful even as τbound decreased, with less than 10% of motors lost after 30 steps for
τbound ≥ τligand. However, for a 20 ms τdiff, and τbound = τligand = 1s, this loss increased to
20%, and rose dramatically to 90%-plus for
τligand
τbound
= 5 (compared to ≤ 40% loss for all of
the other τdiff values investigated). τdiff is evidently important in determining continued
attachment success even when three orders of magnitude shorter than τligand and τbound.
Another realistic issue is that there will be a finite changeover time between one pulse and
another, when all three ligands will be present: a continuous change from 100% pulse 1
to 100% pulse 2 will occur. Kuwada et al. [146] define a time, τ2, over which this change
takes place (100% pulse 1 to 100% pulse 2), so that:
τligand = τ1 + τ2 (1.3)
where τ1 is the time at which one pulse is at 100%. To reduce computation time, they
modelled τ2 as a step of 50:50 pulse 1-pulse 2 mixture between τ1 of (a,b) and τ1 of (b,c)
rather than continuous gradients. For fixed τligand = 1 s, the probability of foot A and
foot B together being bound during τ1 of a (b,c) pulse is zero, but is increasingly likely as
τ2 progresses; the longer τ2 is, the higher the probability (0.1 for τ2 = 0.9τligand, versus ≤
0.05 for 0.3τligand). The misstep probability increases with τ2 too; a longer τ2 corresponds
to a shorter τ1, so less of the AB-bound motors will have stepped to BC (either by lifting
A during (b,c) but not binding C before A can rebind, or by stepping to BC and back to
AB again during τ2). For fixed τligand = 0.1 s, the probability of AB still goes from one to
zero as a (a,b) pulse moves to a (b, c) pulse if τ1 = τ2. If τ2 is longer than τ1, neither a zero
nor one probability occurs and missteps occur, because some motors don’t lift a foot in τ1.
In the 1 s τligand simulation, there are always missteps due to τligand being comparable to
τbound. The difference is that in τligand = 0.1 s, although there is basically no misstepping
for τ2 ≤ τ1, in the region they do occur, the misstep fraction becomes much higher than
the τligand = 1 s fraction ever does. τligand = 0.1 s goes from 0 to over 25% misstepping
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between τ2 = τ1 and τ2 = τligand, while for τligand = 1 s, for the whole range (τ2 = 0 to
τligand), misstepping is never higher than 5%.
Even though speed of the motor is technically dependent on τligand, if τligand is too short,
it may not speed up the motor, as payment will be made in the form of misstepping.
A later study by Kuwada et al. [148] looked at tuning the motor to optimise τdiff, by
adjusting flexibility and non-specific binding (Figure 1.18c). They concluded that there
was no advantage to flexible legs, and that flexible ankle and hub joints, and some non-
specific binding, minimised τdiff. They found that negative effects on τdiff due to high
non-specific binding could be alleviated by some ankle rigidity, or, in the case of a rigid
ankle, some non-specific binding was helpful. As flexibility of the ankle region is thought
to be harder to both predict, and modify, it was suggested that adjusting ionic strength to
change non-specific binding levels might be the most feasible means of optimising a given
motor τligand.
1.5.4 System Components
Track
DNA was chosen for the track material due to its mechanical and self assembling properties,
and its ability to code for particular binding reactions. The DNA track needs to have [149]:
1. repeating sections of the binding recognition sequences for the three repressor feet,
spaced so that they a) correspond to the step size of the motor (11 nm), and b) all
occur on the same side of the helical DNA molecule.
2. a means of being anchored and held on a surface.
3. sufficient length to study motor dynamics.
4. a label, so that the motors’ progress can be tracked, and separated from any drift of
the whole system (the hub should also have a label for tracking).
A DNA sequence of the form L(ABC)NR (the ‘cassette’) was created, where A, B, and
C are the chosen repressors’ recognition sequences (plus some bases to create appropriate
spacing between them), which are repeated N times, and L and R are primers which include
sequences for restriction enzymes (to cut the DNA, allowing ligation and doubling of the
cassette). A genetic algorithm was used to design a suitable sequence of this form, with
desirable thermodynamic properties (a melting temperature of 56◦C was aimed for), and
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no unintended additional recognition or restriction sites. The repetition in the sequence
was also minimised, as bacteria tend to remove repeat sequences. The choice of an E.
coli strain (DH5α) more tolerant of repeats than other strains was also made to tackle
this potential issue. A region of the DNA was labelled with fluorophore. Once the initial
cassette had been produced, L(ABC)1R was used to produce tracks of higher N values;
L(ABC)1R was put into a plasmid, and using restriction enzymes and ligation, another
copy of the ABC sequence was inserted, increasing N to two. The plasmids were then
amplified in the E. coli, and this process was repeated to double N multiple times.
A track of L(ABC)8R has been successfully produced, and extended to a sufficient length
for a DNA curtain experiment (Figure 1.19a), of 14 µm, by the addition of λ DNA (which
has no binding sites for the repressors) [149].
Microfluidics
The microfluidic system for ligand delivery [147] needs to be able to provide the (a,b), (b,c)
and (c,a) pairs of ligands in order, repetitively [1], to motors on a surface bound track
[149]. It is required that the switching time (similar to τ2 in Section 1.5.3, but defined as
the time between switching from 90% of one solution to 90% of another, as opposed to
100% to 100%) is much less than the ligand pulse time, and for fluid velocity to be low
enough so as to not affect the motors’ motion negatively.
The resultant device is shown in Figure 1.19d, a PDMS (polymer) device, made from
a lithographically patterned mould of SU8 2050 on a silicon wafer, bonded to a glass
cover slip for TIRF (total internal reflection fluorescence) imaging, and with silicone tubes
attached to holes into inlets/outlets, connecting the system to solution vials. The device
is operated so that all three fluids flow continuously, around their own U-shaped channels,
and by increasing the pressure on a given outlet (relative to the others), control of which
solution is carried through the main channel to the Tumbleweed system is allowed. The
system is capable of cycling the solutions in both I-II-III and III-II-I orders, and the fluid
switches are well defined even near the surface boundary; the boundary does not hamper
the switching times. The interfaces between the different solutions smeared out as they
traversed the main channel, but the switching time was as low as 0.2 s close to the surface
at the inlet end of the main channel; however, at the pressures used, for the fluid to reach
the main channel away from the inlet branches before switching, the system switching
time is 1 s. Tests of force on a quantum dot for a 100 µms−1 flow found drag to be around
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0.02 pN, lower than the 0.5-1 pN it is expected that the Tumbleweed can step against
[148], so the system-induced drag should not overwhelm the Tumbleweed’s motion.
(a) DNA Track [149]: several strands of 14
µm DNA (to form a DNA curtain) have
been attached to a surface using biotin and
streptavidin.
(b) Repressors TrpR (purple) and DtxR
(green), rendered in PyMol [27] from PDB
structures 1TRO [150] and 1C0W [151].
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(c) The ‘Y’ and triangle configurations
of the Tumbleweed hub (taken from [1]).
Both have three dimeric coiled coils; the
‘Y’ configuration has two parallel coiled
coils and one antiparallel, while the trian-
gle configuration has three parallel coiled
coils. The thin lines linking the coiled coils
represent the bonds which are currently co-
valent disulphide bonds between cysteine
side chain thiol groups.
(d) Microfluidic Chip [147]: the three in-
lets (left) have the three ligand solutions
(shown in red, blue and green) flowing in
and out of them. An increase in the pres-
sure of one allows that solution to fill the
main area and flow through the outlet to
the rest of the system.
Figure 1.19: Progress on the components of the Tumbleweed outside/prior to this project.
42
Chapter 1 Introduction
Feet
The feet must have DNA binding properties that are highly influenced by the presence of
specific ligands [1]. All three feet need to bind to a different DNA sequence in response
to binding to a different ligand, to ensure orthogonality. For molecular biology purposes,
monomers or dimers were required, and searching the PDB [100], three E. coli repres-
sors were originally selected. Since publication of the Tumbleweed paper [1], the chosen
repressors have been revised, due to issues such as uncontrollable non-specific binding.
At present, TrpR remains, while DtxR and another as yet undetermined repressor have
replaced PurR and MetJ (Figure 1.19b).
TrpR is a homodimer formed of two 107-amino acid subunits [86], and represses l-
Tryptophan synthesis when the Trp concentration is high enough that it binds to TrpR,
activating it, through a conformational change [86; 79] (seen in crystal structures of TrpR
with and without Trp [152]) and allowing the dimer to bind to the major groove of DNA.
Trp increases the TrpR dimer binding by a factor of a thousand [152].
DtxR is a homodimer [153; 154], composed of two 226-residue chains [155], and is acti-
vated in vivo by Fe2+ [156], but has been observed in vitro to be activatable by other
divalent transition metal ions such as cadmium, cobalt (as is the case in Figure 1.19b),
manganese, nickel and zinc [157]. Its DNA-binding capabilities appear to be quite specific
to its recognition sequences, and strongly dependent on metal ion concentration [158; 159].
The DNA binding domain contains a helix-turn-helix motif, and binds to the major groove
of DNA [160].
Hub
The hub design is for three dimeric coiled coils in two possible configurations to bind with
each other and the repressors to form a motor capable of walking along a track. There
is a triangular design, and a Y-shaped form (Figure 1.19c). The peptides are designed to
form dimers; more specifically, they are six peptides designed to interact specifically with
a certain partner, with far more efficiency than any of the other present peptides, to form
three different dimers (using the technique discussed in Section 1.4.4). The hub peptide
sequences are shown in Table 1.1. Three peptides (1, 4 and 6) are common to both hubs.
The other three differ. In the Y hub, peptides 1 and 2, and 3 and 4, form parallel dimeric
coiled coils, while 5 and 6 form an antiparallel dimer. All three pairs (1 and β, γ and 4,
and  and 6) in the triangular hub form parallel dimers. At one end of each peptide there
43
Chapter 1 Introduction
Table 1.1: Tumbleweed Peptide Sequences (all written from N to C-
termini, which are labelled in Figure 1.19c). Further details in Appendix
C.
Peptide Sequence
1 CGNGNEIAALEKKIAALKQENAALEQEIAALEY
2 CGNGNKIAALKQEIYALEQKNAALKQKIAALK
β KIAALKQEIYALEQKNAALKQKIAALKQGNNGC
3 EIAALEQEIYALEQKNAALKKEIAALEQGNNGC
γ CGNGNEIAALEQEIYALEQKNAALKKEIAALE
4 NKIAALKQKIAQLKQENAALEQKIYALKQGNNGC
5 CGNGNKIKALKQEIAALEYEINALEQ
 CGNGNEIAALEYEINALEQKIAALK
6 NKIAALKYKIAALKQEIAALEQGNNGC
is a linking region made up of one cysteine, and asparagine and glycine residues (similar
to the peptides in [138]). Prior to mixing all six peptides of a hub, the peptides 6 and 1,
3 and 2, and 4 and 5 (or β to γ, 4 to  and 6 to 1) will be disulphide bonded together
via their cysteine residues, so that once the peptides are mixed and coiled coils form, the
whole hub structure will be complete (Figure 1.19c).
As is clear from the sequences (Table 1.1), β and γ are analogues of peptides 2 and 3,
differing only in the positions of their linking regions. This is so that in the Y hub they can
form disulphide bonded 3 (N to C) - 2 (N to C), while in the triangular hub they form 2 (N
to C) - 3 (N to C). Peptide  varies from peptide 5 more greatly, as ,6 is parallel, and 5,6
is an antiparallel dimer. This project has focussed more heavily on the Y hub, and hence
the triangular hub is only discussed here for completeness, as it was also involved in some
of the early simulation results. The Y hub offers greater functionality; it has a central
vertex for further modification, and the geometry is more open to adaptations, such as a
modification allowing inducible conformational changes (a possible means of introducing
a power stroke into the Tumbleweed). The peptide sequences follow several of the rules
discussed in Section 1.4.3. Apart from in the linking regions (GNNGC or CGNGN), all
of the peptides have a leucine heptad repeat (every d residue is leucine). The first four
peptides (and their analogues) have four heptads, with an asparagine a residue near the
centre of the helix, and the rest of the a residues are isoleucine. The last two (and ), the
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Figure 1.20: Helical wheel diagrams (made using DrawCoil [161]) showing the interactions
between pairs of peptides in the Y hub of the Tumbleweed. Dashed lines show salt bridges
between e and g residues. The blank circles are residues absent from the peptide, but
which have a corresponding residue in the partner (for example, peptide 1 has one more
residue than peptide 2, ending with an f residue, while peptide 2 ends with an e residue
(see Table 1.1).
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three-heptad peptides, have all isoleucine a residues. All of the e and g residues are either
lysine (positively charged) or glutamic acid (negatively charged), to maximise the number
of salt bridges (Figure 1.20). The majority of the b and c positions (38 out of 44) are
alanine. There are no proline residues present and glycine is only present in the linking
regions of the peptides. Cysteine is solely used at the ends of the peptides for its disulphide
bonding property, and there is only one per peptide to constrain the possible disulphide
bonds that can form. All of the peptides have a tyrosine residue to assist concentration
determination and HPLC purification.
1.5.5 Properties Checklist
To summarise, by comparison with the checklist of required and desirable motor properties:
1. The Tumbleweed has a method of being directional.
2. The Tumbleweed should be processive with its current design.
3. The Tumbleweed’s structure should be stable enough that it does not fall apart.
4. The Tumbleweed responds to its environment.
The Tumbleweed is not:
1. autonomous.
2. able to carry a cargo in the current design.
Its efficiency could be increased if it had a power stroke, an obvious future aim.
1.6 Thesis Outline
The keys areas of this thesis are the development of the Tumbleweed hub, and work to-
wards another motor design, the Bar motor.
In Chapter 2, I discuss the experimental techniques used in the later chapters: the basic
theory behind the techniques, and how they are used to gain information on our systems.
Chapter 3 is the first results chapter, containing the results of the Tumbleweed exper-
iments. The individual hub peptides are characterised, their dimeric interactions with
each other, and the bonding of the peptides in order to form a hub are studied. Chapter
4 discusses the Bar motor; the concept, peptide design, and simulations of the system are
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detailed. Chapter 5 describes experiments on the first iteration of the Bar motor. The
thesis is completed with conclusions, possible future directions, and appendices, including
experimental methods. In cases where a person other than the author provided a sample
or collected data, these are acknowledged within the chapters.
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Theory of Experimental
Techniques
This chapter is intended to describe the principles of the chemical and biophysical tech-
niques used in the later chapters of this thesis, and the information we wish to glean about
our systems from each of them, as many of the techniques are common to both systems.
2.1 Production of Purified Peptides
The first step in the experimental work of each of the systems was to synthesise and purify
designed peptides. All of the peptides in this PhD thesis were synthesised via Solid Phase
Peptide Synthesis (SPPS) and purified using High Performance Liquid Chromatography
(HPLC).
2.1.1 Solid Phase Peptide Synthesis (SPPS)
Solid phase peptide synthesis was pioneered by Bruce Merrifield [162]. Previously, pep-
tides had been synthesised in the liquid phase, since the first peptide syntheses of Emil
Fischer at the start of the 20th century [163; 164; 165].
In SPPS, peptides are formed on resin beads. We use Rink Amide resin; the resin has an
-NH2 group, which the first amino acid of each chain bonds to, via its carboxyl group, in
the same condensation reaction that occurs between amino acids to form peptides (Figure
1.7). This means that peptides are built up with the C-terminus attached to the resin.
The steps involved in solid phase peptide synthesis are shown in Figure 2.1. The employ-
ment of microwave energy to assist in the coupling of the amino acids generally makes
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Figure 2.1: The process of solid phase peptide synthesis, using Fmoc protection. The
sequence shown here is that of peptide 2, but the sequence is the only difference between
the peptide syntheses - the synthesis reactions are the same.
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reactions faster, and increases the yield of the correct peptide [166]. This improvement
is likely due to the increased temperature, which is known to increase reaction rates in
peptide synthesis, but it has also been suggested that the means of interaction between
microwaves and molecules helps focus the energy transfer, increasing rates, and that elec-
tric field effects on the polar backbone and N-terminal amine help discourage aggregation
[167], a cause of decreased yield due to sterically hindering reactions. Microwave energy
has been found to increase racemization in cysteine, histidine and aspartic acid residue
reactions [167; 168; 169], but this is largely bypassed in this project due to the absence
of histidine and aspartic acid, and minimal use of cysteine. It is difficult to estimate the
likelihood of a particular synthesis being successful. Particularly by the time lengths of
30 to 40 amino acids are reached, success rates are highly sequence dependent [170]. The
particular amino acids used, and their position in a sequence will influence the success
of a peptide synthesis. The peptides synthesised here have no amino acids known to be
particularly troublesome (such as histidine), and no strong β-sheet regions are included,
which are often the source of aggregation-related synthesis failures [171].
The development of automated microwave-assisted SPPS [166; 162] has greatly simplified
peptide production, making it accessible to researchers such as ourselves with less experi-
ence in chemical synthesis.
The amino ends of the amino acids used are all protected by an Fmoc group, so that two
(or more) of a given amino acid don’t bond to each other, leading to an incorrect sequence
on the resin. Once each coupling reaction has occurred, any remaining uncoupled amino
acid molecules are washed away. The Fmoc groups of the resin-attached amino acids
can then be removed and washed away. Washing is important, both to remove free Fmoc
groups from the system so they cannot reattach, and to remove the deprotection chemicals
so they cannot deprotect subsequent amino acids too early. The next amino acid can then
be added, coupled, and deprotected, and the process is repeated until the sequence has
been produced. Reactive side chains are protected during synthesis to prevent attachment
to other amino acid side chains, allowing a linear peptide backbone to be formed. These
protecting groups (orthogonal to Fmoc and hence not removed by the deprotection solu-
tion used during synthesis) are removed after synthesis, alongside cleavage of the peptides
from the resin.
Details of the syntheses for this project are given in Appendix D.1.
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2.1.2 High Performance Liquid Chromatography (HPLC)
Chromatography involves separating out different molecules according to one of their
properties, such as size, hydrophobicity or charge. We use reverse phase HPLC to purify
peptides according to their hydrophobicity.
Reversed phase chromatography uses a hydrophobic solid/stationary phase and a hy-
drophilic liquid phase [172], while normal phase uses the opposite. The peptides are dis-
solved, and injected onto a column while a predominantly water liquid phase flows through
the system. The peptides bind to the column to reduce their exposure to the polar solvent,
and non-polar solvents are needed to remove them [173]. The liquid phase is constantly
flowed through the system, and a hydrophobicity gradient is carried out, to a solution
of decreased polarity (in our case, predominantly acetonitrile, with a small percentage of
water remaining). As the gradient is carried out, more and more hydrophobic molecules
elute from the column, and can be collected. A UV detector is used to observe when the
peptides are eluted, seen as a series of absorption peaks, and the separate products can be
collected. Figure 2.2 shows an example of a HPLC spectrum. Similar peptides often have
similar hydrophobicity, and hence separation of these can sometimes be difficult if the
resolution of peaks is low. The peptides in this project were all purified via HPLC after
Figure 2.2: The signal received from the UV-Vis detector during a HPLC run of peptide 4
(Chapter 3). The three peaks labelled A, B, and C, and the recession of the highest peak
(D) were tested using MALDI-ToF. C was identified as the target peptide, while B and D
contained similar peptides, but with an additional unwanted amino acid.
synthesis. HPLC was also used at several stages in the production of disulphide-bonded
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peptides, and both before and after the addition of azobenzene to peptide 2.
2.2 Matrix-Assisted Laser Desorption/Ionisation Time-of-
Flight Mass Spectrometry (MALDI-ToF)
MALDI was first demonstrated in 1988 by Karas and Hillenkamp, as a means of using UV
laser desorption to determine molecular weight [174]. It is popular for peptides and other
biomolecules of this size range, which are well above the mass region affected by matrix-
related byproducts [175]. Time-of-flight (ToF) experiments involve the acceleration of
ions to a specific kinetic energy (using an electric potential) and then looking at their
separation after they pass through a region without field and collide with a detector. Ions
of the same charge z will separate due to their varying velocities v, which are dependent
(as they all have the same kinetic energy) on their masses m [176]:
v ∝ (m/z)−1/2 (2.1)
ToF ∝ (m/z)+1/2 (2.2)
MALDI relates to the fact that the ions are produced by a laser hitting a sample compris-
ing of peptide combined with a matrix. The spectra produced give intensity against m/z,
and though predominantly a singly charged peak appears [177], doubly (and more highly)
charged peaks are also sometimes seen.
A successful synthesis would give a MALDI-ToF spectrum dominated by the correct prod-
uct mass, with perhaps a few other additions or deletions present in small quantities. It
was used in this work qualitatively to confirm the presence of the correct peptide after
synthesis - if there is a molecule corresponding to the mass of the peptide synthesised in
the MALDI-ToF results, it was be taken that the peptide was synthesised successfully.
Of course, there are many peptides of the same mass. If one rearranged a sequence with
the same residues, it would have the same mass, but if there has been a problem in the
synthesis, there would be a very small chance of there being an alternative peptide of the
same mass present without peptides of other masses also being present. MALDI-ToF can
also indicate when a peptide has been incompletely deprotected (through the presence
of masses equivalent to the peptide plus deprotecting groups). In this project we there-
fore tested peptides by MALDI-ToF after synthesis, to confirm both successful synthesis
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and cleavage, and after HPLC to identify purified fractions of the correct peptide. The
resolution of the MALDI technique varies, and can provide a far greater resolution than
needed for our experiments; the systems used here for MALDI-ToF analysis are sufficient
to resolve mass differences of ∼1 Da, and hence can easily resolve peptides with mass
differences of ∼100 Da such as ours, or different products of peptide syntheses containing
additions and deletions from the desired sequence as well as the main product. As shown
in Figure 2.3, it is possible to resolve peptides and their sodiated counterparts; the spectra
often contain peaks at 22 and 38 mass units higher than the expected peptide peak value
due to sodium and potassium adduct ions present with the peptides. Figure 2.3 shows an
example of a MALDI-ToF spectrum, where the major peak is the desired product, and
the next (although small) peak present in the region is the peptide+sodium ion peak.
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Figure 2.3: A MALDI-ToF spectrum for a fraction collected from HPLC purification, for
peptide 3 of the Tumbleweed system. The spectrum shows the peptide, and a small peak
due to the commonly occurring sodium adduct, 22 mass units above the peptide peak.
2.3 Characterisation Techniques
After synthesis and purification, the peptides were characterised. Circular dichroism (CD)
was used to measure secondary structure, and to test thermal stability. Absorption spec-
troscopy, in addition to being the detection technique in HPLC, was used to calculate pep-
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tide concentrations, and as an indicator of structural changes in conformational switching
experiments. Dynamic Light Scattering was used to estimate sizes of peptide species. An-
alytical Ultra Centrifugation data carried out by EHCB has been used to complement this
PhD data, as an assessment of species masses, to deduce the oligomeric states present.
2.3.1 UV-Vis Spectroscopy
Concentration
UV-Vis spectroscopy is regularly used as a measure of concentration for peptides and pro-
teins. Each of the peptides in this project contains a Tyrosine residue. Tyrosine has a
strong UV absorption around 276 nm, with an extinction coefficient of 1280 cm-1M-1 [135].
Tryptophan and Phenylalanine, the other aromatic amino acids, also have an absorption
in this region which could be used if present. If peptides do not have aromatic residues,
then the peptide backbone absorption at 220 nm can be used. Samples must be of a
concentration high enough to give a significant aromatic absorption over background ab-
sorptions but not so high that they are subject to adverse scattering effects. Peptides with
other absorbing moieties such as azobenzene can cause issues, as it is necessary that an
absorption peak is attributable to one moiety; the signal should return to a baseline either
side of the peak. If there are too many overlaps, or if the signal of the Tyrosine residue
is swamped by another species, then another absorption peak, or a different method of
determining concentration must be used.
The Beer-Lambert law can be used to calculate the concentrations of peptide solutions
from absorption spectra [178]:
A = cl (2.3)
where A is absorbance, c is concentration, l is path length and  is extinction coefficient.
Structural Changes
In addition to concentration calculations, studying the temporal evolution of UV absorp-
tion spectra over time can be used to track structural changes. If one measures the UV
spectrum of a peptide and then induces a structural change, a change in the UV spectrum
is additional evidence of a change in the molecule’s environment. If there is then migra-
tion of this spectrum back towards the initial spectrum, one can use this to estimate the
lifetime of the switch, or if a reverse does not occur, suggests that the switch is either long
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lasting or irreversible without external intervention. The UV spectrum of 2CL (Chapter
5) was monitored before and after irradiation, to confirm that a change had occurred, and
to study its return to its original state.
2.3.2 Circular Dichroism (CD)
Circular dichroism (CD) is a property exhibited by chiral molecules. Molecules are chiral
if their mirror images can not be superimposed over each other. Amino acids are all chiral
(except for glycine), and hence all peptides except polyglycine are chiral.
Circular dichroism occurs because the electric field vector of circularly polarised light
(CPL) traces out a helix in the direction of propagation, and, as photon absorption causes
electron rearrangement (to higher energy states), in chiral molecules (no plane of reflec-
tion), this rearrangement also has a helical component [179]. The two circular polari-
sations therefore have a differing effect; chiral molecules absorb left (L-) and right (R-)
circularly polarised light to different extents, and the difference in these absorptions is
circular dichroism:
CD = ∆A = AL-CPL −AR-CPL (2.4)
This difference can be measured over a range of wavelengths. The CD spectra of peptides
are taken in the UV region, which involves backbone transitions (as well as some side
chain transitions). There have been found to be characteristic features of the CD spectra
for particular peptide secondary structural motifs (Figure 2.4). Spectra of α-helices have
two minima; one at the lowest energy transition in the peptide chromophore, the n → pi∗
transition, at 222 nm for α-helices, and one which is part of the pi → pi∗ transition, at 208
nm (this transition has a splitting for α-helices). A fully folded helical peptide has -33,000
degcm2dmol−1res−1 at 222 nm [180], and this negative minima disappears as the peptide
loses or changes its secondary structure. CD is thus frequently used to study peptide and
proteins, to assess the secondary structures present, compare the structures of different
peptides, and study stability and changes in structure with changing conditions (such as
pH or temperature). Another method commonly used to look at peptide secondary struc-
ture is X-ray scattering, but crystallization itself can cause changes in the structures of
peptides/proteins [179; 181], and hence may not represent the system as it is in solution.
It is also often difficult to produce good quality crystals suitable for crystallography, so it
may be more reasonable to use CD if one wishes to look at a system in solution.
It is common for CD data to be analysed by comparison with ‘standards’; analysis typ-
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Figure 2.4: Typical CD spectra of common peptide secondary structures. α-helices (red)
generally have 2 minima, at 208 and 222 nm, while β-sheets (blue) have one minima at
around 216 nm [179]. Also shown are a β-turn (green) and poly-L-proline, a left handed
helix found in collagen (black). Adapted from [182].
ically involves using spectra of known helical, beta sheet and random coil molecules to
estimate the amount of each of these secondary structures present in a molecule, by com-
bining the spectra of different secondary structures in different ratios to find a ‘best fit’
to the new molecule’s spectrum. There are many packages available for estimating the
percentages of each secondary structure (α-helix, β-sheet, random coil) present in samples
[183; 184; 185; 186], which generally use a basis set of peptides with known secondary
structure (often from X-ray studies), to compare with data. Obvious issues relating to the
validity of this are whether one fully folded helical peptide will have the same spectrum
as another, and whether the structures found from X-ray data are identical to the struc-
tures found in solution. Libraries are being improved and expanded over time, and fitting
packages are estimating structures more and more accurately [186]. Generally, α-helices
are more accurately predicted than other secondary structures [187]. In this thesis (both
Chapters 3 and 5), I predominantly use direct comparison of my own samples as a means
of interpreting how folded peptides are, and whether helicity is increased in mixtures as a
result of coiled-coil interactions. In both types of comparison, it is important that gases
and other molecules (such as the solvent system) involved in the system do not cause
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absorptions of their own (or that these are minimised) so that the results seen are rep-
resentative of the peptides, and not other presences. The spectropolarimeter is purged
of oxygen, as it absorbs strongly in the 200 - 10 nm range [188] (and the UV produced
by the lamp can also react with surrounding oxygen to form ozone, highly undesirable),
prior to use, and solvents which do not absorb in the regions of interest are chosen. It is
also important to keep conditions constant between samples (temperature, pH, solvent).
By looking at individual peptides, and peptides mixed with others, one can confirm an
interaction between them by whether the mixture’s measured spectrum differs from what
is predicted by combining two peptides’ individual spectra.
2.3.3 Dynamic Light Scattering (DLS)
Dynamic Light Scattering uses the scattering of light by molecules in solution to probe their
properties. The experimental setup is shown in Figure 2.5. The intensity of scattered light
will vary over time as it is scattered by particles which are moving with Brownian motion.
Fluctuations in the intensity are measured, and used to calculate the autocorrelation
function - a measure of correlation between intensity at a time t, and a short time later
t+τ :
G(τ) = lim
T→∞
1
2T
∫ T
−T
I(t)I(t+ τ)dt (2.5)
The correlation between two signals at times very close to each other will be high, as
the scattering particles will not have had time to move significantly, but those signals
separated by long times will have no correlation in a solution undergoing a random process
like Brownian motion. Therefore, for a single species of particle, the correlation function
decays with an exponential form [189]:
G(τ) = A+Be−2Dq
2τ (2.6)
where A accounts for a baseline, B accounts for the fact that the resolution of fluctuations
seen by the detector depends on the angle the detector subtends (if above a certain angle)
relative to the separation of scattering molecules and D is the diffusion coefficient. q is
the scattering vector [190]:
q =
4pin
λ
sin
(
θ
2
)
(2.7)
where θ is the scattering angle and n is the refractive index of the solution.
Smaller particles will move more quickly than larger ones, and hence their correlation will
decay more quickly.
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Figure 2.5: DLS experiment: light, usually from a laser, is passed through a sample
solution, and light scattered in one direction is collected. The fluctuations in the intensity
of the light are related to the properties of the solute, and information such as the diffusion
coefficient, and hence the hydrodynamic radius, can be extracted.
Fitting the measured autocorrelation function to a theoretical function of this form, and
ensuring the suitability of a single exponential form (used for monodisperse molecules) by
calculation of χ2, the diffusion coefficient D can be determined, and then the hydrodynamic
radius r found using the Stokes-Einstein equation [191]:
D =
kBT
6piηr
(2.8)
where T is the temperature, kB is the Boltzmann constant and η is the viscosity. The
hydrodynamic diameter is the diameter of a sphere diffusing at the same rate as the
measured species. We expect coiled-coil peptides to be around 1 nm long per heptad, and
so would expect 3-4 nm structures for coiled coils formed by the hub peptides. As coiled
coils are more cylindrical than spherical in nature, we would expect values of hydrodynamic
diameter to vary slightly from the true length of the coiled coils, but they will give an
indication of whether a structure in the 3-4nm region (for a single coiled coil such as 1,2)
is forming. If we see values much smaller than this, then the peptides are likely forming
compact structures, and if larger, fibrous structures. For longer peptides, formation of a
hairpin and subsequent opening of the hairpin should result in a significant size change seen
between DLS measurements. DLS measurements have been taken for both the systems in
Chapters 3 and 5.
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2.3.4 Analytical Ultracentrifugation (AUC)
AUC involves the application of centrifugal force to solutions, and observation of the
redistribution of the solute. An experimental setup is shown in Figure 2.6. The main
types of AUC experiment are Sedimentation Velocity (SV) and Sedimentation Equilibrium
(SE). Both require measurements at several concentrations, and for SE, several rotation
speeds. Only SE results are discussed in this thesis.
Theory
When samples are centrifuged, they are subjected to centrifugal force [192]:
F = mω2r (2.9)
The effective mass of the particles (here, peptides) is slightly lower than their non-solvated
mass, due to upthrust in response to their displacement of solvent:
meffective = m−mν¯ρsolvent (2.10)
where ν¯ is the partial specific volume.
In SE, rotor speeds are chosen to allow competition between sedimentation and opposing
diffusion, acting to reduce the concentration gradient being produced. An equilibrium is
established, where a time-independent concentration distribution is seen, and from this,
molar mass can be measured [193; 194]. A typical concentration distribution for a sedi-
mentation equilibrium experiment is shown in Figure 2.7. The concentration profile of a
single species is given by Equation 2.11.
C(r) = C0e
meffω
2(r2−R20)/2kBT (2.11)
Analytical Ultracentrifugation is used in studies such as these to elucidate whether dimers
or higher order oligomers are being formed, through measurement of the masses of the
present species.
2.4 Summary
Combining all of these techniques, we can prove that we have interacting peptides, which
are forming structures of a given mass and size. Further to this, experiments to prove the
exclusivity of the peptides are discussed in Chapter 3, and simulations are described and
analysed in Chapter 4.
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Figure 2.6: AUC experimental setup: a sample and standard are centrifuged, and observed
using a detection system.
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Figure 2.7: A typical spectrum seen for the concentration of a sample, as a function of
radius, for SE. Absorbance (via the Beer-Lambert law) directly correlates with concentra-
tion. c(r) at equilibrium for a single species is shown.
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The Tumbleweed Hub
3.1 Hub Structure
As discussed in Section 1.5.4, peptides 1, 2, 3, 4, 5 and 6 are the components of the Y
hub. The initial aim of this PhD project was to synthesise and characterise these peptides.
This chapter initially describes the characterisation of individual and mixtures of single
hub peptides, without any covalent bonding between them. As discussed in Section 1.5.4,
to form the full hub, peptides from different coiled coils have to be chemically bonded,
(from N to C termini) 6 to 1, 3 to 2 and 4 to 5, and when these three chemically bonded
pairs are mixed, the formation of the hub will be completed by preferential coiled-coil
formation between 1 and 2, 3 and 4, and 5 and 6 (Figure 3.1). In this thesis, the covalent
bonding between 1 and 6, 2 and 3, and 4 and 5 has been via disulphide bonds between
cysteine residues, positioned at one end of each hub peptide (Table 1.1). Throughout this
chapter, peptide pairs denoted ‘a,b’ are individual peptides a and b mixed together, while
‘a-b’ denotes a and b linked via a disulphide bond. Through the characterisation of the
individual and mixtures of peptides, the interactions between them are investigated. The
specificity of the designed coiled coils, which is vital for a stable hub with three different
feet to form, is also covered in this chapter.
3.2 Experimental Aims
For this system:
1. All of the six hub peptides were synthesised (four by LSRS, and peptides 1 and 6
by Marc Bruning).
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Figure 3.1: The ‘Y’ configuration of the Tumbleweed hub, with termini labelled, showing
the antiparallel nature of 5,6 and the parallel coiled coils 3,4 and 1,2. To form a hub,
coiled-coil pairs (1,2), (3,4) and (5,6) need to preferentially interact, while 1 and 6, 2 and
3, and 4 and 5 are forcibly linked to ensure all of the coiled coils are connected to form
one structure.
2. All peptides were purified via HPLC.
3. The CD spectra of each peptide and pair of peptides was measured.
4. DLS measurements were taken for each of the designed coiled-coil pairs.
5. Disulphide bonds were formed between pairs of peptides.
6. Disulphide bonds in the system were allowed to rearrange to investigate pair speci-
ficity of the coiled-coil peptides.
In addition to these experiments, data taken by Elizabeth Bromley (EHCB) on this system
is used in the discussion, and labelled appropriately.
3.3 Results and Discussion: Individual Peptides
3.3.1 CD
In this work I have used CD to study the helicity of the hub peptides, and the changes
they undergo when mixed with their designed coiled-coil partners and other peptides in
the Tumbleweed system.
In addition to a CD spectrum taken at 20 ◦ C (shown in Figure 3.2), studies of the
stability of the peptides were also carried out, by measuring their CD at 222 nm as a
function of temperature, between 10 and 90 ◦ C (Figure 3.3). For individual peptides,
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circular dichroism measurements were performed on 20 µM solutions in PBS (pH 7.4),
to assess their helicity without a partnering peptide. CD spectra were also measured for
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Figure 3.2: Individual CD spectra for the six Y hub peptides (1 to 6), each measured at
20 µM concentration in PBS buffer (pH 7.4), at 20◦C. The peptides 1 to 6 are shown in
red, blue, green, purple, orange and magenta respectively.
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Figure 3.3: Melt spectra for the six Y hub peptides (1 to 6), each measured at 20 µM
concentration in PBS buffer (pH 7.4), from 10 to 90◦C. The peptides 1 to 6 are shown in
red, blue, green, purple, orange and magenta respectively.
each of the 15 possible two-peptide mixtures. Each peptide in the mixtures was at a
concentration of 20 µM, and hence the mixtures had a total peptide concentration of 40
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µM. All of the spectra have been converted to Molar Residue Ellipticity, so as to remove
the effect of varying residue concentration, as the peptides differ in sequence length.
For each two-peptide mixture, the individual peptide spectra have been plotted alongside
the mixture data, and a theoretical mixture spectrum calculated from the single peptide
data. These theoretical spectra are what would be expected if there was no interaction
between the two peptides present, a weighted average of the two individual peptides’ CD
spectra (Appendix F.2.3). Figure 3.4 shows the CD data for the designed dimers, while
the other 12 mixtures are shown in Figure 3.5. Melt data for the 15 mixtures was also
taken; the designed pair data is shown in Figure 3.6 (the other 12 spectra are in Appendix
E.2). The resultant melting temperature values are shown in Table 3.1. Finally, the CD
spectrum of all six peptides mixed together was taken, and compared with the spectra
predicted from the six individual peptides (no hetero-oligomeric interactions), and from
the three designed pairs (Figure 3.7). The melt data of the full set of peptides was also
taken and compared with the sum of the designed pairs (Figure 3.8).
The design requisite for the peptides in the Tumbleweed hub was not to form individual
α-helices, but to form helical structures - dimeric coiled coils - in the presence of a specific
partner. There may be some individual helicity, due to an overlap between the design of a
coiled-coil peptide pair and a helical peptide, but there should be greater helical structure
when the peptides are in a 1:1 mixture with their intended partners than when they are
alone in solution. To form the hub, they must also preferentially bind to this partner when
given a choice between the partner and other hub peptides.
As shown in Figure 3.2, the individual peptides, as indicated by their CD spectra, have
varying degrees of helicity. Their helicity could be due to the peptide being intrinsically
helical, or because multiple copies of the peptide are forming homo-oligomers.
The CD designed pair data (Figure 3.4) shows that all three fulfil one element of the
design criteria; they are well designed to form coiled coils. There is a consistent increase
in helicity when the pairs are mixed together. The measured mixtures show significantly
increased helicity than the theoretical spectra, which would be expected if the peptides
present were not interacting. In all three of the pairings, the mixture is also more helical
than the individual peptides.
An unsurprising but complicating factor in testing the 15 peptide mixtures is evident from
the other 12 possible pairings (Figure 3.5). All of the non-designed mixtures also appear
to interact and form hetero-oligomeric species that are more helical than their homo-
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Figure 3.4: CD spectra of the three mixtures of the designed pairs of peptides - 1 and 2,
3 and 4, 5 and 6 (shown in green). Each figure also shows the individual peptide spectra
(red and blue, in numerical order), and the theoretical signal for a mixture of the two
without interaction (a combination of the two single peptide signals, shown in purple).
Each sample had a concentration of 20 µM per peptide, in PBS buffer (pH 7.4), measured
at 20◦C.
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Table 3.1: Melt temperatures of peptides studied
Peptide Sample Type Melting Temperature (◦C)
1 single 49 ± 3
2 single 65.6 ± 0.2
3 single 52.8 ± 0.1
4 single 75 ± 1
5 single -
6 single 43 ± 3
1,2 designed pair 52.2 ± 0.4
3,4 designed pair >80
5,6 designed pair >80
1,3 not designed pair 50.1 ± 0.1
1,4 not designed pair 69.2 ± 0.2
1,5 not designed pair 64 ± 2
1,6 not designed pair 50 ± 3
2,3 not designed pair 69.8 ± 0.3
2,4 not designed pair 73.4 ± 0.4
2,5 not designed pair 70.5 ± 0.5
2,6 not designed pair 65.3 ± 0.2
3,5 not designed pair 57.8 ±0.4
3,6 not designed pair 62.2 ± 0.1
4,5 not designed pair 67.4 ± 0.3
4,6 not designed pair 73.2 ± 0.3
1,2,3,4,5,6 full mixture >80
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Figure 3.5: CD spectra of the 12 non-designed peptide pairings. Each sample had a
concentration of 20 µM per peptide, in PBS buffer (pH 7.4), measured at 20◦C. The spectra
of the individual peptides present in the mixture are shown in red and blue respectively,
while the spectrum of the mixture is shown in green. The theoretical spectrum for the
mixture, calculated from the individual spectra, is shown in purple.
oligomeric species. As all of the peptides are designed to have a hydrophobic seam, it is no
surprise that interacting with other peptides, or copies of themselves, to bury hydrophobic
residues, is energetically favourable over remaining as monomers in solution. All 15 of the
mixtures appear to have melting temperatures sufficiently high to be functional at room
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Figure 3.5: CD spectra of the 12 non-designed peptide pairings. Each sample had a
concentration of 20 µM per peptide, in PBS buffer (pH 7.4), measured at 20◦C. The spectra
of the individual peptides present in the mixture are shown in red and blue respectively,
while the spectrum of the mixture is shown in green. The theoretical spectrum for the
mixture, calculated from the individual spectra, is shown in purple.
temperature, in which future experiments could be expected to be performed in. With
this interaction between non-designed pairs of peptides visible, it is even more important
to use other methods to confirm that the set of six follow the design criteria of forming the
three designed dimers when they are all mixed, and not a mixture of all 15 possibilities
68
Chapter 3 The Tumbleweed Hub
10 20 30 40 50 60 70 80 90
Temperature (°C)
-30000
-20000
-10000
0
CD
 (M
RE
)
Figure 3.6: Melt curves for the three designed dimers. Each sample had a concentration
of 20 µM per peptide, in PBS buffer (pH 7.4), measured from 10 to 90◦C. 1,2 is shown in
red, 3,4 in blue and 5,6 in green.
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Figure 3.7: CD spectrum of all six hub peptides mixed together (green), compared with
the spectrum expected from the individual spectra (i.e. if there was no inter-peptide
interaction, shown in magenta), and from the designed pair spectra (i.e. if the designed
pairs, and those only, interact, shown in purple). The spectra for 1,2 is also shown, in red,
3,4 in blue and 5,6 in orange. The sample had a concentration of 20 µM per peptide, in
PBS buffer (pH 7.4), measured at 20◦C.
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Figure 3.8: Melt spectrum of all six hub peptides mixed together (shown in green), com-
pared with the spectrum expected (shown in purple) from the designed pair melt spectra
(i.e. if the designed pairs, and those only, interact). The sample had a concentration of
20 µM per peptide, in PBS buffer (pH 7.4), measured from 10 to 90◦C.
(or an even greater number of higher order oligomeric species).
The data from the mixture of all six peptides is positive towards this conclusion; the
measured CD spectrum and melt are very similar to what would be expected for a mixture
of the three designed pairings, as calculated using the spectra from the three individual
designed pairs (Figures 3.7 and 3.8).
3.3.2 DLS
DLS was used to measure the hydrodynamic diameters of the three designed coiled-coil
peptide pairs, at concentrations of 100 µM per peptide. 50 measurements were taken
of each pair (with each measurement being the result of five 10-second DLS runs), and
peaks in the region of interest, of intensity as a function of size, on the DLS spectra were
fitted with a Gaussian function, to extract the peak values. An example of the fits is
shown in Figure 3.9. Using a Gaussian fit should be more accurate than using the point
of maximum intensity, as this could be biased to one side of the peak due to a low number
of data points defining the peaks’ maxima. An average was then found for each pair of
peptides. Some of the spectra had more than one peak in the region of interest (Figure
3.9), but as these were likely artifacts due to the algorithm used by the DLS software to
create the spectra, as opposed to being true second species, they were discarded and not
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included in the averaging process. Most spectra also had peaks in the 102-104 nm region of
the spectrum, and a few had peaks in the 40-100 nm region, but not a constant alternative
species present. To decide a suitable numerical cutoff to remove bad fits, the standard
deviation of each data set was calculated (using normalised intensities, as some runs had
higher intensities than others), for the 0-20 nm region. It was found that a cut off of 0.08
(any sets with a standard deviation above were discarded) removed any visibly bad fits
to peaks, but that this did not necessarily cut out all of the double-peaked sets, as some
of the second peaks were small, and the first peaks were fit well to a Gaussian function,
making the overall fit better than some fits to single peaked spectra. The average size
from each data set, with no exclusions, all double peaked data sets removed, all above
0.08 standard deviation data sets removed, and both above-0.08 standard deviation sets
and double peaked sets removed, are shown in Table 3.2. It is obvious from the small
differences between the results in Table 3.2 that the exclusions do not greatly affect the
resulting averages.
1,2
All 50 data sets had peaks in the region of interest, but only 48 were fitted, as the remaining
two had two peaks of competing size, making the choice between them difficult for the
fitting protocol, when they would be discarded later regardless, due to the twin peaks. A
further 11 were discarded later due to their possessing a double peak, leaving 37 sets with
a single peak. Four more data sets were excluded based on their standard deviations. 33
sets were used for the final average, of 3.41 ± 0.08 nm.
3,4
All 50 data sets contained peaks in the region of interest. Five were excluded due to the
presence of a second smaller peak in the region of interest, and two more due to their
standard deviation values. The average from 43 data sets was 5.04 ± 0.06 nm, consistent
with the average found if the main peak from all 50 data sets was used.
5,6
Only 43 data sets had a peak in the region of interest, immediately reducing the set size.
Two more were excluded by the selection criteria, giving an average from 41 sets of 4.25
± 0.05 nm.
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Table 3.2: DLS Averages: Tumbleweed Designed Pairs
Sample Criteria Sets
used
Average
(nm)
Standard
Deviation
(nm)
Standard
Error
(nm)
1,2 All data sets 481 3.48 0.64 0.09
Double peak sets
removed
37 3.43 0.50 0.08
σ < 0.08 34 3.43 0.49 0.08
No double peaks,
σ < 0.08
33 3.41 0.49 0.08
3,4 All data sets 50 5.01 0.42 0.06
Double peak sets
removed
45 5.05 0.42 0.06
σ < 0.08 47 5.02 0.41 0.06
No double peaks,
σ < 0.08
43 5.04 0.42 0.06
5,6 All data sets 432 4.23 0.34 0.05
Double peak sets
removed
42 4.24 0.32 0.05
σ < 0.08 41 4.25 0.32 0.05
No double peaks,
σ < 0.08
41 4.25 0.32 0.05
1 Two sets were removed prior to fitting, as they contained two competing peaks in
the region of interest.
2 7 data sets had no peaks in the region of interest.
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Figure 3.9: Two examples of DLS data sets (runs 13 and 32) for the 5,6 sample. The first
shows a single peak, well fitted to a Gaussian function, while the second is an example of
a double peak, and was not included in the averaging process.
Discussion
The DLS data adds some evidence backing the success of the design requisite of blunt
ended coiled-coil dimers. As discussed in Section 2.3.3, one would expect each of these
coiled coils to form a species of 3-4 nm, and hence have a hydrodynamic diameter of similar
size. It is unusual that the 5,6 pair appears to have a larger hydrodynamic radius than
1,2, as both 1,2 and 3,4 are four-heptad coiled coils, while 5,6 has only three heptads.
However, the data from all three pairs indicates strongly the presence of a species with
a size close to that expected of single peptide-lengthed species, such as those shown in
Figure 1.10. One cannot tell from DLS data the oligomeric state of the coiled coil, as a
trimer or tetramer would give a similar size, but one can exclude the possibility of fibrous
species. The data implies that structures of the length expected from blunt-ended coiled
coils are forming. Sticky-ended peptides (Figure 1.14) would result in fibrous structures
of longer lengths, and there was no persistent peak between these ∼4 nm peaks analysed
and those caused by dust/other contaminants to indicate the presence of such a species.
3.3.3 AUC
The AUC data shown here was carried out on other syntheses of these peptides, by EHCB,
and is included here to support this work. All samples were made up so that their con-
centrations corresponded to optical depths between 0.3 and 0.45. The molecular weights
measured are shown in Table 3.3. The original data is in Appendix E.3. The molecular
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Table 3.3: AUC Data: Designed Pairs
Sample Expected Molecular
Weight
Measured Molecular
Weight
v¯
1,2 7041 7000 ± 1000 0.7467
3,4 7397 7100 ± 1000 0.7467
5,6 5816 5900 ± 1000 0.764
weights measured by AUC for the designed peptide pairs were all consistent with their
expected molecular weights, within the experimental error given. Two of the three de-
signed pairs had measured masses within 100 Da of their expected masses, even though
they each had an error of ± 1000 Da. The third, (3,4), had a measured value within 300
Da of the expected value, with an error of ± 1000 Da. This data indicates that dimers
are being formed as opposed to higher order (and heavier) species.
3.4 Results and Discussion: Disulphide-bonded Peptides
3.4.1 Disulphide Bonding Between Peptides
pep pep
SH
NS
SN
+
N SH
pep pep
Pys
pep pep
Pys
pep pep
SH
pep pep
Pys
pep pep
SH
+
+
N SH
+
Figure 3.10: Formation of a disulphide bond between peptides, using Aldrithiol-2. One
cysteine-containing peptide is first reacted with Aldrithiol-2, and then with a second
cysteine-containing peptide.
One method of bonding the peptides together is via disulphide bonding, mediated by
Aldrithiol-2 (also known as 2,2’-Dipyridyldisulphide and 2,2’-Dithiodipyridine), an oxidis-
ing agent. In order to facilitate this, all of the peptide sequences include a single cysteine
residue. Peptides 1, 2 and 4 were each individually treated with Aldrithiol-2 to form S-Pys
cysteine sidechains [195]. Each of these was then mixed with another hub peptide (6, 3,
and 5 respectively) to form a disulphide bond between the cysteine residues (Figure 3.10).
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The resultant bonded peptide masses are shown in Appendix C.1. The peptides were
purified after each step to remove any unreacted Aldrithiol-2, and the waste molecules
formed by each reaction.
3.4.2 Proving Exclusivity of Coiled-coil Pairs
In order to prove the exclusivity of the coiled-coil pairs, the use of the disulphide bonding
property of cysteine can again be used. Glutathione is used as a reducing and oxidising
agent for peptides/proteins, depending on which of its forms is used (Figure 3.11). In order
to gain evidence that the coiled-coil hub will successfully form, we performed experiments
where all three disulphide bonded species were mixed in a 1:1:1 ratio, and placed in a
mildly reducing environment, sufficient that disulphide bonds could be broken and new
ones reformed, but were not reduced fully, returning the original individual peptides.
For this we used a low concentration of reduced glutathione. If the coiled-coil peptide
pairs preferentially bind, they should become disulphide bonded when the three originally
disulphide bonded pairs are given the opportunity to rearrange (Figure 3.12). The MALDI-
ToF spectrum of (6-1, 2-3, 4-5) in a 1:1:1 ratio shown in Figure 3.13a was performed on a
sample of the three species mixed in water pretreated with TFA, and measured within an
hour of mixing. This lowering of the environment’s pH (a total of 7.8µl peptide in water
was placed in 50µl of pH 2 TFA-water) appears to have kept the original species intact; a
test experiment, with the three species mixed in water, indicated that this environment was
sufficient to allow the disulphide bonds to reform within days, and the disulphide-bonded
designed pairs were seen on a comparable level to the starting peptides. The ability of
the disulphide bonds to exchange so easily in water indicates that for future experiments,
the conditions of the system need to be more tightly controlled to prevent rearrangement
and subsequent dissociation of the hub components, and that there may be more reliable
methods of ensuring the hub’s stability than via disulphide bonding. The two main peaks
visible are the 2-3 and 4-5 species; 6-1 is one of the smaller peaks seen, of a comparable
height to some of the minor impurities seen in the starting materials. The MALDI-ToF
spectrum shown in Figure 3.13b shows the state of the system when the (6-1), (2-3), and
(4-5) species were mixed in PBS buffer, with a low concentration of reduced glutathione
(after 5 minutes, water pretreated with TFA was added to quench the reaction). The
spectrum has altered significantly. The disulphide bonds have rearranged. The peaks for
the designed pairs in disulphide bonded form, 1-2, 3-4 and 5-6 are all present, and the
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Figure 3.11: The reduced (left) and oxidised (right) states of glutathione, known as GSH
(glutathione) and GSSG (glutathione disulphide) respectively. In nature, GSH undergoes
thiol-disulphide exchange with protein disulphide bonds to produce GSSG. We will use
the same reaction to break disulphide bonds between our peptides, but at a low enough
concentration that disulphide bonds can be reformed.
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Figure 3.12: If the coiled-coil hub peptides preferentially interact, when allowed to rear-
range, the disulphide bonds should switch from linking the chemically reacted pairs to
between the designed pairs.
fourth strong peak belongs to the starting pair 2-3. There appears to be a trace amount
of 4-5 remaining, no 6-1, and none of the other undesired pairings are present. The other
small peaks are impurities. This provides rather compelling evidence that the designed
pairings are highly preferred interactions in the system.
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Figure 3.13: MALDI-ToF spectra of the species present before and after treatment of the
hub with glutathione. a) The two main peaks in the spectrum correspond to the 3-2 (MW
7095) and 4-5 (MW 6682) disulphide-bonded peptides. Additionally there are peaks at the
(M + Na)+ masses (7117 and 6704 for 3-2 and 4-5), and the smaller peaks in this area are
from the 6-1 peak (6470), and peptides which have been formed from these correct pairings
of peptides, but where one of the contributing peptides had an additional/missing residue
(as seen in the single peptide MALDI-ToF spectra in Appendix E). b) The dominant
species present (in the region of interest) after rearrangement are 6-5 (MW 5814), 1-2
(MW 7039), 3-4 (MW 7395) and 3-2 (MW 7095).
3.4.3 Additional Data for Disulphide-bonded Peptides
The data in this section was taken by EHCB on a previous synthesis of the hub peptides.
The findings of the glutathione experiments indicate that the current peptides, although
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prepared in the same preparation conditions, are in an environment which does not allow
long-term disulphide bonding between non-designed dimers, and hence we would not ex-
pect to see a hub-sized species in AUC or DLS data due to rearrangement of disulphide
bonds and consequent dissociation of the hub components. However, in a previous synthe-
sis, this issue was not seen, and successful data was taken, supporting the design success
of the hub.
CD
The three disulphide-bonded peptides, the pairs of disulphide-bonded peptides, and the
full hub (Figure 3.14) all give strong helical CD signals. The melt data for the disulphide-
bonded peptides is shown in Figure E.8.
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Figure 3.14: CD data of the disulphide-bonded peptides, taken by EHCB. The red spectra
are the single disulphide-bonded peptides, 1-6, 2-3 and 4-5, while the blue spectra are
the pairs of disulphide-bonded peptides, (1-6, 2-3), (2-3, 4-5) and (4-5, 1-6). The green
spectrum is the mixture of all three disulphide-bonded peptides.
DLS
Figure 3.15 shows a representative sample of runs for each of the three disulphide-bonded
peptides, 1-6, 2-3, and 4-5, the three possible pairs of disulphide-bonded peptides, and
all three disulphide-bonded peptides mixed together. The three single disulphide-bonded
peptides have peaks around 4 nm (two between 3 and 4 nm, and one slightly above 4
nm), while the pairs all have a higher value around 5 nm. The three disulphide-bonded
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peptide mixture also has a value centred around 5 nm. No unusual behaviour is seen
here. The single peptides have hydrodynamic diameters which are compatible with hairpin
formation, which is not unexpected given the behaviour seen in the CD spectra of the
peptide mixtures without disulphide bonds, indicating interaction between undesigned
pairs in the absence of designed partners. The pairs have larger hydrodynamic diameters
that the single disulphide-bonded peptides, indicating different interactions from the single
species: interactions between the two species present. The hub would be expected to have
a similar diameter to the pairs, as we would not expect a change in the longest dimension
of the system when moving from a disulphide-bonded pair of peptides to the full hub.
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Figure 3.15: DLS data of the disulphide-bonded peptides, taken by EHCB. The red peaks
are representative measurements of the disulphide-bonded peptides, 1-6, 2-3 and 4-5, while
the blue peaks are the pairs of disulphide-bonded peptides, (1-6, 2-3), (2-3, 4-5) and (4-5,
1-6). The green peak is the mixture of all three disulphide-bonded peptides.
AUC
The measurement and fitting of the AUC data gave no indication that anything other than
a single species was present. The molecular weights measured by AUC for the disulphide-
bonded peptides and their mixtures (shown in Table 3.4), with the exception of 2-3, were
all consistent with the expected molecular weights, within the experimental error given.
The measured (within errors) and expected values of 1-6 and 4-5 were consistent with each
other, while 2-3, even with a larger error than the other species of the same type, of ± 2000
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Table 3.4: AUC Data: Disulphide-bonded Peptides
Sample Expected Molecular
Weight
Measured Molecular
Weight
v¯
6-1 6470 7300 ± 1000 0.746
2-3 7096 9700 ± 2000 0.7482
4-5 6682 7600 ± 1500 0.7458
6-1, 2-3 13566 16000 ± 3000 0.7467
2-3, 4-5 13778 14000 ± 2500 0.7467
4-5, 6-1 13151 16000 ± 3000 0.746
6-1, 2-3, 4-5 20248 19000 ± 4000 0.746
Da, was not consistent; the expected mass was over 2600 Da smaller than the measured
mass. The measured mass is consistent with the masses of homotrimers and heterotrimers
of single peptides 2 and 3. However, this would only be possible if the peptides were able
to reduce their disulphide bonds. The masses measured for 1-6 and 4-5 are consistent
with the presence of single disulphide-bonded species, not multiple copies interacting to
form larger species. While the mass of 2-3 is not consistent with the mass of a single
2-3 species, it is also inconsistent with a species formed from multiple interacting copies
of 2-3. The molecular weights of (6-1, 2-3), (2-3, 4-5) and (4-5, 6-1) are consistent with
interactions between a single molecule of each of the two pairings present. The fact that
the single disulphide-bonded peptide measurements did not measure species with masses
corresponding to multiple copies interacting to form larger structures indicates that, in
the mixtures of two disulphide-bonded peptides, it is likely that one of each species is
interacting as opposed to two copies of the same molecule. The mass of the whole set of
(6-1, 2-3, 4-5) is consistent with a species formed from one copy of each of the disulphide-
bonded species present.
3.5 Conclusions
Helicity of the six hub peptides was measured and compared to the peptides when mixed
with both designed and non-designed peptide partners. It appears that all of the peptide
pairings have a more helical structure than individual contributing peptides, regardless
of whether the pair are intended partners. However, the preferential pairing of the de-
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signed pairs above all of the other possibilities was strongly supported by the disulphide
exchange reaction, which displayed the three desired pairs, and none of the 12 undesired
dimer pairings, excepting an excess of 2-3 (and a trace of 4-5), both starting products.
Hydrodynamic diameters of the designed hub peptide pairs, measured using DLS, were
consistent with blunt ended species. The AUC data was consistent with the interaction of
one set of the three disulphide bonded peptides to form a structure. There was no evidence
from the AUC data that the disulphide bonded peptides would form larger species than
designed. The DLS data of the full set of disulphide bonded peptides also gave a hydrody-
namic diameter of the size approximately expected for a hub of the structure suggested in
Figure 3.1. This combined information indicates that the hub system is able to form well
defined designed structures. The peptides involved are functioning as desired. The main
concern is the inconsistent behaviour of the disulphide bonds within the system. Although
prepared in the same way, with the same buffer solutions and pH values, the disulphide
bonds in one sample of the system were stable whilst in another they rearranged readily.
The redox potential of the system needs to be more strongly controlled, or the disulphide
bonding in the system replaced by a less sensitive linkage between the three coiled coils of
the system.
To further develop the system, a more robust means of connecting the three legs of the
Tumbleweed is desirable. It is clear that the disulphide bonds in the system are easily
compromised. The synthesis of three long peptides, each with two coiled-coil domains, as
opposed to six peptides later linked via disulphide bonding is one option. This could be dif-
ficult, due to the general decrease in successful syntheses with increased sequence lengths,
yet, as seen in Chapter 5, it is possible. The extra time and effort spent achieving success-
ful long syntheses will likely save effort in the later stages in ensuring that the system does
not rearrange and dissociate. Further data on the dimensions of the system, using other
techniques, would be advantageous. The synthesis of fluorescently tagged analogues of the
hub peptides, and measurement of Fo¨rster Resonant Energy Transfer (FRET) between the
tags in an analogue hub structure would give dimensional and dynamical information on
the system.
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Bar Motor - A Two-footed Design
4.1 Concept
The bar motor is the second motor design discussed in this thesis. It has two legs and feet,
in contrast to the Tumbleweed’s three. Again, the legs are formed by coiled-coil dimers
and it is coiled-coil interactions that will connect the components of the motor. The idea
  a1             b1                   a2                1 b2
Figure 4.1: The concept of the bar motor. The motor would start in a V conformation
bound at sites a1 and b1. In order to move the motor there is then a removal of the
A ligands from the system, coincident with switching to a straight bar conformation.
This is followed by a return of the A ligands, encouraging binding to a2 (now spatially
preferable to a1). Removal of the B ligands and switching to the V conformation should
encourage lifting of the b1-bound foot, followed by the return of the B ligands to finish
the sequence by facilitating binding to the spatially preferred b2. This leaves the motor in
the V conformation bound to a2 and b2, one a,b binding site set further along the track.
Repetition of this cycle would allow subsequent steps.
is to have a motor with two legs, and a method through which it can switch between
two conformations - in this case, a bar-like straight conformation, and a middle-hinged
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V-shaped conformation. Figure 4.1 explains the stepping method of the bar motor. In the
straight conformation, the separation of the feet is larger than in the V conformation. To
encourage progressive motion in the desired direction, the track would have a repeating
a,b sequence of binding sites, where (as shown in Figure 4.1) xb1 − xa1 6= xa2 − xb1 .
The difference in separation of b1 with a1 and a2 should mean that movement across the
shorter distance is unfavourable when the motor is in the bar configuration, and in the
V conformation, the closer site should be more favoured due to compatibility between
the conformation’s feet separation and the track spacing. For these conformations to be
possible, the peptide hub needs a central region which is switchable to allow them, and this
change needs to be controllable. The initial design idea was to have a long peptide with
a flexible central region connecting two coiled-coil sequences which each bind to a shorter
partner peptide to form a dimer. These two dimeric coiled coils should give the ‘legs’ of
the hub stable structures. As with the Tumbleweed, the coiled-coil peptides need to be
orthogonal so that each motor forms with two different feet. The intention for this design
is that when in one conformation, the whole long peptide will be helical and rigid, making
a bar-like motor, and in the other, have two rigid legs with a flexible middle, allowing a
V shape (along with other conformations between a bar and a hairpin).
This was thought to be possible if the amino acids comprising the central region were
chosen to have sufficient inclination for helicity as to allow it, but not be so stable in
the helical conformation that it could not be broken by a change in environment. Being
surrounded by coiled-coil regions was thought to likely further encourage any natural
helicity in the central region. One possible switching mechanism is to have an azobenzene
molecule bridging the central region.
Azobenzene is a compound which can be switched between cis and trans conformations
using irradiation with different wavelengths of light. Irradiation using wavelengths around
360nm has been used for switching from the trans to cis conformations [196; 197; 198]. The
azobenzene isomers have different end-to-end lengths, and it has been used by groups such
as that of G. Andrew Woolley as a means of switching peptides between conformations
[196; 197; 198; 199]. It isomerizes very quickly, on the scale of picoseconds [199]. As it has
been found to be sufficient to disrupt the amino acid chain over which it is attached in
some model peptide systems, it may also be able to disrupt the potentially helical central
region of the bar motor. If successful, this switching, and coincident removal of ligands,
will be sufficient in working against the binding strength of the feet to the track, to force
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the motor to remove one foot from the track, and allow subsequent binding to the next,
more suitably distanced, binding site.
In summary, the system requirements are:
1. A means of ensuring that the motor forms one unit with two different feet.
2. Two stable switchable motor states.
3. A method of switching from one state to the other in a controlled, repeatable manner.
4. A method of making the steps directional.
Our proposed methods of fulfilling these requirements:
1 a) One component which spans the distance from one foot to the other foot, so that the
motor forms one unit - a long peptide sequence with the form (coiled-coil sequence
A)-(switchable linking region with two cysteine residues)-(coiled-coil sequence B).
In Figure 4.1, this is represented by the dark red-green-dark blue chain.
1 b) Two peptide sequences complementary to sequences A and B (represented by the
lighter red and blue rectangles in Figure 4.1), to form dimeric coiled coils. The two
dimers need to be orthogonal so each motor has two different feet (one foot will be
bound to each of these complementary sequences prior to mixing these with the long
peptide to form the whole motor domain).
2&3 A light-switchable azobenzene moiety (the black staple-like component in Figure
4.1) bound to the long peptide via two cysteine residues in its linking region.
4 A directional track as shown in Figure 4.1, and the motor states to have sufficient
differences in foot separation to be influenced by the unequally spaced track binding
sites.
The design of the track (including the binding sites, the large circular objects in Figure
4.1), and two different DNA binding ‘foot’ domains (the small circular objects in Figure
4.1), as with those of the Tumbleweed, are outside the scope of this thesis.
4.2 Coarse-grained Simulations
3D coarse-grained (CG) Langevin dynamics simulations were carried out by Martin Zuck-
ermann to complement our work, to check whether the bar motor design would work in
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concept. The Langevin equation (originally formulated by Paul Langevin in 1908) used in
our simulations describes the Brownian motion of solute particles in a solvent where the
solvent molecules are much smaller than the solute particles. It is a stochastic differential
equation in which two force terms have been added to Newton’s deterministic equations
(Newtons second law) to approximate the effects of the fast microscopic degrees of free-
dom. In this case, the solvent molecules present in the system are not directly simulated
and the effect of their collisions with the solute particles is approximated in terms of a vis-
cous drag force on the solute as well as a random force representing the random collisions
with the solute particles associated with the thermal motion of the solvent molecules. We
use the overdamped version of the Langevin equation, which can be applied to situations
such as the motion of our nanomotors where the inertial component of the equation can
be disregarded due to the dominance of the viscous drag force (systems which have a low
Reynolds number). The equations used for the simulations are included in Appendix G.
The CG model of the bar motor strips away the molecular details of the system, and
simply consists of three spheres, representing the two feet, and a hinge (joint that can be
varied) between the coiled-coil legs, and two stiff harmonic bonds (of length l) to represent
the legs, all connected in a linear conformation (Figure 4.2). The track has repeated a,b
binding sites, where
xbi − xai = 2l (4.1)
xai − xbi−1 < 2l (4.2)
and the feet, FA and FB, can only bind to a (or b for FB) when the correct ligand A
(or B) is present. As discussed in Section 4.1, the steps of the bar motor are driven by
the coincident switching of the motor conformation and ligand concentration change. The
conformational switching is represented in these simulations by the changing of the FA-
H-FB angle, θ0 (Figure 4.2). A ‘pulse’ is defined here as a timestep during which a set
of parameters are fixed. At the end of each pulse, there is a change in the parameters;
here, the ligands present in the system change at the end of every pulse, and the angle θ0
changes every two pulses. The simulation repeats four ‘pulses’: (A, 0, ψ), (A, B, ψ), (0,
B, φ), (A, B, φ), where A and B denote the presence of the two ligands, and ψ and φ are
the values of θ0. Two simulation conditions have been carried out thus far, both with ψ
= 180◦, and (a) φ = 80◦ and (b) variable φ. For simulation one, xai − xbi−1 = 2lsin(φ2 ).
For an l value of 15 nm, this is 19.5 nm. For simulation two, xai − xbi−1 is set to 23
nm (equating to ∼100◦). The simulation is then carried out by solving the overdamped
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Langevin equation (Appendix G). In simulation one, the system is directional without
pauses (provided there is no external backward force), while in simulation two, the motor
could pause due to the flexibility of φ allowing the motor to stay at 180◦ during variable
φ pulses.
4.2.1 Results and Discussion
Scenario One: Two Fixed Angles
As shown in Figure 4.3, the two feet begin with a separation of 30 nm, indicating the system
is in pulse 2, with both ligands present and the motor in the 180◦ conformation. When
pulse 3 begins, foot FA lifts, as expected, and vibrates around positions approximately
centred on the position of bound foot FB, until pulse 4, and the return of ligand A allows
it to rapidly bind at x = 74.5 nm. Once pulse 1 begins, a similar process occurs with
foot FB; it lifts, samples positions within a 30 nm radius, and binds shortly after ligand
B is returned to the system in pulse 2 to a binding site at x = 104.5 nm. Each pulse
is 2.88 ms, and after 4 pulses, 11.52 ms, each foot has taken a step, moving the whole
motor ahead by 49.5 nm (one 30 nm and one 19.5 nm step). With two fixed angles, the
motor is processive, does not backstep, does not stall, and appears to bind rapidly after
the required ligand is reintroduced to the system.
Scenario Two: One Fixed Angle, One Flexible Angle
Scenario two is a more realistic scenario. Even in the design stages, prior to experiment,
it was hoped that rigid and flexible states could be created. It was always expected that
the flexible state would undergo a range of different angles. This scenario represents that:
half of the simulation pulses have a fixed angle of 180◦, while the other half allow the angle
to be varied. The results of this are shown in Figure 4.4. For this simulation, a spacing
corresponding to a 100◦ angle was chosen for xai − xbi−1 . It is clear from both axes of
Figure 4.4 that there are three missed (pairs of) steps. After the first step of each foot,
foot FB (blue) lifts, but upon the return of ligand B, replaces its foot in the same place as
it was previously bound (x = 78 nm). This means that foot FA has to remain at its (x =
108 nm) position during its next pulse changes, instead of stepping forward. In this case,
foot FB misses two possible stepping opportunities, before stepping on the third attempt.
Another single step per foot is missed at t ∼ 1.75 s. In total, after 2.5 s, and 13 four-pulse
cycles, 10 cycles led to successful stepping. Each foot progressed by 530 nm, of a possible
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l
Figure 4.2: The coarse-grained model has three spheres to represent the two feet, and the
azobenzene/hinge region. The coiled coils are represented by two stiff bonds.
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Figure 4.3: Scenario One: stepping of a motor with θ0 switching between 180
◦ and 80◦.
The leg length is 15 nm, and the track separations are 30 nm (to fit well with a motor
where θ0 = 180
◦) and 19.5 nm (80◦). Pulses are 2.88 ms long, and hence there is an angle
switch every 5.76 ms. The two lines (purple, red) in the top graph show the x-coordinates
of the two feet, while the lower graph shows the angle θ0, as a function of time.
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Figure 4.4: Scenario Two: stepping of a motor with θ0 at 180
◦, but with the binding
energy potential value switched, between fixed and variable θ0. The leg length is 15 nm,
and the track separations are 30 nm (to fit well with a motor where θ0 = 180
◦) and 23
nm (equating to 100◦). Each pulse is 46 ms long. Again, the two lines (purple, red) in the
top graph show the x-coordinates of the two feet, while the lower graph shows the angle
θ0, as a function of time.
88
Chapter 4 Bar Motor
689 nm, giving an efficiency of 77%. Whilst this is clearly less efficient that a fixed angle
motor, this indicates that a motor system much closer to that which we will be able to
create is still able to make progress.
4.3 System Design
The first attempt at experimentally testing the concept was the design and synthesis of
a 59-amino acid peptide which interacts with peptides 1 and 6 (two of the Tumbleweed
peptides). This long peptide will be henceforth known as 2, due to its being based on
the sequences of peptide 2 (previously discussed), and a sequence known as .  is an
alternative peptide to 5 as a partner for peptide 6, and forms a parallel coiled coil with
peptide 6 instead of the 5,6 antiparallel coiled coil. ,6 was originally one of the pairs for
the triangular version of the Tumbleweed hub (Figure 1.19c). The helical wheel diagrams
for 1,2 and ,6 are shown in Figure 4.5. In addition to its forming coiled coils with part-
ners, a desired characteristic of the long peptide is that the central region (replacing those
residues intended to form a flexible linker in the Tumbleweed peptides  and 6) forms
neither a highly stable helix nor is completely unfolded, so that it can be switched from
rigid to flexible. This central region therefore needed to be adapted from the original
sequences.
Figure 4.6 shows the steps of designing a suitable long peptide sequence for the first in-
carnation of the bar motor. The sequences of peptides  and 2 were put together, and
the linking regions shifted to the centre (steps 1 and 2). In the triangle design,  was
disulphide-bound to another peptide at the N-terminus, hence the linking region being at
the N-terminus, but here it will be covalently linked to 2 at the C-terminus. It is at this
point that the requirements for the azobenzene moiety had to be taken into consideration.
Figure 4.7 shows the azobenzene linker synthesised by Asahi Cano-Marques (ACM). The
trans isomer is the more energetically favoured, and has the larger end-to-end separation.
It can be bound to a peptide via cysteine residues. With an (i, i+7) spacing between the
involved cysteine residues, the azobenzene’s trans state will cause a separation between the
linked residues too large to allow helical structure between them [197] (Figure 4.8). When
the azobenzene is switched to the cis isomer, the residues should be brought together close
enough for helicity to be possible. Helicity is compatible with an (i, i+7) separation of
cysteine residues and an azobenzene cis isomer, or an (i, i+11) separation and azobenzene
trans isomer [197; 196]. Switching of the azobenzene is done using different wavelengths
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Figure 4.5: Helical wheel diagrams (made using DrawCoil [161]) showing the interactions
between pairs of peptides in the Bar motor. Dashed lines show salt bridges between e
and g residues. The blank circles are residues absent from the peptide, but which have a
corresponding residue in the partner (for example, peptide 1 has one more residue than
peptide 2, ending with an f residue, while peptide 2 ends with an e residue (see Table
1.1).
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CGNGNEIAAL...IAALKCGNGNKIAA...IAALK
EIAAL...IAALKCGNGNCGNGNKIAA...IAALK
EIAAL...IAALK?C??????CNKIAA...IAALK
EIAAL...IAALK???C??????CNKIAA...IAALK
EIAALEYEINALEQKIAALKQKNCAGAANACNKIAALKQEIYALEQKNAALKQKIAALK
Peptide 
CGNGNEIAALEYEINALEQKIAALK
Peptide 2
CGNGNKIAALKQEIYALEQKNAALKQKIAALK
Centralise linking regions
Move cysteines to i, i+7 separation
Insert residues to shift cysteines
from hydrophobic seam
Determine suitable linking sequence
Figure 4.6: Steps of designing the bar motor sequence.
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Figure 4.7: Azobenzene linker synthesised by ACM. The azobenzene molecule switches
isomer when photoexcited by 380 nm light. The trans (left) and cis (right) isomers are
shown. As implied by the figure, the isomers have different end-to-end separations, which
is the property we wish to exploit.
of irradiation, and the success of it dependent on whether this switching is strong enough
to overcome the interactions causing the helicity. In this case, we placed the two cysteines
Figure 4.8: For a 7 residue separation between the azobenzene ends, the azobenzene in
the trans state should provide an end-to-end separation sufficiently long as to distort
the contained residues’ helicity. When the azobenzene is switched to the cis state, the
extremities of the azobenzene are brought together, allowing the surrounded residues to
be close enough to form a helix.
7 residues apart, and all of the other central region amino acids were set to undefined
(Step 3 of Figure 4.6). We added two residues before the first cysteine to shift the cys-
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teines to b positions, towards the outside of the coiled coil (Step 4); in a or d positions
they are more likely to interfere with coiled-coil formation in an unintended manner, by
disrupting the formation of a hydrophobic seam. Various alanine, asparagine and glycine
combinations were tested as possible six residue linking region sequences using AGADIR
[200; 201; 202; 203; 204].
AGADIR is an algorithm for calculating the helicity of peptides in solution, using helix-
coil transition theory. AGADIR uses early helix-coil transition models (describing the
transition from α-helix to random coil) by Zimm & Bragg [205] and Lifson & Roig [206]
as a basis, which contain nucleation and elongation/propagation parameters - whether a
residue was likely to initiate a helical region, and/or continue an existing one, along with
more recent information. It includes hydrogen bonding, capping interactions, the intrinsic
helical tendencies of given residues, charge-dipole interactions, interactions between side
chains, and some local motifs which stabilise helices. It includes the effect of temperature,
ionic strength, and pH. It gives a residue-by-residue helicity content, which is the data we
extracted and used here to influence our choice of central sequence.
Various linking regions were inserted into the sequence and assessed using AGADIR. The
results are shown in Figure 4.9. The helicities found by the program are low in general
for the whole peptide, but this is unsurprising, as the peptides are designed to be helical
when forming coiled coils with a partner, not to necessarily be naturally helical alone
and AGADIR does not have this coiled-coil information. Setting aside this generally low
helicity percentage, the AGADIR results show that the linking region (independent of the
sequence within the test set used) has a lower helicity than the two would-be coiled-coil
regions, which we were aiming for. Of the tested sequences, an all-alanine linker was found
to be the most helical of the test sequences, as one might expect from previous studies
(discussed in Section 1.4.2). It is then difficult to determine which of the other sequences
are least helical, due to the small differences between them. It is clear that the least
helical sequences generally had less alanine, with the least helical, GAGGAG, having no
sequential alanine residues. Asparagine residues seemed to be less disruptive to helicity
than glycine, but sequence position was important (likely due to whether a residue broke
an alanine chain or not). The sequence chosen for the centre of 2 was somewhere between
the two extremes, to hopefully allow switching: AGAANA.
Putting both peptide sequences together with linking regions in the centre meant that the
two coiled coils were out of register. If labelling the residues a-g straight through (starting
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at g), the second half had hydrophobic residues at e and a instead of a and d positions.
This still leaves the hydrophobic residues on the right side of the helix. By shifting the
positions of the cysteine residues through the insertion of additional residues, we have put
in a stutter [207] which may result in a straight coiled coil, which would be desirable for
a bar motor. The sequence chosen was EIAALEYEINALEQKIAALKQKNCAGAANAC-
NKIAALKQEIYALEQKNAALKQKIAALK.
As discussed in Section 4.1, for the bar motor to be successful, conformational differences
must exist between the cis and trans azobenzene-containing peptide systems. The angles
open to the two conformations need to be sufficiently different so as to make the motor
processive and resilient to backstepping. The CG simulations showed that in a rigid and
flexible switching system, though there were some missteps, there was still progression,
and hence feasibility in the design. Our next step, in addition to carrying out experiments,
was to gain some MD data to investigate whether the system as designed would be able
to fulfill this criteria.
4.4 Molecular Dynamics Simulations
To study the angles that the molecules are likely to sample, we are interested in the actions
of individual sets of interacting peptides, and hence atomistic simulations are required.
Computational power limits the system size and timescale for which a system can be sim-
ulated, due to the number of atoms and bonds present, which are all modelled in these
simulations. A less complex system (or simplified version of a complex system) can be
simulated for a longer timescale in the same amount of real time, which is why in some
simulations, such as the proof of concept simulations (Section 4.2), coarse-graining is use-
ful. As we are interested in both the motion possible, and the timescales of this motion,
Molecular Dynamics (MD), with its simulation of a molecule’s time evolution, is suited to
the task.
First demonstrated in 1957 [208], MD is frequently used for systems such as ours, due
to this ability to provide dynamical information on an atomic scale. It is completely
classical. One copy of the molecule (or molecules) to be simulated is put into a periodic
box (surrounded by identical boxes of identical molecules), the box is filled with water
(in our case), and forces (described by a force field) act on the molecule. The simulation
progresses in small time steps, where Newton’s equations are solved to find the force on
each particle, and hence their velocities and positions at each time step. The simulation
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Figure 4.9: Results of test sequences in AGADIR. Each sequence was EIAALEYEINALE-
QKIAALKQKNC******CNKIAALKQEIYALEQKNAALKQKIAALK where ****** is
the sequence shown in the legend. The coiled-coil regions are shown to be fairly con-
stant in helicity level with changing central sequence.
outputs the trajectory of the molecule as a function of time.
GROMACS [209; 210; 211; 212; 213] is a popular MD package due to its user friendli-
ness, speed, availability, compatibility with a range of force fields and water models, and
its lacking the requirement of specialist computing equipment; as the tagline states, it is
‘Fast. Free. Flexible.’ [211]. GROMACS requires the initial coordinates of the atoms in
the molecule(s) to be simulated; we used models constructed by Richard B. Sessions (RBS)
using Insight II (Accelrys Inc, 2005) from the sequences we provided (LSRS and EHCB).
Models of the three free peptides, 2, 1 and 6, and the three peptides with an azobenzene
moiety on 2, in each of the cis and trans isomer conformations, were produced (Figure
4.10). We have made the assumption, based on the sequences and previous Tumbleweed
data, that the (1,2) and (,6) domains of the system will be helical, and have assumed
the central region to be helical unless disallowed by the dimensions of the azobenzene
molecule (the model with azobenzene in the trans conformation). As is seen in the results,
the simulations then allow this region to explore alternative configurations. Additionally,
one provides GROMACS with a model for the water surrounding and interacting with
the simulation molecule(s); TIP3P, an explicit water model, is used in these simulations.
Many force fields, or potential energy functions, as they are also known, can be used with
GROMACS, providing the coefficients needed for force calculations of various molecular
interactions. These interactions include those between non-bonded atoms, such as the
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Figure 4.10: Models used for simulations. Peptides 1 and 6 with (a) 2, (b) 2 with cis
azobenzene linker across Cys24 and Cys 31, and (c) 2 with trans azobenzene linker.
Coulomb interaction, repulsion (due to electron cloud overlap) and dispersion (attraction
due to instantaneous multipoles), and bonded interactions: bond angles, lengths, torsions
and dihedrals. We use the Amber ff99SB-ILDN force field. The TIP3P water model was
chosen for the simulations as the Amber force field was developed using TIP3P [214],
and the combination of the two has been used extensively over the last 20 years. The
Amber ff99SB-ILDN - TIP3P combination has been found to give a reasonable descrip-
tion of peptide/protein systems when compared with experimental data [215; 216; 217].
Additionally, periodic boundary conditions [218] are used in the simulations to avoid the
difficulty in modelling the differing behaviour of molecules at surfaces: a box containing
one copy of the molecules to be simulated is surrounded by identical boxes of identical
molecules, and if a molecule leaves one box from one side, it is replaced by the identically
behaving molecule from the box on the opposite side. The minimum image convention is
used so that a particle can’t see the copies of itself, and only one copy of any neighbouring
particles also present in each box; to do so, a cut off of half (or less) of the shortest box
dimension [219; 220] is applied for these short range non-bonded interactions. A sensible
choice of box type (in this case, dodecahedral) minimises the proportion of the simulation
that is just between water molecules (as opposed to between atoms of the peptides, or
peptide-water interactions), and reduces computing time.
4.5 Initial MD Study
Upon construction of the peptide models, RBS ran a preliminary 100 ns simulation of each
of the three systems which were analysed by myself. Visual observation of the simulations
as movies gave an impression of the behaviour. Of course, repeat simulations are needed
to give more information, and determine which motion is most common, but these give an
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indication of the behaviour possible. For all three systems, the coiled coils remained intact
throughout the simulations, indicating that the models were not too unstable to function,
and worth further consideration. In order to quantify the useful motion of the peptide
system, the varying end-to-end separation of the peptides, and angle made between the
two coiled coils at the central hinge, were extracted, as it is a difference in these which is
necessary for the system to function.
4.5.1 Results
End-to-end Separation Measurements
The separation between the α-carbon atoms of two residues is easily extractable using
VMD (Visual Molecular Dynamics) [221], a molecular graphics program. Some of the
extremely-placed residues were seen to uncoil, and not represent the movement of their
coiled coil as a whole. In order to ensure that the data extracted was representative, four
separation measurements were taken, instead of one, between the four pairs of opposite
peptide termini (Figure 4.11a). The α-carbons of the extremity-positioned residues Leu5
and Leu58 of 2, Leu31 of Peptide 1 and Ile3 of Peptide 6 (unless stated otherwise)
were used, as they were at extreme positions, but did not frequently uncoil. To confirm
that the chosen residues were suitably stable relative to the rest of their coiled coil, the
measurements shown in Figure 4.11b were taken (a sample is shown in Appendix H.1).
As each of these separations are between an outer residue and inner residue of a single
peptide, within a single coiled-coil region, they should be close to constant in a stable
coiled coil. If any of these measurements changed significantly over the course of the
simulation, i.e. there was structure in the time evolution instead of a noise-like spectrum,
due to a particular residue, the residue was usually also seen visibly to leave the stable
coiled-coil region for some of the simulation time. Frequently, it was proven that it was the
internal residue which was causing the variations, when the outer residue was compared
with an alternative inner residue. In cases where the outer residue was the source, those
separations were treated with more caution than the other three measurements of the
system.
Upon inspection of all of the measurements for each system, it became clear that there
was no significant difference in the shape of the four measurements, despite any occasional
erratic motions, and so an average of the four was taken and plotted here, to more clearly
display the system’s behaviour.
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(a)
(b)
Figure 4.11: Four values of the end-to-end separation were found for each system to avoid
any anomalous measurements due to a single residue, using the combinations of 2’s Leu5
and Leu58, peptide 1’s Leu31 and peptide 6’s Ile3 shown in (a). To confirm that the
chosen residues remained part of coiled-coil structure and didn’t uncoil, the evolution of
the separations (between each of the residues in (a) and a stable internal residue of the
same coiled coil and peptide chain) shown in (b) was checked, to ensure that the evolution
of the separations in (a) represented the motion of the whole system, and not the motion
of a short uncoiled region at the peptide extremities. For the cis linked system, Glu27
was used as well as Leu31 in the measurements, as Leu31 formed part of the region shown
uncoiling in (c). As with the other residues, the constancy of Glu27 within its coiled coil
was checked (d).
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(c) (d)
Figure 4.11: For the cis linked system, Glu27 was used as well as Leu31 in the measure-
ments, as Leu31 formed part of the region shown uncoiling in (c). As with the other
residues, the constancy of Glu27 within its coiled coil was checked (d).
Central Angle Measurements
Angles between three α-carbons are also easily extractable from VMD, but choosing
residues for this was the more difficult task, as the ‘centre’ of the system is not a well
defined point. For each of the systems, the evolution of the angle formed by Leu5, Lys52,
and one of Lys20, Asn23 and Ala27 on peptide 2 was extracted (Figure 4.12a), and for
the azobenzene-free and cis azobenzene systems, this method gave a good graphical rep-
resentation of the motion of the system. For the trans azobenzene system simulation, the
central region was far more flexible, frequently with more than one turning point, and this
made the calculation of a representative angle more difficult. The inner ends of the coiled
coils did not stay together in the centre of the system, due to the increased flexibility of the
central region. This did not affect the method of end-to-end separation measurements, but
meant that choosing a central residue for the angular measurements was problematic and
often an produced an uninformative measurement. Placing three points on the ‘T’ shaped
structure in Figure 4.12b to approximate the angle calculated by this method demonstrates
its failure for the trans azobenzene simulation. To produce a more insightful angular mea-
surement, I produced vectors representing the axes of the two coiled coils, and found the
corresponding angle if the vectors had a common origin (Appendix H.2). For this, a pair
of a or d residues near each end of each coiled coil (but well within the stable coiled-coil
structure) was used (Figure 4.12c), as they were thought to be stable residues to produce
accurate vectors. The separations shown in Figure 4.12c were confirmed to be stable, and
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then midpoints between each pair of residues (Leu5 and Leu6 is one pair, for example,
Figure 4.12c) were used to create two vectors representing the coiled-coil axes, and calcu-
late a subsequent angle. For the systems where the molecules have hinge-like behaviour,
this method should be equivalent to the three-point method, and this was confirmed for
the first azobenzene-free and cis azobenzene simulations. End-to-end separations for the
trans system using the residues in the vector method were also calculated and found to
be consistent with the patterns seen using the extreme residues. The residues used (a
midpoint between 2’s Ile55, and p1’s Ile28, as opposed to the α-carbons of both Leu58
and Leu31, and a midpoint between 2’s Leu5 and p6’s Leu6 instead of the α-carbons
of both Leu5 and Ile3) were generally further from the ends than the VMD-calculated
end-to-end separation residues, and hence the separations appear generally lower. The
original separations therefore give values closer to the actual separations of the ends of the
peptide systems during the simulations, being from residues closer to the extremities, and
continued to be used. Of course, even these vector measurements do not display the lack
of central origin to the observer, and hence must be used in conjunction with the movies,
and with an awareness of their limitations.
4.5.2 Discussion
The 2 starting conformations for the cis and azobenzene-free systems have no clear break
in helicity, as breaking the helicity of the peptide was not necessary to attach a cis azoben-
zene to the desired residues. For the trans isomer, the dimensions of the azobenzene
molecule did not allow it to be bound to the correct peptide residues whilst the 2 peptide
was fully helical, and hence the secondary structure had to be modified to accommodate
it (Figure 4.10).
Azobenzene-free System
The 100 ns simulation indicated that the unmodified three-peptide system could exhibit a
considerable angular range, from around 180◦ (outstretched), to near-90◦ angles (Figures
4.13 and 4.16). From a movie of the simulation, one can see that the system undergoes
rapid fluctuations, as expected from a dynamic molecule. It does not progress in one
direction from 180◦ to smaller angles without fluctuations to larger angles, but there is
only one eventual movement to a small angle; the system does not move back and forth
between the outstretched state and more compact state within the simulation time.
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(a)
(b)
(c)
Figure 4.12: (a) The three-point angle method is simple using VMD. (b) An example from
the trans azobenzene simulation where the three-point method fails - the angle calculated,
between the residues labelled in (a), does not follow the shape of the system. (c) Angles
formed between two vectors were calculated as an alternative to the three-point angle
method.
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Figure 4.13: Evolution of the end-to-end separation and hinge angle of the azobenzene-free
bar system over a 100 ns simulation.
The graphs of both end-to-end separation and angular variation (Figure 4.13) display
two significant regions, almost as if the system is occupying two significant states, with
fluctuations around them. Both graphs have the same features, as most of the movement
affecting the angle and the separation is in the same plane. The system’s near-straight
starting conformation corresponds to a separation between the bar ends of around 8 nm
(with a 160◦ central angle). The system fluctuates around this state for around 60 ns, after
which it switches rapidly to a conformation giving an end-to-end separation of around 5.5
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Figure 4.14: Evolution of the end-to-end separation and hinge angle of the cis azobenzene-
containing bar system over a 100 ns simulation.
nm (and an 80◦ angle). The N-terminal residues of peptide 6 uncoil so that the inner
residues can overlap - if they remained helical there would likely be greater restrictions to
the angle possible in the cases where the partner peptides are held closer as a result of the
bending (as is the case in most of these simulations where bending is seen). It fluctuates
around this region until near the end of the simulation, where it looks as if the system
may be undergoing a more gradual change to an even smaller end-to-end separation/angle.
This system appears to undergo steady motion, with no erratic changes, but as it lacks
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Figure 4.15: Evolution of the end-to-end separation and hinge angle of the trans
azobenzene-containing bar system over a 100 ns simulation.
a means of being switched between two or more states, is not useful unmodified as a bar
motor hub. The simulation indicates that there is no cause due to the peptides in the
system for the angles required to be unattainable.
Cis-azobenzene System
Figure 4.17 shows some of the frames from the cis azobenzene simulation, while Figure
4.14 shows the end-to-end separation and angle evolution of the system. For the cis
azobenzene system, Glu27 was used in addition to Leu31 due to Leu31’s uncoiling during
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Figure 4.16: Stills from the initial 100 ns simulation of the azobenzene-free bar system.
the simulation (Figure 4.11c, d). However, it was found that although Leu31 visibly
uncoiled during the simulation, this did not significantly alter its separation from its
coiled coil (Figure H.1), and end-to-end separations using Leu31 still exhibited the same
patterns as the other measurements, including those of its substitute, Glu27 (Figure 4.11c).
The Leu31 measurements were therefore used in end-to-end separation averages. Visually,
the cis system seems to have a similar separation range open to it as the azobenzene-free
system. However, the motion does not have the two distinct regions of the azobenzene-free
system (graphically more obvious by comparing Figures 4.13 and 4.14). As this is only
based on a single 100 ns simulation of each it is likely not to be a characteristic feature,
but future simulations will confirm this. As is shown by the figures, the system first enters
a sub-90◦ conformation earlier in the simulation than in the azobenzene-free simulation.
The angular variation patterns again mimic the patterns seen in the end-to-end separation
evolution, with a slightly smaller range covered than the azobenzene-free system, of 5 -
8.5 nm, and a similar angular range of 50 - 180◦.
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Figure 4.17: Stills from the 100 ns initial simulation of the cis azobenzene bar system.
Trans-azobenzene System
The movement of the trans system is somewhat different to the other two systems. The
forced reduction in 2 central structure due to the trans isomer dimensions has a significant
effect. The stills of the simulation (Figure 4.18) indicate increased mobility; by 15 ns
(Figure 4.18c), the central region’s flexibility has already resulted in the two coiled coils
lacking a shared central origin. Frames 149 and 999 have similar T-like structures; Figures
4.18c and Figure 4.18f show appearances from two viewing angles. While the linking region
is not in fact a single hinge point in any of the realistic systems (unlike the concept and CG
simulations), in the initial absent and cis isomer azobenzene systems, it was a (flexible)
helical region with a small end-to-end separation, and predominantly behaved in ways that
could be approximated by a hinge point. In the trans system, it has very little resemblance
to a hinge, and is far more like two cylinders attached at one end by a length of string
(Figure 4.18b).
Figure 4.15 shows that the end-to-end separations in the trans system vary from around
9 nm to 3.5 nm, and the angles created between the α-carbon atoms of three residues
range from around 25 to 180◦. It was at this point that it was decided, as discussed
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previously, that these angles were somewhat redundant as the system rarely conformed to
a variable-angle V-like system. The angles calculated from the axis vectors (Section 4.5.1,
Figure 4.12c) give a slightly closer representation, as they are at least correctly aligned
with the coiled coils, but as the origin is not shared they still have limited use; in this
method a ‘T’ shaped conformation and an ‘L’ shaped confirmation would each give a 90◦
angle. The angular range covered during the simulation is wide, from around 180◦ to
20◦, a much smaller minimum angle than that of the two other systems, enabled by the
flexible central region. Due to the system’s angle changes being less restricted than the
other systems, the end-to-end variations are less coincident with the calculated angular
variations. This central region’s high level of movement is consistent with the design
aim of preventing helicity by using the trans conformation of the azobenzene moiety to
separate the intervening residues by a distance greater than that which would allow helical
secondary structure.
4.5.3 Findings from Initial Simulation
The initial study indicates that the coiled coils behave as intended. With regards to the
central region, it indeed appears to be forced into a more flexible state when connected to
a trans isomer of the azobenzene moiety than a cis isomer. Longer simulations are needed
to ensure sampling of the full spectrum open to the system if it is given sufficient time.
It is already clear that the two angles desired for the system (Section 4.1) are possible;
lack of flexibility seems to not be an issue. It is unclear, however, whether the motion is
sufficiently controllable; these simulations imply not. The issues encountered tend towards
the opposite of what was anticipated; it was thought that the presence of the coiled coils
could potentially remove flexibility from the central region, and allow the formation of
a helix too rigid to be affected by the switching of an azobenzene molecule. In fact, it
appears from the MD simulations that we have a system that is ‘too’ flexible; instead of
rigid and flexible states, we have flexible and very flexible conformations. The CG simula-
tions indicate that this may not be an insurmountable problem (discussed further in this
chapter’s final discussion). All that is necessary for a (non-optimally efficient) progressive
system is two states with a significant difference in average end-to-end separation. Further
studies into the apparent differences between the free and cis isomer systems is of interest,
as it is unclear as to their origin and significance at present.
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Figure 4.18: Stills from the 100 ns initial simulation of the trans azobenzene bar system.
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4.6 MD Simulations Round 2: Increasing the Rigidity of
the Bar System
The initial simulations indicated that by focussing on preventing the design of an unswitch-
able helix, we have instead designed a system which is able to sample a larger conforma-
tional space than is desired. As it is, the system is unlikely to fulfil the criteria of having
switching bar and V-like states. Even the seemingly helical cis azobenzene system allows
more flexibility than is required, and has characteristics closer to what we wished from the
trans system, for a V-like conformation, rather than a bar like conformation. The origi-
nally intended V-like conformation, the trans system, is altogether too flexible. Changing
the system to add more rigidity is desirable. The key question is whether a peptide sys-
tem can be designed which is rigid enough for our purposes, but also switchable to a more
flexible state. The cis azobenzene conformation of 2 appears to be helical, but is still too
flexible. Is there a sequence that is as rigid as a coiled coil but which can be switched?
There are many changes that we could make to the system to try to increase the rigidity.
At present, we are still in a position where the effect of single point mutations in peptides
cannot be fully predicted, and hence further MD simulations are useful to guide us before
synthesis of 2 Version 2.0 is attempted. We have some general ‘rules’ which are good
starting points in trying to improve the system, and we have tried to use some of these in
the second round of MD simulations.
4.6.1 Excluded Ideas for Round 2
There are some ideas for rigidity increases which could be successful. However, some may
not be switchable, and others are only discounted temporarily, and could be tested at a
later stage.
Coiled-coil Central Region
A near certain way of increasing the rigidity of the system would be to have coiled-coil
interactions continuing through the linking region of 2 and the partner peptides. From
the initial simulation we have done here, and significant numbers of previous studies on
coiled coils, it is clear that coiled-coil regions should be sufficiently rigid. We have seen
that it is the linking regions and the free ends of the peptides that are open to erratic
motion. To remove the instability of the inner free peptide ends, which could still have
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some freedom, even with coiled-coil interactions, a second long peptide would be needed
(discussed below). We initially rejected using coiled-coil interactions in the central region
of 2 as we anticipated creating a helix that was too stable. We now reject the idea due to
experimental findings in our group. Experiments, by ACM, using a (i, i+11) azobenzene
spacing within a coiled coil, indicate that the azobenzene switch is not strong enough
to disrupt a coiled coil. Further experiments using an (i, i+7) azobenzene spacing in a
coiled-coil system would be desirable, but this current evidence is sufficient to reject the
idea unless any contrary evidence is obtained.
A Second Long Peptide to Replace the Short Partners
This is another idea which comes to mind when considering reducing the flexibility of the
system. At present, this idea is not particularly desirable for several reasons. We would
need to synthesise a second ∼60 residue peptide and from experimental evidence, this is
known to be difficult. 2 was a complicated synthesis, while a similarly lengthed peptide
attempted with standard conditions did not result in a successful synthesis. If the second
long peptide follows the same design as 2, including the azobenzene moiety, but without
coiled-coil interactions, there is no reason to expect the linking region sequences will
interact with each other, and hence the rigidity will unlikely increase. Furthermore, when
switched to the trans state, although there may be a slight decrease in the conformational
space open to the system due to the connecting of the inner ends of the partner peptides
(for example, the conformation at 15 ns in Figure 4.18c, may be prevented due to a
maximum separation of the current inner residues being imposed by the introduction of a
second linking region), most of the flexibility will remain. In addition to this, there could
be a future issue regarding molecular biology and the repressor feet; in order to synthesise
a peptide with an azobenzene linker, one would likely wish to attach the repressor feet
to other peptides, and it would be substantially more difficult to produce a ∼60 residue
peptide with a repressor on each end, than to produce a single foot with a coiled-coil
linker.
(i, i+11) Spacing
This idea has only been rejected due to time restrictions, as we are nearing the end of the
project. We have seen that both the cis and trans systems are less rigid than we had hoped.
The cis system is still able to bend even though it is the more helical state. The trans
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system both disrupts the linking region structure, and has a greater spatial separation
between the coiled coils than the cis system. There are several possible changes that could
occur if the spacing was changed from (i, i+7) to (i, i+11). There is first the decision as
to whether the central region is extended, so that there are 10 residues rather than six in
the region interceding the cysteine residues, or whether the cysteines are simply shifted so
they are placed more firmly in the ends of the coiled-coil regions as opposed to being in
the central region. The (i, i+11) system may be slightly more restricted in its movement
than the (i, i+7) system, simply due to the fact that if the trans system behaves similarly
to the cis system of (i, i+7), and helicity persists as in cis 2, it will likely still have the
same tendency to bend more than we had intended, but the corresponding cis version
may be more restricted than the trans 2, due to the fact that the cis isomer has less
spatially separated ends, and hence reduces the allowed separation of the coiled-coil ends.
Whether this is in fact useful, or just a slightly improved version of the current system
is currently undecided - it is likely that this would only be useful in combination with a
central region sequence change to improve its rigidity. This may be a useful change to
make small improvements to the control of the system, once the rigidity issue has been
resolved.
4.6.2 Mutations of the Central Region
Figure 4.19: Ala27Phe Mutant of 2CL, with peptides 1 and 6.
It was decided that trying the increase the rigidity of the central region using subtle
changes in the system, without changing the cysteine/azobenzene locations, or introducing
a coiled-coil region, was a sensible first step. As we have found that our issue is a lack of
rigidity and not an unswitchable helix, we tried to make mutations towards increasing the
helicity, and hopefully, consequently, the rigidity. The mutants tested were single point
mutations: Ala27Phe, Gly26Ala and Asn29Ala, and a mutant with both Gly26Ala and
Asn29Ala mutations. The residues were mutated using UCSF Chimera [222], and the
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energy minimisation and simulations carried out again using GROMACS, in collaboration
with RBS. Gly26Ala and Asn29Ala are single point mutations which will increase the
number of alanines (and the length of polyalanine present) in the central region, which
should increase the helicity of the region [80; 81; 82]. Ala27Phe was simulated to investigate
the possibility of an interaction between a phenylalanine side chain and the azobenzene
moiety stabilising the structure. The model of Ala27Phe is shown in Figure 4.19.
4.6.3 Results and Discussion
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Figure 4.20: Evolution of Azobenzene-free Bar System - Runs 1-3
The second 100 ns simulation of the azobenzene-free system has a highly flexible central
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Table 4.1: MD Simulation Sequences
2 variant used Sequence Azobenzene
conformation1
No. of 100ns
simulations
2 2barCAGAANAC2bar
3 - 1+24
2 bar CAGAANAC 2bar cis 1+2
4
2 bar CAGAANAC 2bar trans 1+2
4
Ala27Phe bar CAGFANAC 2bar cis 3
Gly26Ala bar CAAAANAC 2bar cis 3
Asn29Ala bar CAGAAAAC 2bar cis 3
Gly26Ala-Asn29Ala bar CAAAAAAC 2bar cis 3
1 Azobenzene is attached to the long peptide via the two cysteine residues in the se-
quence.
2 bar is the peptide -based 2 component (residues 1-23): EIAALEYEINALEQKI-
AALKQKN.
3 2bar is the peptide 2-based 2 component (residues 32-59): NKIAALKQEIYALEQK-
NAALKQKIAALK.
4 These simulations were initially carried out once for the initial study, and then re-
peated twice during round 2 of simulations.
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Figure 4.21: Evolution of Cis-azobenzene-containing Bar System - Runs 1-3
region, indicating that it is the peptide sequence which allows this as much as the trans
azobenzene molecule. At one point, at ∼91 ns, it has near-parallel coiled coils (Figure
4.27a), dubbed a ‘Π-like’ conformation, having displayed much greater angular variability
than any of the three initial simulations. It demonstrates the system’s ability to take
straight and V-like conformations, along with conformations between the previously seen
V- and T-like structures (Figure 4.27b), and the new Π-like conformation. The third sim-
ulation shows no new behaviours, occupying various states between bar-like and an 80◦
‘V’ conformation.
Nothing significant occurs in the second and third simulations of the cis azobenzene sys-
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Figure 4.22: Evolution of Trans-azobenzene-containing Bar System - Runs 1-3
tem. The end-to-end separations and angles trace similar patterns, and, like the initial
simulation, occupy a variety of straight and V-like states, with a range of angles from 50
to 180◦.
The second simulation of the trans azobenzene system shows behaviour akin to two inde-
pendent coiled coils for the first 25 ns, and afterwards a more connected system. There
is a lot of uncoiling of the inner ∼7 residues of peptide 6 (Figure 4.27j) and the linking
region undergoes a lot of erratic motion. The system does however, still spend a lot of
time at a small angle with a slightly displaced origin. The third simulation shows a much
more steady system. Representation of this simulation using a single central origin would
be much more applicable than in the other two trans simulations. There is no T- or Π-like
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Figure 4.23: Evolution of Cis-azobenzene-containing Bar System - G26A mutant - Runs
1-3
behaviour. Closer inspection of the simulation shows that there is a crossover between the
peptides in the system (Figure 4.27e, 4.27f). There is only one long peptide, and hence
the peptides cannot be fully intertwined, but this occurrence may assist the stability of
the system, as the fact that this does not occur in any of the other simulations hints that
there may be a connection (Figure 4.27d shows a more typical arrangement of 2, with no
crossover).
Two of the G26A runs do very little, and spend the majority of the simulations almost
completely outstretched, with angles averaging around 140 - 160◦. The first run demon-
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Figure 4.24: Evolution of Cis-azobenzene-containing Bar System - N29A mutant - Runs
1-3
strates, however, like its wild type counterpart, that the system is able to form V-like
conformations, and shows a 40 - 180◦ range (∼40 - 90 A˚ end-to-end separation).
The N29A runs all spend the majority of their time in a straight conformation, and also
display some V-like behaviour.
The G26A-N29A mutants show little unusual behaviour, again displaying oscillations be-
tween bar to V conformations. There is one occurrence of interest: in Run 1, at ∼21 ns
(Figure 4.27g), the bend in the system is not due to a flexible helical region. The helix
appears to continue from peptide 2 through the central region, and the distortion allowing
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Figure 4.25: Evolution of Cis-azobenzene-containing Bar System - G26A, N29A mutant -
Runs 1-3
bending is between residues 18 - 23, within the  domain. This behaviour is unusual,
and undesirable, but as it is not seen frequently, is unlikely to represent a statistically
significant issue.
The A27F mutants, again, show very little difference in overall behaviour. The first sim-
ulation spends much of its time seemingly locked in a ∼100◦ angle V-like conformation,
whilst the other two simulations display bar and V-like behaviour.
Many of the simulations show ∼7 residues uncoiling at the inner end of the shorter peptides
(Figure 4.27c, 4.27d, 4.27i, 4.27j), in particular peptide 6.
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Figure 4.26: Evolution of Cis-azobenzene-containing Bar System - A27F mutant - Runs
1-3
4.7 Conclusions
With the first and second rounds of simulations, we are starting to gain a better idea
of what is common behaviour for the systems. It appears that the system when uncon-
strained by an azobenzene molecule often displays bar and V-like behaviour, but is able to
have an almost completely unstructured central region, and display accompanying erratic
behaviour with no single hinge point. The trans azobenzene systems display far more
erratic behaviour than the cis systems, but this behaviour is tempered somewhat in the
simulation where there is some degree of ‘tangling’ between the peptide chains. As there
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(a) Free 2:906 (b) Free 2:995 (c) Free 3:822
(d) Trans 2:734 (e) Trans 3:623 (f) Trans 3:623b
(g) G26A-N29A 1:207 (h) Trans 2:61
(i) Free 2:961 (j) Trans 2:381
Figure 4.27: Snapshots of Simulation Round 2. The labels state the peptide system (‘Free’
refers to the azobenzene-free system), and simulation number:frame number.
is no way we could force this behaviour, whether it is a significant effect or purely coin-
cidental with the more hinge-like behaviour of the system is slightly redundant. Of all
of the 21 simulations, it is only the trans systems, and one of the three non-azobenzene
linked runs which show significantly unhelical regions. This is clearly displayed in the
separations of the two cysteine residues of 2 for the different runs, shown in Figure 4.28.
There are several others where a few central residues are distorted, allowing bending, but
120
Chapter 4 Bar Motor
not to an extent which compromises the hinge like-behaviour of the systems. None of the
mutations tested gave a sufficiently rigid performance to create a bar to V switch system.
It seems a reasonable assumption however, based on the data set so far, that having a cis
azobenzene molecule in the system, although allowing bending, prevents the coiled coils
from separating far from each other, and so can be modelled as a hinge-like system. The
mutations may add some stability, but a greater number of simulations would be required
to see if there is a significant increase in rigidity in any of them compared with the wild
type. As they all contain cis isomer azobenzene molecules, however, they show that in 15
100 ns simulations, the cis system does not stray from a hinge system, while both of the
other systems do, even with only three 100 ns simulations each thus far. A cis azobenzene
system could potentially display all of the characteristics needed for a bar motor hub. It
is able to occupy a range of conformations, including those originally suggested for the
two states. The purpose of the azobenzene moiety was to be able to apply a switch to the
system, and although this switch does not have as great an effect as hoped in these sim-
ulations, it may still have potential if the switch is sufficient to move the system between
two states which are a less-flexible state and a more-flexible (open to smaller end-to-end
separations more frequently) state. Further simulations are required to give significance
to the difference in average flexibility of the cis and trans azobenzene systems.
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Figure 4.28: Separations between the two cysteine residues in the different MD simulation
runs. The black spectra are of the non-azobenzene system, while the cis (wild type and
mutants) systems are shown in blue, and the trans systems in green.
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Bar Motor Experiments
Alongside the MD simulations of 2 and 2 with an azobenzene molecule (Figure 4.7)
attached (from here denoted as 2CL), experiments on the system were carried out on the
initial sequence of 2. 2 and 2CL were synthesised by ACM. The experiments in this
chapter were carried out by the author.
5.1 Experimental Aims
These experiments investigated the feasibility of a system such as 2, 1 and 6 as a motor
hub. Experiments were carried out with the following aims:
• to establish whether 2 is helical, and whether it interacts with partners, by mea-
suring the circular dichroism signals of it in isolation, and with partners.
• to measure the effect of attaching an azobenzene moiety, and the effect of this moiety
when its conformation is switched, by comparing 2 alone, 2 plus azobenzene, and
2 plus azobenzene when irradiated.
• to establish how long the azobenzene moiety remains in the second conformation
after irradiation, before switching back, or whether it has to be irradiated at another
wavelength to achieve this.
• to establish approximate sizes (using DLS) of the species present for samples of 2
and 2CL alone, with partners, and with disulphide bonded partners (peptide 1-6);
for 2CL, these sizes will be examined both before and after irradiation with 360nm
light.
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5.2 Results and Discussion
5.2.1 CD Data
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Figure 5.1: CD data of 2 (magenta) compared with its nearest single analogues (though
they differ by linking regions),  (red) and 2 (blue), and with those single analogues
in solution together (green). The theoretical spectrum of ,2 is also shown (purple).
Measurements were taken at 20◦C at 20µM concentration in PBS buffer (pH 7.4).
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Figure 5.2: CD data of ,6 (green). The spectra of the individual peptides are also shown,
 (red), peptide 6 (blue), along with the theoretical spectrum of the mixture (purple). The
other coiled-coil pair in the bar motor, (1,2), is shown in Figure 3.4. Measurements were
taken at 20◦C at 20µM concentration in PBS buffer (pH 7.4).
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Figure 5.3: CD melt spectra of  (red) and , 6 (purple). Measurements were taken at
10-90◦C at 20µM concentration in PBS buffer (pH 7.4).
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Figure 5.4: CD spectra of single peptides 2 (red), 1 (blue), 6 (orange), compared to a
mixture of 2, 1 and 6 (green). The theoretical spectrum of 2, 1, 6 is also shown (purple).
Measurements were taken at 20◦C at 20µM concentration in PBS buffer (pH 7.4).
2 appears to be more helical than its individual contributing peptides and the mixture
,2. ,2 itself appears to be slightly more helical than predicted for a system where pep-
tides  and 2 were not interacting (this theoretical spectrum is shown in Figure 5.1). This
is not surprising given the interactions seen between the non-designed pairs of Chapter 3.
The ,6 mixture also appears more helical than predicted by the non-interacting theoret-
ical spectrum (Figure 5.2). The melting temperature of ,6 is 69.5 ± 1.1◦C (spectrum
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Figure 5.5: CD spectrum of 2CL (blue), compared to 2CL mixed with 1 and 6 (purple),
and 2CL with disulphide-bonded 1-6 (magenta). Measurements were taken at 20◦C at
100, 80 and 50µM concentration respectively, in PBS buffer (pH 7.4).
shown in Figure 5.3).
Figure 5.4 shows the CD spectrum of the 2, 1, 6 mixture along with those of its con-
tributing peptides and the theoretical spectrum calculated from them. The mixture of
2, 1, 6 is again more helical than predicted by the theoretical spectrum, indicating that
hetero-oligomeric interactions are present. The mixture, and 2 alone display clear char-
acteristics of helical structures, with minima around 208 and 222 nm.
Due to the change in the UV spectrum of 2 when attached to an azobenzene moiety,
the usual means of concentration determination was not possible. Ideally, the extinction
coefficient of the new peptide 2CL would be determined, but the amount of product after
reactions and multiple purification stages made this impossible. As there should not be a
major change in the CD signal of the peptide upon reaction with the azobenzene moiety, a
comparison of the 2 and 2CL CD spectra was used to estimate the concentration of 2CL.
For this reason, there is no comparison between the CD spectra of 2 and 2CL, as we
have had to assume for the present time that they are approximately the same. The shape
of the spectra did indeed indicate that this was not a blatantly inaccurate assumption.
As shown in Figure 5.5, all three samples containing 2CL appear to have CD spectra
that are characteristic of helical species. 2CL and 2CL,1,6 appear to be significantly
more helical than 2CL,1-6. Upon irradiation with 360 nm light for 30 minutes, CD, UV
and DLS measurements were taken to compare with those taken before irradiation. The
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CD spectra did not display a visible change, and only showed minor changes comparable
to those between repeats of a single sample. This is unsurprising, as under 10 of the 59
residues of the peptide would be expected to be affected if switching occurred, and full
conversion is also not expected [196].
5.2.2 UV Data
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Figure 5.6: UV spectra of crosslinked 2 (37µM, in PBS buffer, pH 7.4) before irradiation
(cyan), and recovery after irradiation at 360 nm for 15 minutes. The red, magenta, violet,
indigo and blue spectra are taken at t, t+28, t+50, t+77 and t+102 minutes, where t is
5 minutes after irradiation.
The UV spectrum of 2CL and 2CL with both 1,6 and 1-6 are shown in Figures 5.6
and 5.7. Figure 5.6 shows preliminary data of the system prior to and after 15 minutes
of irradiation with 360 nm light. Figure 5.7 shows the three 2CL-containing samples,
after irradiation for 30 minutes at 360 nm. In the preliminary data sets, both 2CL and
2CL,1,6 show a significance decrease in the absorption peak in the region of 360-370 nm.
The 2CL sample, perplexingly, appears to slightly overshoot the pre-irradiation spectrum
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after around 100 minutes of recovery. The recovery of 2CL,1,6 was only tracked for 25
minutes, but also indicates a recovery time in the region of 100 minutes. For the later
data of the systems, the switch appears to be less pronounced for the 2CL and 2CL,1-6
samples, even though the irradiation time was increased to 30 minutes. The 2CL spectrum
appears to be behave in a similar manner to previously seen, while the 2CL,1,6 sample
shows a shift in its absorption peak. The 2CL,1-6 sample, as it at half the concentration
of the 2CL sample, appears to have undergone a similar change to the 2CL species.
From the data shown in Figure 5.7, one would assume that a more significant change has
occurred in the 2CL,1,6 sample. This would be a good outcome as this is one of the
potential Bar motor systems. The fact that the spectrum returns to almost the same
spectrum as its pre-irradiation state after an hour of recovery implies that the peak shift
observed is not a measurement error. 2CL,1,6 may show a more pronounced switching
than the other systems due to its having greater freedom in terms of being switched; the
2CL will be resistant to switching if it is forming a hairpin like structure, while 2CL, 1-6
would be expected to be less flexible than its non-disulphide bonded counterpart. The fact
that this is not seen in the preliminary data, and that the percentage of switching seems
to be highly variable indicates that optimisation of the switching protocol is required, but
there are clear signs of the azobenzene moiety inducing changes to the system.
5.2.3 DLS Data
DLS data was taken for the long peptide alone (2), mixed with the two partner peptides
(1,6), and mixed with the disulphide-bonded pair of partner peptides (1-6), at 100µM per
peptide. The same measurement and fitting methods were used as in Chapter 3. These
three experiments were then repeated using the long peptide 2 linked via its cysteine
residues to the azobenzene moiety (Figure 4.7), known as 2CL. Due to limited product,
these were carried out at 100µM for 2CL alone, at 80µM per peptide for 2CL with
peptides 1 and 6, and 50µM per peptide for 2CL mixed with 1-6.
2
2 was a difficult data set. There were 10 sets out of the 50 taken which had double peaks,
and many of the peaks were less Gaussian shaped than seen in other samples, resulting
in more sets with a standard deviation greater than 0.08. It seemed sensible to keep
this cut off, however, as the shape of the peaks implied the possibility of a double peak
127
Chapter 5 Bar Motor Experiments
200 250 300 350 400 450 500
Wavelength (nm)
0.2
0.3
0.4
0.5
0.6
0.7
A
bs
or
pt
io
n
(a) 2CL (100µM)
200 250 300 350 400 450 500
Wavelength (nm)
0.2
0.3
0.4
0.5
0.6
0.7
A
bs
or
pt
io
n
(b) 2CL, 1-6 (50µM)
200 250 300 350 400 450 500
Wavelength (nm)
0.2
0.3
0.4
0.5
0.6
0.7
A
bs
or
pt
io
n
(c) 2CL, 1, 6 (80µM)
Figure 5.7: UV spectra of the three 2CL-containing samples (in PBS buffer, pH 7.4) before
(cyan) and after 30 minutes of irradiation at 360 nm (red). The 2CL, 1, 6 spectrum also
shows the sample an hour after irradiation (the purple spectrum was taken 56 minutes
after the red spectrum).
mostly concealed by the strength of the more dominant peak. Excluding the results with a
standard deviation greater than 0.08, and spectra with two peaks in the region of interest
(ROI) left 23 data sets, and gave a size of 3.92 ± 0.21 nm. Testing with other cut offs
gave results which were the same within the error found (Table 5.1).
2, 1, 6
For this data set, only one spectrum was excluded using a cut off of 0.08 standard deviation.
Six spectra were excluded when double peaked spectra were removed (only one of which
was excluded by the 0.08 cut-off). With a cut off of 0.08 and no double peaks, an average
of 4.83 ± 0.05 nm was found, from 44 measurements.
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Figure 5.8: An example (left) of a good (included in the averaging process) and (right)
bad fit (discarded) to two DLS data sets (runs 1 and 2) for the 2, 1, 6 sample.
2, 1-6
All 50 data sets had one peak between 1 and 10 nm. No data sets were excluded for having
a double peak, nor a greater than 0.08 standard deviation. An average size of 4.48 ± 0.06
was found from all 50 data sets. An average size of 4.44 ± 0.06 was found if one data
set was excluded, which, with a σ of 0.053, was significantly greater than all of the other
standard deviations, but using the same fitting procedure of all of the other sets, there
was no need to exclude any data.
2CL
This sample was carried out at 100µM concentration, and yet of the initial set of mea-
surements taken, a significant proportion (over 30%) showed no useful information. Extra
measurements were performed, and of 144 runs, 61 showed peaks in the region of inter-
est. Of these, 8 were excluded due to the presence of double peaks. Of the remaining 53
sets, a hydrodynamic diameter of 7.06 ± 0.11 was found. After irradiation for 30 minutes
at 360 nm, 50 measurements were taken and all 50 contained information below 30 nm.
The removal of double peaked sets was more difficult for this sample, as, while five sets
had clearly excludable peaks, 9 had two slightly separated peaks in the region. The fact
that these 9 generally had one peak located above and below the single peak of the other
spectra in the set implied that they were likely products of the software’s fitting process,
and were discarded. From 36 data sets, a hydrodynamic diameter of 7.44 ± 0.24 nm was
found.
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2CL, 1, 6
Again, the initial 50 measurements taken contained few useful measurements of the species
present, and hence additional sets were taken. Out of 182 measurements, only 59 had
peaks in the region of interest. Of these 59, 17 were excluded for failing the selection
process (one of the sets included and one of the sets excluded are shown in Figure 5.8).
An average hydrodynamic diameter of 6.70 ± 0.10 nm was found from 42 measurements.
After irradiation, 50 measurements were taken. 18 of the data sets had no peaks below
700 nm. The other 32 sets had one peak which fit well to a Gaussian curve. An average
hydrodynamic diameter of 6.43 ± 0.18 nm was found from 32 data sets.
2CL, 1-6
Due to sample constraints, this sample was run at a lower concentration, of 50µM per
peptide. The initial 50 measurements of 2CL, 1-6 prior to irradiation had many data sets
with no peaks of a non-contaminant origin. 150 measurements were carried out in total,
and of those, 80 had peaks in the region of interest. 15 of these sets were then removed
by the selection criteria of no double peaks, and standard deviations being below 0.08.
For the remaining 65 sets, a hydrodynamic diameter of 6.05 ± 0.09 nm was found. After
irradiation, 50 measurements of the sample were taken. Of these, only one data set had
no peaks in the region of interest. 11 sets were removed for failing to fulfill the selection
criteria. From 38 data sets, an average hydrodynamic diameter of 6.08 ± 0.10 nm was
found.
Discussion
As discussed in Sections 2.3.3 and 3.3.2, we would expect a coiled-coil dimer made up of
two ∼30-residue peptides to have a hydrodynamic diameter ∼4 nm. We would therefore
also expect the bar system (2,1,6 and variants) to have a similar size if it was sufficiently
flexible, and energetically favoured a structure such as that shown in Figure 4.27a. If
the system is fixed in a more extended structure, such as those shown in Figure 4.10, we
would expect a hydrodynamic diameter approximately twice that size, of ∼8 nm. Here,
it appears that the three samples containing 2 are close to a 4nm diameter (Table 5.1),
while the three samples containing 2CL (particularly 2CL and 2CL,1,6) have diameters
which are larger, nearer to 8nm (Table 5.2).
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Table 5.1: DLS Averages: Bar Motor 2 Samples
Sample Criteria Sets
used
Average
(nm)
Standard
Deviation
(nm)
Standard
Error
(nm)
2 All data sets 50 4.14 1.01 0.14
Double peak sets
removed
40 4.05 0.91 0.14
σ < 0.08 27 3.92 0.99 0.19
σ < 0.1 41 4.11 1.02 0.16
No double peaks,
σ < 0.08
23 3.92 1.02 0.21
No double peaks,
σ < 0.1
34 4.06 0.96 0.17
2, 1, 6 All data sets 50 4.86 0.33 0.05
Double peak sets
removed
44 4.83 0.32 0.05
σ < 0.08 49 4.84 0.31 0.05
No double peaks,
σ < 0.08
44 4.83 0.32 0.05
2, 1-6 All data sets 50 4.48 0.43 0.06
Double peak sets
removed
50 4.48 0.43 0.06
σ < 0.08 50 4.48 0.43 0.06
σ < 0.05 49 4.44 0.40 0.06
No double peaks,
σ < 0.08
50 4.48 0.43 0.06
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Table 5.2: DLS Averages: Bar Motor 2CL Samples
Sample Criteria Sets
used
Average
(nm)
Standard
Deviation
(nm)
Standard
Error
(nm)
2CL All data sets 611,2 6.93 0.92 0.12
No double peaks,
σ < 0.08
53 7.06 0.81 0.11
2CL post-
irradiation
All data sets 50 7.44 1.75 0.25
No double peaks,
σ < 0.08
36 7.44 1.43 0.24
2CL, 1, 6 All data sets 591,3 6.72 0.89 0.12
No double peaks,
σ < 0.08
42 6.70 0.62 0.10
2CL, 1,
6 post-
irradiation
All data sets 324 6.43 1.00 0.18
2CL, 1-6 All data sets 801,5 6.14 0.83 0.09
No double peaks,
σ < 0.08
65 6.05 0.69 0.09
2CL,
1-6 post-
irradiation
All sets 496 6.07 0.75 0.11
No double peaks,
σ < 0.08
38 6.08 0.64 0.10
1 Initial 50 measurements had low count of peaks in ROI, so further sets were taken.
2 61 out of 144 sets had peaks in the ROI.
3 59 out of 182 sets had peaks in the ROI.
4 Only 32 out of 50 data sets had a peak in the ROI; no data was excluded due to
double peaks or bad fits.
5 80 out of 150 sets had peaks in the ROI.
6 One of 50 data sets had no peak in the ROI.
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Table 5.3: DLS Averages (time spaced): Irradiated 2CL
Criteria Sets used Number
of sets
Average
(nm)
Standard
deviation
(nm)
Standard
Error
(nm)
All data sets 1-10 10 7.20 2.31 0.73
11-20 10 7.99 1.88 0.60
21-30 10 7.23 1.34 0.42
31-40 10 7.73 1.45 0.46
41-50 10 7.06 1.81 0.57
No double
peaks, σ <
0.08
1-10 6 7.15 1.18 0.48
11-20 7 7.45 1.90 0.72
21-30 9 7.50 1.07 0.36
31-40 8 7.90 1.33 0.47
41-50 6 7.01 1.92 0.78
Table 5.4: DLS Averages (time spaced): Irradiated 2CL, 1 ,6
Criteria Sets used Number
of sets
Average
(nm)
Standard
deviation
(nm)
Standard
Error
(nm)
All data sets1 1-10 7 6.50 0.68 0.26
11-20 5 6.79 1.14 0.51
21-30 8 6.62 0.61 0.22
31-40 6 6.02 1.34 0.55
41-50 6 6.19 1.35 0.55
1 32 data sets, not 50, were used in total, due to some sets having no peaks. Therefore,
for example, the 1-10 set measurement is made up of the average of 7 sets, as three
were blank.
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Table 5.5: DLS Averages (time spaced): Irradiated 2CL, 1-6
Criteria Sets used Number
of sets
Average
(nm)
Standard
deviation
(nm)
Standard
Error
(nm)
All data sets 1-10 10 5.79 1.06 0.33
11-20 10 6.12 0.64 0.20
21-30 10 6.32 0.47 0.15
31-40 10 5.84 0.82 0.26
41-50 91 6.29 0.58 0.19
No double
peaks, σ <
0.08
1-10 9 5.56 0.80 0.27
11-20 8 6.23 0.39 0.14
21-30 8 6.48 0.35 0.12
31-40 5 5.70 0.38 0.17
41-50 8 6.35 0.59 0.21
1 One data set had no peaks in the ROI.
5.2.4 Discussion: 2 With and Without Partners
The DLS data of 2 showed a species of approximately 4 nm. As 2 is a 59-residue peptide,
with seven coiled-coil heptads and ten other residues (the linking region), we would expect
a length of 8-9 nm if the peptide was forming a straight helix. As we are measuring the
hydrodynamic diameter and not the true length, the values seen may vary somewhat from
this. However, a size half of this, as seen for 2 in isolation, implies that the peptide
has formed compact structures; it may have formed a hairpin, with the peptide 2-based
heptads interacting with the -based heptads. Alternatively, the peptide could be forming
some intermediate between the two extremes of hairpin and bar, but as this is a single
peptide with the hydrophobic a and d residues typical of a coiled-coil peptide, the preferred
state is likely to bury these residues; forming a hairpin is the most obvious choice given the
size measured. The flexibility seen in the MD simulations of the azobenzene free system
of 2, 1 and 6 supports this hypothesis; the linking region does seem to be sufficiently
unstructured in the absence of an azobenzene moiety to allow a hairpin (or near-hairpin)
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to form (the closest resemblance to a hairpin seen in the simulations is shown in Figure
4.27). The simulation was carried out for the peptide with partnering peptides without a
linking disulphide bond and the V-like, T-like and Π-like conformations seen would all give
similar sizes if observed by DLS. The 2, 1, 6 and 2, 1-6 DLS samples both give similar
results to the isolated peptide, with hydrodynamic diameters of 4.83 ± 0.05 nm and 4.44
± 0.06 nm respectively. For these systems, the peptides may be less driven to form a
hairpin, though from the DLS data alone, it is difficult to speculate on the structures
forming. The values again rule out a straight coiled-coil-like structure, and do not rule
out the possibility of hairpin formation. The simulations indicate that these systems (as
the disulphide bonded system is unlikely to have greatly different behaviour to the ,1,6
system) may be forming intermediates such as the V-, T- and Π-like structures. The fact
that both systems give slightly larger diameters than the single peptide supports this. We
had expected that the disulphide bond between peptides 1 and 6 could possibly cause the
two helical regions to be brought closer together, but this technique is not sensitive enough
to measure such a change, especially given that our system is not spherical, and hence
the hydrodynamic diameter does not represent the true length, only an approximation.
Even if this change were measurable, the fact that intermediates between a hairpin and
a straight helical structure are likely the present structures, this change would not be
pronounced enough to be observed.
5.2.5 Discussion: 2 vs. 2CL
Unlike the change between a lone 2 and 2 with the addition of free and disulphide bonded
partners, the addition of the azobenzene moiety to the system does appear to have a
significant effect on the species size. It appears that the 2CL peptide is forming a larger
structure than the 2 peptide. This indicates that at least some of the 2CL peptides may
be making a homodimer (or higher order structure) to bury their hydrophobic residues,
as opposed to forming hairpins, as this is surely preferable than exposing a number of
hydrophobic residues. This measurement does not rule out the presence of some hairpins,
but indicates that there has been a shift in the population towards a larger structure.
5.2.6 Discussion: 2CL With and Without Partners
Like 2, 2CL does not seem to undergo a major size change upon addition of partners.
2CL has a hydrodynamic diameter of 7.06 ± 0.11 nm, while 2CL, 1, 6 has a radius of
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6.70 ± 0.10 nm, and 2CL, 1-6 a diameter of 6.05 ± 0.09 nm. The simulations indicated
that the cis isomer systems tended to spend more time in a near-bar state than the trans
systems. However, both were able to occupy both near-bar and more bent V-like states.
These DLS results indicate that the structure of the peptide with an azobenzene attached
is more rigid without irradiation than expected, or predicted by the MD simulations. The
fact that there is a significant change between the 2 and 2CL peptides implies that the
azobenzene is successfully connected to 2CL at two points, and is able to inflict change
on the system. There is no obvious reason for the size of 2CL, 1, 6 to be greater than
that of 2CL, as both are clearly in extended states. The fact that 2, 1-6 results in a
hydrodynamic diameter 1 nm smaller than 2 may show the effects of the disulphide bond
restricting the flexibility of the central hinge, but all of these changes seen between the
2CL samples are small compared with the change from an azobenzene-free system.
5.2.7 Discussion: Irradiation of 2CL
Irradiation of the samples does not result in a large effect as measured by DLS. From UV
data, it is clear that the system is undergoing some level of azobenzene conformational
switching (Figure 5.7). It appears that the switching is reversed without stimulation
within ∼100 minutes. As it takes ∼43 minutes to take 50 DLS measurements, we would
expect half of the switched molecules to have reverted back to their original state within
this time frame. In order to ensure that no trend was missed, from the DLS data sets
of the three 2CL-containing samples, the average size found for each ten data sets was
found, so that the average hydrodynamic diameter for the samples within ∼15 minutes of
irradiation was measured, and in 8 minute steps after this (Tables 5.3 - 5.5). This data
showed no progressive increase or decrease in size over time, and the deviations found did
not indicate an increase or decrease in variability over time. It is unclear whether there
is significance in the fact that the partner-free system (2CL) showed an increase in size
upon irradiation while the other two (2CL, 1-6 and 2CL, 1, 6) showed almost no change
and a slight decrease, respectively. The expectation was to see a more compact structure
prior to irradiation, and potentially a larger (more rigid) structure upon irradiation. As
there is already a population of larger structures prior to irradiation, it is more difficult
to observe the effect of the irradiation.
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5.3 Conclusions
In this chapter, we have established that the introduction of an azobenzene molecule has
a significant effect on the size of the 2 peptide. The CD data of the system indicates that
interaction between the peptides is present, and the UV data of the azobenzene-containing
systems shows that the system’s irradiation does induce a change. However, the effect of
the introduction of the azobenzene moiety on the system was greater than predicted by
the MD simulations. Determination of the extinction coefficient, allowing the collection of
further information on the differences between the structures of 2 and 2CL, is desirable.
Further work into the optimisation of azobenzene switching would be beneficial to ensure
optimal efficiency of any future systems. This would give a clearer view of the effect of
irradiation on the system; at the moment we are observing a larger structure that the
compact 2 structures prior to irradiation, and so changes upon irradiation are less clear.
The use of techniques which are sensitive to individual molecules are needed to gain a
better insight into the system’s behaviour. FRET, using fluorescently tagged peptides,
with fluorescent tags placed at the extremities of the system (for example, at the two
ends of peptide 2), would be a useful technique, as we would be able to determine the
separation of the fluorescent tags, and hence the ends of the peptide system. The fact
that such a significant change occurs between the azobenzene-free and azobenzene-bound
peptides presents a possible future direction; the switchable attachment and detachment
of the azobenzene moiety (with one end permanently attached and the other detachable)
could be worth investigation. If possible, it appears that the two resulting structures
would have significant size differences as desired in the Bar motor design.
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Conclusions
The experimental study of the components and formation of two hub systems has been
carried out, along with simulations of the second system.
For the Tumbleweed hub, there is strong evidence that the design specification of pro-
ducing three orthogonal coiled-coil dimers has been successful. The data gained on the
system indicates that the pairings are sufficiently specific that a hub with three differ-
ent coiled-coil pairs, and hence three different feet in the final motor hub, should form.
The linkages provided at present by disulphide bonding could be replaced in order to form
more robust links between the three hub legs, and this would hopefully widen the chemical
environment in which the hub can successfully function, including those required for the
preferential DNA-binding of the different foot domains. There are many possibilities for
this change, including the synthesis of three long peptides which each span the distance
between two feet of the hub, or by native chemical ligation of the peptides.
For the Bar motor, coarse-grained simulations indicate that a motor can still be progres-
sive even if the switch in the system is not between two states of fixed angles, but one
fixed state and one flexible state. The MD simulations of the system indicated that both
the cis and trans azobenzene states allow some level of flexibility in the peptides, but that
the trans state spends more time in non-bar-like states. If there is no difference between
the foot separations open to the two states, we would still likely have a motor which could
move along a track but directionality would be lost and the processivity would be lowered.
The simulations indicated, however, that there is a difference in the average conforma-
tion of the two systems, and hence some level of directionality could be introduced to
the system using the two azobenzene isomers and two varying binding site separations,
by choosing one binding site separation which is more regularly accessed by each of the
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isomer states of the azobenzene-linked peptides.
The experimental studies of the system, however, indicated that the 2CL samples all
contained structures which were much closer to bar-like states than more compact con-
formations; the presence of the azobenzene moiety appears to have a greater effect on the
structure than expected from MD simulations. It would therefore be desirable to investi-
gate further the source of the current discrepancies between the experimental observations
and the MD results. The choice of force field and water model for the simulations have
been used to predict several experimental peptide systems successfully [215; 216; 217] and
hence it would be interesting to establish whether it is an issue with these, or perhaps
the representation of the azobenzene molecule in the models, which is the source of the
mismatch. Further experimental work and corresponding MD simulations could assist in
this. Irradiation did not indicate a switch from bar-like to a significantly more compact
structure for the levels of irradiation achieved. For the current system, optimisation of the
azobenzene molecule switching, by increasing the efficiency of transfer through the irradi-
ation method, is important to ensure that a larger proportion of the molecules are effected
by the irradiation, and can be studied further to determine the difference between the
conformations of peptides attached to the two different isomers of the azobenzene moiety.
Following this, studying the effects of different linking regions on the levels of switching
achieved is another possibility. It may be possible to simply use the 2CL peptide as the
hub, as it appeared to undergo a size change of 0.5 nm after irradiation (which was not cov-
ered by the standard error of the two measurements), which may be sufficient to exploit.
The 2 peptide, without azobenzene, with, and without peptide partners formed signifi-
cantly more compact structures that the azobenzene-containing systems. This clear result,
that even the unpaired 2CL system is forming larger structures than the azobenzene-free
systems indicates that the introduction of the azobenzene is successfully counteracting
the tendency of the peptides to bury their hydrophobic residues with the most convenient
partner (in this case, the peptide folding up to interact with the other half of itself). The
system must be forming dimers (or higher order oligomers) instead of hairpins to bury
these residues in a way allowed by the restrictions enforced by the azobenzene moiety.
Based on the current results, exploiting the difference between the azobenzene-free and
azobenzene-containing systems may be a good future direction to follow, with the use of
switchable azobenzene attachment.
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Abbreviations
B.1 Abbreviations
ADP Adenosine diphosphate
AFM Atomic Force Microscopy
ATP Adenosine triphosphate
AUC Analytical Ultra Centrifugation
BLAST Basic Local Alignment Search Tool
bZIP Basic leucine zipper (protein domain)
CAP Catabolite Activator Protein
CCHMM Coiled-Coil domains with Hidden Markov Models
CCHMM-PROF Profile-based version of CCHMM
CD Circular Dichroism
CG Coarse-Grained (simulations)
COMP Cartilage Oligomeric Matrix Protein
Da Dalton (atomic mass unit, 1g/mol)
DCM Dichloromethane
DIPEA N,N-diisopropylethylamine
DLS Dynamic Light Scattering
DMF N,N-dimethylformamide
DMSO Dimethyl sulfoxide
DNA Deoxyribonucleic acid
DtxR Diphtheria toxin repressor
Fmoc 9H-fluoren-9-ylmethoxycarbonyl
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FRET Fo¨rster/Fluorescence Resonance Energy Transfer
GROMACS GROningen MAchine for Chemical Simulations
HIV Human Immunodeficiency Virus
HPLC High Performance Liquid Chromatography
KIH Knobs-Into-Holes
LC Liquid Chromatography
L-J Lennard-Jones (potential)
MALDI Matrix-Assisted Laser Desorption/Ionisation
MARCOIL Hidden MARkov model-based program that predicts potential
coiled-COIL domains in protein sequences
MBHA Methylbenzhydryl amine
MD Molecular Dynamics
MeCN Acetonitrile
MetJ Methionine repressor
MRE Mean Residue Ellipticity
MW Molecular Weight
NCL Native Chemical Ligation
NMP N-methylpyrrolidone
NMR Nuclear Magnetic Resonance
OD Optical Depth
Pi Inorganic phosphate molecule
PBS Phosphate Buffered Saline
PCOILS Profile-based version of COILS
Pd(II) Palladium (oxidation state 2; charge +2)
PDB Protein Data Bank
PDMS Polydimethylsiloxane
PSIBLAST Position-Specific Iterated BLAST
Pt(II) Platinum (oxidation state 2; charge +2)
PurR Pur operon repressor
PyBOP Benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate
rpm revolutions per minute
RNA Ribonucleic acid
ROI Region of interest
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SARS Severe Acute Respiratory Syndrome
SE Sedimentation Equilibrium
SV Sedimentation Velocity
SPPS Solid Phase Peptide Synthesis
TCEP-HCl (tris(2-carboxyethyl)phosphine) hydrochloride
TFA Trifluoroacetic acid
TIPS Triisopropylsilane
ToF Time-of-flight
Tris-HCl Tris(hydroxymethyl)aminomethane hydrochloride
TrpR Tryptophan repressor
UV Ultraviolet
VMD Visual Molecular Dynamics
Collaborators
ACM Asahi Cano-Marques
EHCB Elizabeth H. C. Bromley
MJZ Martin J. Zuckermann
RBS Richard B. Sessions
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B.2 Amino Acid Abbreviations
Table B.1: Amino Acid One- and Three-letter Codes
Amino Acid Name Three-letter code One-letter code
Alanine Ala A
Arginine Arg R
Asparagine Asn N
Aspartic Acid Asp D
Cysteine Cys C
Glutamic Acid Glu E
Glutamine Gln Q
Glycine Gly G
Histidine His H
Isoleucine Ile I
Leucine Leu L
Lysine Lys K
Methionine Met M
Phenylalanine Phe F
Proline Pro P
Serine Ser S
Threonine Thr T
Tryptophan Trp W
Tyrosine Tyr Y
Valine Val V
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Product Masses
Table C.1: Peptide disulphide pairings and resultant masses
Peptide Sequence Calculated
Mass
6-1 NKIAALKYKIAALKQEIAALEQGNNGC
CGNGNEIAALEKKIAALKQENAALEQEIAALEY
6470
3-2 EIAALEQEIYALEQKNAALKKEIAALEQGNNGC
CGNGNKIAALKQEIYALEQKNAALKQKIAALK
7096
4-5 NKIAALKQKIAQLKQENAALEQKIYALKQGNNGC
CGNGNKIKALKQEIAALEYEINALEQ
6682
1-2 (CGNGNEIAALEKKIAALKQENAALEQEIAALEY)1
CGNGNKIAALKQEIYALEQKNAALKQKIAALK
7039
3-4 EIAALEQEIYALEQKNAALKKEIAALEQGNNGC
(NKIAALKQKIAQLKQENAALEQKIYALKQGNNGC)1
7395
6-5 NKIAALKYKIAALKQEIAALEQGNNGC
CGNGNKIKALKQEIAALEYEINALEQ
5814
1 All of the sequences are written from N to C termini. The brackets denote that
the peptide is disulphide-bonded C-N, due to the position of its cysteine residue.
The N-termini of peptides 1 and 2 bind, while the C termini of peptides 3 and 4
bind. This is clarified in Figure 3.12.
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Appendix D
Experimental Methods
D.1 Peptide Synthesis
All peptides were synthesised using a CEM Liberty 1 Automated Microwave Peptide Syn-
thesiser, and PepDriver software, on a 0.1mM scale. Table C.2 lists all of the peptide
sequences synthesised and used in this thesis, with modifications and masses. Peptides
1 and 6 were provided in crude form by Marc Bruning (Woolfson Lab, Bristol Univer-
sity). Piperidine (20% in DMF) was the deprotect solution, PyBOP (0.5M in DMF) the
activator, and 2M DIPEA in NMP the activator base for all syntheses. Fmoc amino
acids (dissolved in DMF) were used at a concentration of 0.2M, and all Fmoc groups
were removed in the synthesis process. Rink amide resin, which has an NH2 group, was
used for all syntheses, so upon removal from the resin, peptides were amidated at the
C-terminus. The following amino acids were used (side chain protecting groups shown
in brackets): Fmoc-Gly-OH, Fmoc-L-Tyr(tBu)-OH.H2O, Fmoc-L-Glu(tBu)-OH, Fmoc-L-
Leu-OH, Fmoc-Asn(Trt)-OH, Fmoc-L-Gln(Trt)-OH, Fmoc-L-Ala-OH.H2O, Fmoc-L-Lys(Boc)-
OH, Fmoc-L-Ile-OH, Fmoc-L-Cys(Trt)-OH. All of the amino acids used were purchased
as powders from AGTC Bioproducts Ltd, along with PyBOP, and solutions prepared on
the day of a synthesis. DIPEA, NMP, and Piperidine were all purchased from Sigma
Aldrich. DMF was purchased from Rathburn Chemicals and AGTC Bioproducts. Rink
Amide MBHA resin, 100-200 mesh, substitution 0.59mmole/g, was purchased from Nov-
abiochem. Peptides 1 to 6 were all synthesised using the standard method described below
(Section D.1.1). Deviation from this method for 2 is discussed in Section D.1.2.
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D.1.1 Standard Synthesis
1. The required peptide sequence was put into the PepDriver software, and all of the
solutions made up for a synthesis. Any solutions remaining from previous syntheses
(unless syntheses were performed directly one after another) were replaced with fresh
solutions. The piperidine solution could be kept for much longer.
2. Resin was weighed out and swelled in a small amount of DMF (∼1ml) in the reaction
vessel prior to synthesis. This was then replaced in the centre of the microwave,
ready for synthesis. Additionally, the machine automatically allowed 15 minutes for
swelling as part of its run sequence.
3. The automated synthesis was then carried out. The synthesiser takes around 19
hours to synthesise each of the hub peptides discussed in this report (varying with
length/composition) and hence syntheses were usually carried out overnight. Once
the synthesis was completed, the peptide, still attached to the resin, was removed
from the machine.
4. The peptide resin beads were transferred to filter tubes (with open tops, and filters
and stoppers at the bottom), and acetylated using acetic anhydride (20% in DMF,
5ml total volume per 0.1mM scale peptide synthesis), stirred for 30 minutes at room
temperature using a magnetic stirrer and stirring plate.
5. The acetic anhydride-DMF solution was removed from the peptide resin via the
stopper, and the resin rinsed several times with DMF, before it was dried using a
pump. (In later syntheses, they were further rinsed and shrunk with diethylether,
as cleavage does not require swollen resin).
6. Once the peptide resin was dry, the stopper was replaced, and the peptide cleaved
from the resin. This was done using a solution of TFA (95%), TIPS (2.5%) and
distilled water (2.5%). If cysteine was present, as it was in the hub peptides, 1,2-
ethanedithiol was also added, in the same volume as the TIPS and distilled water.
The resin (with peptide attached) was left in this solution for at least three hours,
stirred constantly using a magnetic stirrer and stirring plate. If the resin turned red
immediately after addition of the solution, more TIPS was added. After one hour of
stirring, the colour was again checked to ensure that sufficient scavenger was present
to prevent unwanted reactions between the peptide and the removed groups.
149
Chapter D Experimental Methods
7. After three hours, the peptide should be in solution, and separable from the resin
via the filter. The peptide was precipitated into chilled diethylether via the tube
filter. The tubes of peptide in cleavage solution and ether were spun down in a
centrifuge at 3000 rpm for 10 minutes in order to separate the cleavage chemicals
from the peptide. The peptide settles to the bottom of the tubes (the solvent remains
cloudy, and more centrifugation is needed, if this does not occur) and the solvents
are then poured off carefully, leaving the white powder sedimented at the bottom of
the tubes. More diethylether was then added to each tube, the powder re-dispersed
and centrifugation repeated in order to remove any remaining cleavage solution. The
solvent was again poured off, leaving the peptide.
8. The peptides were then dissolved in 5ml of distilled water per tube, frozen and freeze
dried, after which they were kept in a freezer for significant amounts of time.
D.1.2 Non-standard Syntheses
2 Synthesis
2 was synthesised by Asahi Cano-Marques. The same chemicals were used as previously
stated.
There were some changes to the standard synthesis scheme:
• The peptide was synthesised in three stages, with test cleaves carried out after
synthesis of 30, 45 and 59 residues.
• The resin swelling time was longer - two hours in DCM prior to synthesis, six hours
in DCM prior to addition of residues 30 to 15, and 16 hours in DMF prior to addition
of residues 14 to 1.
• Resin was shrunk in diethylether prior to storage between stages and prior to cleav-
age, to remove DMF.
• Fmoc deprotection was carried out using two treatments of piperidine in DMF, for
5 and 10 minutes respectively.
• Most of the couplings were double couplings (residues 44-30, 28-15, 12-2), while
residues 59, 29, 14, 13 and 1 were triple coupled, and 58-45 single coupled. Single
couplings used a fivefold excess of amino acids, 10 equivalents of PyBOP, and 20
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equivalents of DIPEA. Double couplings used single coupling amounts of amino
acid, DIPEA and PyBOP, reacted, removed and repeated, so double couplings used
twice the single coupling quantities in total.
• Reaction volumes were also varied - residues 58-30, 28-15 and 12-2 used double
volumes. These volumes were at the same concentrations as previously stated, and
hence contained twice the number of equivalents. For double volumes in the first
stage, this meant a total of double the equivalents of the single couplings above, and
quadruple equivalents for those with double couplings. Due to the resin being split
after residue 30 (half was saved for later additions to be carried out via an alternative
method if the initial synthesis scheme failed), these equivalents were in fact doubled
again for double volumes in stages 2 and 3, as the additions were left at previous
volumes/concentrations, even though only half the amount of resin remained.
Once 2 was synthesised, it was purified, and some of it was crosslinked with azobenzene
via its cysteine residues:
1. A 1.1ml, 1.4mM solution of the peptide in water was stirred at room temperature
with 5ml, 5mM of Tris-HCl (pH 8.5) and 5ml, 5mM TCEP-HCl (pH 8.5) for at least
2 hours under N2, then covered by aluminium foil to protect from the light, and
heated to 40◦ C.
2. Once the solution was at 40◦ C, 2ml of 1.1mM azobenzene in DMSO was added
dropwise to the solution, and stirred for 20 minutes. This was followed by 2ml of
18mM azobenzene in DMSO (added dropwise) and a further 20 minute stirring.
3. The solution was then exposed to the light and stirred for a final 20 minutes.
4. The product was then lyophilised and purified using HPLC.
D.2 MALDI-ToF
The MALDI-ToF experiments were done through the Chemistry Department Mass Spec-
trometry Service, using a Bruker Daltonics Autoflex II ToF/ToF machine. The peptides
were mixed with α-cyano-4-hydroxycinnamic acid matrix.
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D.3 HPLC
All peptides were purified using a C18 column with a Perkin Elmer 785A UV/Visible
Detector, and Series 200 LC pump, and Clarity software. Peptides were dissolved in water,
or, if not fully soluble in water, were wet with a small amount of acetonitrile, followed by
water. Samples were spun down, and also filtered in some cases, in order to remove any
particulate matter from the sample before injection into the HPLC system. HPLC was
carried out using gradients from Solution A (95% distilled water, 5% acetonitrile, +0.1%
TFA) to Solution B (95% acetonitrile, 5% water, +0.1% TFA), and monitoring elution of
the Tyrosine-containing peptides via the 280nm wavelength.
An example of a HPLC method used:
• 3 minutes at 100% solution A
• 40 minute linear gradient from 100% solution A to 100% solution B
• 10 minutes at 100% solution B
• 10 minute linear gradient from 100% solution B to 100% solution A
• 5 minutes at 100% solution A
Fractions were collected as they left the machine and peptide fractions identified using
MALDI-ToF. Methods were lengthened and gradients modified in some cases to try to
increase resolution of peaks, and better separate products.
D.4 Disulphide Bonding
0.017g of Aldrithiol-2 was dissolved in 1ml of acetonitrile (MeCN). Each of the five peptides
to be reacted with Aldrithiol-2 were dissolved in water, to a concentration of ∼1mg/ml,
and 40µl of Aldrithiol in MeCN was added per millilitre of peptide solution, providing a
tenfold excess of Aldrithiol-2. Each solution was then agitated and freeze-dried. HPLC
purification was then used to separate the peptides from excess Aldrithiol-2, and side
products from the reaction. Each aldrithiol peptide and its partner peptide were then
reacted together in water, and the disulphide-bonded pair separated from other products
via HPLC purification.
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D.5 Samples for Characterisation
For each peptide, the purest fractions from HPLC were combined and dissolved in water,
and these were kept as stock solutions. The stock solutions were made to approximately
1mg/ml concentrations and more accurate values were then found using UV-Vis spec-
troscopy. These stock solutions were then used for CD and DLS characterisation. CD and
DLS measurements were carried out in phosphate buffer solution.
D.6 UV-Vis Measurements
D.6.1 Concentration Determination
Each of the six regular hub peptides contain one tyrosine residue, and it was the UV
absorption of this which was used to measure the concentration of samples. Using the ty-
rosine absorption to measure tyrosine concentration gives peptide concentration, as they
exist in a 1:1 ratio. For 2, which has two tyrosines, there is a trivial change in the concen-
tration calculation (Appendix F.1). All UV-Vis spectra for non-fluorescent peptides were
carried out between 200 and 320nm or 340nm, on a UNICAM UV2 UV-Vis spectrometer,
using a reduced volume quartz cuvette of 1cm path length. Most measurements were
carried out on peptides dissolved in water. If there were signs of unusual activity, such as
aggregation, PBS buffer was used. Measurements involved taking three spectra of each
sample, and taking measurements of three samples for each peptide, allowing an average
to be calculated.
UV Measurement Protocol:
1. Peptide samples of 10% stock concentration were prepared, i.e. 30µl of stock solution,
and 270µl water.
2. A baseline was carried out using the UV cuvette filled with distilled water.
3. The sample was measured three times, and files converted to ASCII. The 280nm
peak should have an OD approximately between 0.1 and 1. If solutions were found
to be too weak/strong to make meaningful measurements, different concentrations
were prepared, to achieve absorptions in the 0.1-1.0 region.
4. Once all measurements were taken, the concentrations were determined using the
absorption at 280nm, compared with the baseline (Equations in Appendix F.1).
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D.6.2 Switching Effects
For 2CL, a UV spectrum was taken of the sample prepared for CD (using a 0.1cm cuvette,
and 0.9cm spacer). After irradiation and CD measurements, the sample was measured
again, and at intervals after this, to monitor the spectrum as the system returned towards
its pre-irradiated state.
D.7 Circular Dichroism
CD measurements were taken using a JASCO J1500 (earlier measurements with a J-
810) spectropolarimeter with a 150W Xenon arc lamp light source, and J-815 MCB-100
mini circulation bath and peltier stage to control temperature. The machine is purged of
oxygen with nitrogen gas before and during use, as oxygen absorbs strongly in the region
of interest, and to prevent ozone production.
1. 300µl, 20µM solutions were made, with the required volume of peptide solution from
the stock solutions, 10% (30µl) PBS (10x concentrated), and the remainder of the
300µl, distilled water.
2. Spectra were collected at 20 ◦C over a wavelength (λ) range of 260-190nm (other
parameters shown in Table D.1).
3. Melts were also performed (parameters shown in Tables D.2 and D.3).
4. The results were then converted into mean residue ellipticity units, using Equation
F.12.
A typical PBS solution baseline spectrum (formed from multiple mesurements of PBS
solutions at various points between the peptide measurements) was removed from all of
the peptide λ vs. CD spectra. I took five λ vs. CD spectra at 20◦ C both pre- and
post-melt for each solution and one melt.
For mixtures, the concentration of each peptide was 20µM, so the required volume of each
peptide was added to 30µl of PBS (10x) and the water required to make a 300µl volume
sample.
D.7.1 Concentration of 2CL
The azobenzene moiety of 2CL meant that the UV signal from Tyrosine could not be seen,
and hence comparison of the CD of 2CL with 2 was used to estimate the concentration
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Table D.1: Parameters used in CD measurements over a range of wavelengths at 20 ◦C
Parameter Explanation/Options Value Used
Sensitivity ‘Low’, ‘Standard’ or ‘High’ Standard
Wavelength Wavelength range used for measurements 260-190nm
Data Pitch Interval between data points recorded 1nm
Mode ‘Step’ or ‘Continuous’ Continuous
Scan speed Wavelengths scanned per interval time 50nm/min
Response Time over which data is averaged (smooths out in-
stabilities), related to scan speed
2s
Bandwidth Similar to resolution; can be coarse as the peaks
measured here are broad
1nm
Accumulation No. of scans averaged to get result 11
1 Instead of using accumulation, multiple scans were taken manually and results aver-
aged
Table D.2: Parameters used in CD melt experiments - wavelength options
Parameter Explanation/Options Value Used
Sensitivity ‘Low’, ‘Standard’ or ‘High’ Standard
Wavelength Wavelength range used for measurements 260-190nm
Data Pitch Interval between data points recorded 1nm
Mode ‘Step’ or ‘Continuous’ Continuous
Scan speed Wavelengths scanned per interval time 50nm/min
Response Time over which data is averaged (smooths out in-
stabilities), related to scan speed
2s
Bandwidth Similar to resolution; can be coarse as the peaks
measured here are broad
1nm
Accumulation No. of scans averaged to get result 11
Delay time Time machine waits between achieving required
starting temperature and starting measurement
30s
1 Instead of using accumulation, multiple scans were taken manually and results aver-
aged
155
Chapter D Experimental Methods
Table D.3: Parameters used in CD melt experiments - temperature options
Parameter Explanation/Options Value Used
Wavelength Wavelength CD is measured at as a function of tem-
perature
222nm
Temperature Temperature range measured over 10-90 ◦C
Data Pitch Interval between data points recorded 1 ◦C
Delay time Time machine waits between achieving required
starting temperature (10 ◦C) and starting measure-
ment
30s
Scan speed Temperature range covered per interval time 60 ◦C/hour
Sensitivity Low, standard, high Standard
Response Time over which data is averaged (smooths out in-
stabilities), related to scan speed
8s
Bandwidth Similar to resolution; can be coarse as the peaks
measured here are broad
3nm
of 2CL.
D.8 DLS
DLS measurements were taken on a Malvern Zetasizer µV machine using Sarstedt dis-
posable transparent cuvettes. 100µM samples were made in PBS buffer solution. For
multiple-peptide samples, each peptide was present at a concentration of 100µM.
D.9 Glutathione Experiments
Concentrations of the 1-6, 2-3 and 4-5 disulphide bonded peptides (dissolved in water)
were measured using a Thermo Scientific Nanodrop 1000, so that a 1:1:1 ratio could be
produced as accurately as possible using low concentrations and low volumes of peptides.
In order to encourage disulphide exchange, the peptides were added to PBS buffer solution
containing a low concentration of reduced glutathione. As the exchange was expected to
be rapid, the solution was left for under 10 minutes, after which the volume of the sample
was almost doubled (from 58 to 108 µl) with TFA in water (4µl in 15ml water), to lower the
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pH and quench the reaction. This sample was then submitted for MALDI-ToF analysis.
A 1:1:1 ratio of the three disulphide bonded peptides was also added into a separate 50µl
TFA in water sample for submission for MALDI.
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Spectra
E.1 MALDI Spectra
1000 1200 1400 1600 1800 2000 2200 2400 2600 2800 3000 3200 3400 3600 3800 4000 4200 4400 4600 4800 5000 5200 5400 5600 5800 6000 6200 6400 6600 6800 7000
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Figure E.1: MALDI-ToF spectrum of  (synthesised by EHCB).
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(a) Peptide 1
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(b) Peptide 2
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(c) Peptide 3
Figure E.2: MALDI-ToF spectra of the individual hub peptides 1, 2 and 3.
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(d) Peptide 4
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(e) Peptide 5
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(f) Peptide 6
Figure E.2: MALDI-ToF spectra of the individual hub peptides 4, 5 and 6.
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Figure E.3: MALDI-ToF spectra of the disulphide-bonded hub peptides. The main peak
at higher masses is the desired product in each, with masses of 6461, 7086, and 6677 Da
measured respectively.
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Figure E.4: MALDI-ToF spectra of 2 during synthesis, after a) 30 residues and b) 45
residues (credit: ACM).
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Figure E.5: Final MALDI-ToF spectrum of crude 2. The spectrum does not look ideal,
but there are clearly several peaks near the peptide mass, indicating some peptide and
some near-correct peptide constituents (credit: ACM).
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Figure E.6: MALDI-ToF spectrum of 2CL. The peak is at the desired mass of 6642 Da.
2CL was synthesised by ACM.
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E.2 CD Melt Data for Peptide Mixtures
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Figure E.7: Melt spectra for the 12 non-designed two-peptide mixtures, taken at 20µM
concentration per peptide in PBS buffer (pH 7.4).
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Figure E.8: Melt data of disulphide-bonded peptides, taken by EHCB. Red lines are the
spectra of single disulphide peptides, pairs are shown in blue, while the full hub is shown
in green.
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E.3 Raw AUC Data
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Figure E.9: AUC data of coiled-coil pairs and disulphide-bonded peptides.
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Figure E.10: AUC data of pairs of disulphide-bonded peptides, and all three disulphide-
bonded peptides together.
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UV and CD Calculations
F.1 Calculation of Concentration from UV Absorbance
The Beer-Lambert law:
A = cl (F.1)
where A is absorbance (measured), c is concentration (desired), l is path length (known)
and  is extinction coefficient (known from literature). This gives:
csample =
A
 · l (F.2)
For these samples:
csample(M) =
A
(M−1cm−1) · 1(cm) (F.3)
where  depends on the number of tyrosine residues present:
Tyr = 1280M
−1cm−1 (F.4)
2Tyr = 2 · 1280M−1cm−1 = 2560M−1cm−1 (F.5)
Once the concentration of the sample has been calculated, the stock concentration is found:
cstock(M) = csample · d (F.6)
where d is the dilution factor
d =
Vtotal sample(µl)
Vstock solution in sample(µl)
(F.7)
A is measured directly by the spectrometer, but there is a baseline, a non-tyrosine contri-
bution, which needs to be removed. Therefore
A = Apeak −Abaseline (F.8)
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Abaseline was found by extrapolating a baseline from the best fit to the data at 310-320
nm, which was normally (and this was confirmed by eye) unaffected by the peak.
F.2 Circular Dichroism Units, Conversions and Calculations
F.2.1 Explanation of CD Units
Circular dichroism is recorded by the spectropolarimeter in mdeg, units of ellipticity. This
is usually then converted to molar ellipticity, Mθ, or mean residue ellipticity (MRE), which
is molar ellipticity per peptide bond.
Mθ =
deg · cm2
dmol
Mθ =
deg · cm3
dmol · cm
Mθ =
10deg · cm3
mol · cm
Mθ =
1000deg · cm3
100mol · cm
1000cm3
mol
= M−1
100cm = 1m
Mθ =
degM−1
100 · cm
Mθ =
degM−1
m
Mθ = degM
−1m−1
(F.9)
This molar ellipticity, Mθ, is historically displayed in the units degcm
2dmol−1, which is
equivalent to deg M−1m−1 (as shown in Equation F.9). It is therefore common to use
Equation F.10, with pathlength in cm, and a balancing factor of 100 to convert to metres.
This is then equivalent to the traditional units. The units of Mean Residue Ellipticity
(MRE) are degcm2dmol−1res−1.
Mθ
(
degcm2
dmol
)
=
100θ(deg)
l(cm)M(moles/litre)
(F.10)
F.2.2 Conversion of Raw Data to Final Units
In order to present the CD data in its final form, an average of the CD runs (usually five) at
20◦C (pre-melt) was taken for each sample. A PBS baseline was removed from the sample
average to give the corrected measurements in units of mdeg. The data was then converted
168
Chapter F UV and CD Calculations
into molar ellipticity by dividing the corrected values by the molar concentration (other
factors cancel in our case, Equation F.11). To then convert to MRE, the molar ellipticity
is divided by peptide bond number (Equation F.12). Our peptides have one more peptide
bond than residue, due to there being one less peptide bond than the number of residues
between the residues, plus one bond for each of the acetylation and amidation of the N-
and C- termini respectively. For the mixtures this calculation is slightly more complicated,
and no molar ellipticity was calculated, only MRE, as shown in Equation F.13, where θ is
again the baseline-corrected data.
Mθ =
100θ(deg)
l(cm) ·M(moles/litre)
l = 0.1cm
Mθ =
100 θ(mdeg)1000
0.1 ·M(moles/litre)
Mθ =
θ(mdeg)
M(moles/litre)
(F.11)
MRE =
θ(mdeg)
M(moles/litre) ·Npeptidebonds (F.12)
MREmixtureA,B =
θ(mdeg)
MA(moles/litre) ·Npeptide bonds, A +MB(moles/litre) ·Npeptide bonds, B
(F.13)
F.2.3 Theoretical Curves for Mixtures
Theoretical spectra of mixtures were calculated by summing the baseline-corrected data
of the two contributing peptides, and then converting to MRE in the same way as with
the measured mixtures - dividing by the sum of the concentration-peptide bond product
of each peptide (Equation F.14).
MREtheor. A,B =
θA(mdeg) + θB(mdeg)
MA(moles/litre) ·Npeptide bonds, A +MB(moles/litre) ·Npeptide bonds, B
(F.14)
169
Appendix G
Coarse-grained Simulations
Martin Zuckermann carried out 3D coarse-grained Langevin dynamics simulations, solving
the overdamped Langevin equation (Equation G.1).
∆x
(j)
i =
F
(j)
i ∆t
γ
+
(
2kT∆t
γ
)1/2
ζ
(j)
i (t) (G.1)
∆x
(j)
i is the change in the ith co-ordinate (i = 1,2,3) of the j th bar motor component(
j = 1,2,3, representing FA, H and FB, the three spherical components, shown in Figure
4.2) over a time ∆t, at time t. F
(j)
i is the ith component of the force acting on the
j th component at time t, which is a sum of an internal conservative force
(
F
(j)
Ci
)
and
an external force
(
F
(j)
Ei
)
. In these simulations, F
(j)
Ei is set to zero. F
(j)
Ci is the negative
gradient of a potential, the sum of WH , WL−J , WSB and WBE . WH is a harmonic
potential defining length l. WL−J is a Lennard-Jones repulsive interaction representing
the excluded volume between the feet FA and FB. WSB is the specific binding potential:
WSB(rj) = −VSB e
−r2j
d2
b (G.2)
where rj is the separation between component j and its nearest specific binding site on
the track; db is the effective range of the specific binding interaction strength VSB.
WBE , the bending energy, fixes the angle θ0 between the two stiff bonds (legs), if VBE is
positive and sufficiently large:
WBE = −VBE cos2(θ − θ0) (G.3)
γ, the drag coefficient for each of the spheres is given by the Stokes-Einstein equation:
γ = 6piηr (G.4)
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where η is the viscosity of the solution, and r is the radius of the sphere.
ζ
(j)
i (t) is a random number from a zero-mean Gaussian distribution where〈
ζ
(j)
i (t)xζ
(j′)
i′ (t
′)
〉
= δii′δjj′δ(t− t′) (G.5)
For pulses where a ligand is absent, WSB(rj) is set to zero.
It is through the binding energy equation that the two simulated scenarios were created.
In scenario one, VBE is always 8000kT, so the angle is fixed, and θ0 is switched from 180
◦
to 80◦ at the start of the pulse which switches from θ0 = ψ to θ0 = φ. In scenario two, θ0
is kept at 180◦, but in the θ0 = ψ pulses, VBE is 8000kT, and in the θ0 = φ pulses, VBE
= 0, allowing θ0 to vary.
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Molecular Dynamics
H.1 Residue Stability Checks For End-to-end Separation
Measurements
The evolution of the separations shown in Figure 4.11b were checked for all simulation runs
to ensure that the residues chosen for the end-to-end separations remained part of their
respective coiled coils for the duration of the simulation. The same type of measurements
were taken for the residues chosen for vector angle calculations, shown in Figure 4.12c.
Figure H.2 shows the evolution of the separation between six pairs of residues for the initial
azobenzene-free system simulation. Four of those shown are those in Figure 4.11b. The
other two are quickly identifiable due to their possessing of structure dissimilar to noise.
Figure H.2a, upon comparison with Figure H.2b, demonstrates that Ile2 is the cause of
such structure, and not Lys20. Ile2 is a more extreme residue than Leu5 at the N-terminal
end of 2. Ideally, we would like to use residues close to the ends of the peptides, but Ile2
is clearly erratic. We wish to see the behaviour of the coiled coil as a whole, and Leu5 will
be more representative. It will give a slightly lower separation value than if Ile2 was used,
but the actual values of the separation are less important than the differences in separation
over time; the repressor feet are not included in these test systems, and their size will make
the differences here (of the order of a few A˚) insignificant in the final system. However,
the changes the system can undergo are important for our simulation studies. Figure H.2c
demonstrates another spectrum with structure, but Figure H.2d shows that this is due to
the inner residue, which was later seen to often form part of the erratic central region.
Any residue separations for which this structure was seen were investigated further: if
the outer residue was proven to be the cause of an irregular structure, the end-to-end
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separations were scrutinised to confirm that no unusual artifacts (such as in H.2a) were
seen. Generally, very few problems were found.
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Figure H.1: Evolution of the coiled coil measurements from Figure 4.11b for the cis-
azobenzene system. The same residues as the azobenzene-free system were initially chosen,
but Leu31 was found to be part of the uncoiling region of peptide 1, and so separations
using Glu27 as its replacement were taken in addition, to ensure system representative
behaviour was measured. It was found that the uncoiling had very little effect on the
measurements taken; as can be seen here, there is only one siginificant structure in the
Ile7-Leu31 separation, and it remains for only a small proportion of the simulation.
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Figure H.2: Evolution of the coiled coil measurements from Figure 4.11b for the
azobenzene-free system. The chosen residues show a variation of 2 - 3A˚ for a separa-
tion variation that in an ideal system would be zero. The initial choice of Ile2 at the
extreme of 2 was replaced by Leu5 due to Ile2’s movement independent of the rest of the
coiled coil (indicated in the Ile2-Lys20 separation shown here). The first choice of Asn24
as the inner residue with which to compare Ile3 was replaced by Glu21, due to the erratic
region shown in the Ile3-Asn24 separation, found to be due to Asn24 as opposed to the
extremely placed residue of interest.
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H.2 Vector-based Angle Calculations
The coordinates of two residues (a pair of a or d residues) at both extremities of each
of the two coiled coils (8 residues in total, Figure 4.12c, H.4a) were used to calculate
midpoints between the two peptides at each of the coiled-coil ends (red points shown in
Figure H.4b), and from these, two vectors representing the axes of the coiled coils were
constructed (Figure H.4c). The angle between two vectors, if they shared an origin, could
then be calculated using Equation H.1 (angle and vectors defined in Figure H.3), but this
lack of shared origin is the main issue with the trans system measurements. The closest
to a realistic angle determinable reasonably was calculated, by treating the vectors as if
they had a shared origin, but remaining in the true directions of their parent coiled coils
(Figure H.4d).
cosθ =
~ab · ~cd
|ab| |cd| (H.1)
ab
cd
Figure H.3: The angle between two vectors can be calculated using Equation H.1.
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(a) Four a and d pairs were chosen (b) Midpoints were calculated
(c) Vectors were constructed
(d) An angle was calculated for the vectors
with a shared origin
Figure H.4: Construction of vectors from residue co-ordinates, to use with Equation H.1.
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